This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other disorders starting during childhood or adolescence
KRA_PSY_CHILDOTH
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
2344 |
6. Filter based on genotype QC (FinnGen only) |
2185 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF12
- Parent code in ICD-10
- F90-F98
- Name in latin
- Aliae perturbationes modi se gerendi et emotionales usitate in pueritia sive adolescentia incipientes
Similar endpoints
↥List of similar endpoints to
Other disorders starting during childhood or adolescence
based on the number of shared cases.
Similar with more cases:
- Other disorders starting during childhood or adolecense, excluding more controls
- Any mental disorder
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2185 | 1347 | 838 |
| Unadjusted period prevalence (%) | 0.44 | 0.48 | 0.38 |
| Median age at first event (years) | 10.44 | 10.89 | 9.71 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2342
- Matched controls
- 23165
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
14.5
307.7
513
440
F98.9
ICD-10 Finland
Unspecified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
257.8
307.7
461
22
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
132.6
307.7
530
51
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
215.8
307.7
457
26
G04BD04
ATC
oxybutynin; oral, transdermal
15.7
307.7
312
225
F98.02
ICD-10 Finland
Non-organic nocturnal and diurnal enuresis
1400.8
263.5
253
*
F98.01
ICD-10 Finland
Non-organic diurnal enuresis
652.3
243.8
238
*
XKD00
NOMESCO Finland
Uroflowmetry
7.7
208.9
317
461
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
1994.9
204.3
196
*
R32
ICD-10 Finland
Unspecified urinary incontinence
17.3
195.7
165
101
N06BA04
ATC
methylphenidate; oral
4.3
185.6
586
1653
F98.0
ICD-10 Finland
Nonorganic enuresis
624.9
179.3
176
*
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.9
164.9
612
1925
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
137.5
744
2936
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
6.0
133.2
253
459
F98.5
ICD-10 Finland
Stuttering [stammering]
161.8
118.0
124
8
N05AH04
ATC
quetiapine; oral
2.7
99.4
708
3167
Z2445
NOMESCO Finland
Psychologist
3.5
98.6
384
1216
N05AX08
ATC
risperidone; systemic
3.9
96.0
315
888
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
3.8
82.8
280
803
XKC03
NOMESCO Finland
Water cystometry
9.1
78.4
98
111
ZY010
NOMESCO Finland
Hospital outpatient
3.1
78.4
372
1320
1530
FHL
Urethrocystoscopy
14.6
76.0
69
48
Z2446
NOMESCO Finland
Social worker
2.9
74.9
404
1539
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.5
73.7
616
2919
3076C
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[YÖ- JA PÄIVÄKASTELU]
+∞
70.9
68
*
F98.10
ICD-10 Finland
Non-organic encapsulation never normal control of intestinal function
+∞
70.9
68
*
N06AB03
ATC
fluoxetine; oral
2.9
70.1
392
1519
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.9
68.6
386
1500
N05AH03
ATC
olanzapine; systemic
3.2
68.3
301
1018
F98.19
ICD-10 Finland
Non-organic encopres UNS
181.0
68.1
71
*
Z3231
NOMESCO Finland
Registered nurse
2.2
67.0
795
4353
N05AX12
ATC
aripiprazole; systemic
3.3
66.0
282
936
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.1
65.9
303
1050
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.1
59.7
273
941
N06AX12
ATC
bupropion; oral
2.7
58.5
366
1495
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
3.4
57.4
225
706
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
3.0
57.3
273
963
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.3
56.7
233
753
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.9
56.4
294
1090
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.9
55.8
283
1033
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.9
54.6
171
462
N05AF03
ATC
chlorprothixene; systemic
5.7
52.2
100
181
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.9
51.7
266
977
N06AB06
ATC
sertraline; oral
2.3
50.9
461
2224
UKC02
NOMESCO Finland
Cystoscopy
3.4
50.6
194
599
N06AX16
ATC
venlafaxine; oral
2.4
50.5
426
1992
N05BA04
ATC
oxazepam; oral
2.2
50.4
564
2965
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
48.9
236
836
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.3
48.5
200
646
IGY99
NOMESCO Finland
Other psychiatric treatment contact
3.0
48.1
226
788
3076A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[YÖKASTELU]
+∞
47.9
46
*
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
47.8
419
1989
G04AC01, ,
ATC
6.4
47.7
80
127
N06AB04
ATC
citalopram; systemic
2.5
47.6
353
1555
N03AG01
ATC
valproic acid; systemic, rectal
3.1
47.5
209
702
ZYC01
NOMESCO Finland
Remote contact by phone
2.9
47.3
248
919
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.6
46.8
296
1208
Z3226
NOMESCO Finland
Physiotherapist
2.2
46.7
475
2396
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.7
46.7
279
1107
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.2
46.0
199
661
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.6
45.4
154
439
F84.5
ICD-10 Finland
Asperger syndrome
4.7
45.2
107
233
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.6
44.8
152
433
N06AX11
ATC
mirtazapine; oral
2.0
44.5
699
4132
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.2
44.0
183
594
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.5
43.7
161
484
3076B
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Enuresis[PÄIVÄKASTELU]
+∞
43.7
42
*
J01XE01
ATC
nitrofurantoin; oral
7.6
43.2
62
83
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.9
42.0
210
757
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
41.8
213
776
IGV01
NOMESCO Finland
Psychiatric network contact
3.6
41.5
140
397
N03AX09
ATC
lamotrigine; oral
2.8
41.4
231
883
N06AX21
ATC
duloxetine; oral
2.6
40.8
263
1081
XA800
NOMESCO Finland
Neuropsychological investigation
2.9
40.2
199
713
331
Kela drug reimbursment
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
3.3
39.8
156
488
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
39.7
193
685
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.7
39.5
128
353
3077A
ICD-9 Finland
Special symptoms or syndromes not elsewhere classified, Encopresis
+∞
38.5
37
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.8
38.2
211
802
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.4
37.8
145
447
Z2221
NOMESCO Finland
Medical doctor
1.9
37.4
631
3782
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.7
36.9
123
346
K59.09
ICD-10 Finland
Constipation, unspecified
3.1
36.8
165
559
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.8
36.5
189
694
N05AH02
ATC
clozapine; systemic
4.3
36.1
94
221
P99
ICPC
Psychological disorders other
3.1
36.0
160
539
R5599
NOMESCO Finland
Other rehabilitation service
3.8
35.4
112
304
N39.4
ICD-10 Finland
Other specified urinary incontinence
4.0
35.3
103
264
N03AX16
ATC
[U] pregabalin
2.3
35.0
287
1313
N06AB10
ATC
escitalopram; oral
1.8
34.7
657
4070
F90.8
ICD-10 Finland
Other hyperkinetic disorders
9.6
34.6
41
43
N05BA01
ATC
diazepam; systemic, rectal
2.5
34.3
237
1004
P29
ICPC
Psychological sympt/compl other
2.0
34.3
444
2426
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.9
33.9
592
3571
N06AX26
ATC
vortioxetine; oral
2.2
33.8
315
1519
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
33.7
612
3737
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.9
33.5
166
594
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.8
33.2
104
280
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
1.9
32.7
523
3065
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.6
32.2
199
799
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
32.1
973
6853
XKD06
NOMESCO Finland
Physiologic investigation of micturition
6.4
32.0
53
83
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
31.8
408
2218
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
31.7
156
556
A06AD11
ATC
lactulose; oral
2.6
31.5
190
753
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
2.6
31.4
196
790
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
2.7
31.3
185
726
N06AB05
ATC
paroxetine; oral
3.2
31.0
130
423
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
3.0
31.0
143
492
N06BA12
ATC
lisdexamfetamine; oral
3.1
30.8
132
435
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
3.6
30.7
104
296
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.4
30.3
113
342
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.4
29.6
224
987
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.9
29.2
403
2240
F88
ICD-10 Finland
Other disorders of psychological development
5.9
29.2
53
91
R62.0
ICD-10 Finland
Delayed milestone
3.2
29.2
120
386
F83
ICD-10 Finland
Mixed specific developmental disorders
3.2
28.9
121
393
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
2.6
28.6
179
723
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.4
28.4
105
316
F43.1
ICD-10 Finland
Post-traumatic stress disorder
2.6
28.2
171
679
IGP01
NOMESCO Finland
Psychiatric family contact
2.9
28.2
139
496
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
4.1
28.1
79
197
C07AA05
ATC
propranolol; systemic
1.8
27.3
503
3060
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
5.1
27.2
57
112
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
3.6
26.8
91
259
IEV99
NOMESCO Finland
Other psychiatric network intervention
3.5
26.5
91
261
N05BE01
ATC
buspirone; oral
3.8
26.5
83
224
F50.9
ICD-10 Finland
Eating disorder, unspecified
3.2
26.4
107
341
R4110
NOMESCO Finland
Physiotherapy
1.8
26.4
523
3245
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
26.4
688
4603
602
Kela drug reimbursment
Children's severe malnutrition
3.6
26.2
87
244
IGY02, ,
SPAT
3.5
25.9
91
265
ZXE00
NOMESCO Finland
One hour or less
1.6
25.9
818
5742
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.2
25.9
244
1178
R15
ICD-10 Finland
Faecal incontinence
6.1
25.5
44
72
SPAT1240
SPAT
Therapeutic discussion
1.8
25.2
438
2610
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
25.2
675
4538
F40.1
ICD-10 Finland
Social phobias
2.4
25.0
184
800
N05AN01
ATC
lithium; oral
3.5
24.8
88
258
F98
ICD-10 Finland
Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence
69.9
24.7
28
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
4.0
24.6
70
176
F60.9
ICD-10 Finland
Personality disorder, unspecified
4.2
24.6
65
155
N06BA09
ATC
atomoxetine; oral
4.3
24.5
63
147
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
2.8
24.3
123
445
N05AA02
ATC
levomepromazine; systemic
3.4
24.2
89
267
F82
ICD-10 Finland
Specific developmental disorder of motor function
3.4
24.1
87
258
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.9
24.0
324
1781
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
23.9
251
1262
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.0
23.6
261
1337
J01EA01
ATC
trimethoprim; systemic
1.8
23.6
458
2815
F98.1
ICD-10 Finland
Nonorganic encopresis
239.7
23.6
24
*
F91.9
ICD-10 Finland
Conduct disorder, unspecified
6.6
23.1
37
56
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
4.6
23.0
55
121
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.9
23.0
114
408
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
23.0
226
1108
N05CF01
ATC
zopiclone; oral
1.9
22.9
354
2030
U04
ICPC
Incontinence urine
3.6
22.8
77
219
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
2.9
22.7
106
367
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.1
22.7
237
1189
N03AE01
ATC
clonazepam; systemic
3.2
22.6
92
294
SPAT1389
SPAT
Visit based on need for special support
2.0
22.5
279
1489
K59.0
ICD-10 Finland
Constipation
2.5
22.3
146
602
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
22.2
449
2787
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
22.2
537
3499
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
3.0
22.1
101
346
ICB06, ,
NOMESCO Finland
3.2
21.5
85
267
Z63.5
ICD-10 Finland
Disruption of family by separation and divorce
4.7
21.4
49
104
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
21.4
376
2241
N05AB03
ATC
perphenazine; systemic, rectal
3.4
21.3
78
234
R68.88
ICD-10 Finland
Other specified general symptoms and signs, not elsewhere classified.
4.3
21.2
55
129
R11
ICD-10 Finland
Nausea and vomiting
1.9
21.2
298
1656
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.8
21.2
397
2409
SPAT1307
SPAT
Psychosocial counselling and guidance
1.8
21.1
386
2326
P72
ICPC
Schizophrenia
3.9
21.1
62
160
F20.9
ICD-10 Finland
Schizophrenia, unspecified
3.8
21.0
65
174
N04AA02
ATC
biperiden; systemic
4.8
21.0
47
98
A01
ICPC
Pain general/multiple sites
2.1
21.0
214
1063
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
20.7
431
2691
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
20.7
195
939
P76
ICPC
Depressive disorder
1.9
20.7
286
1581
U02
ICPC
Urinary frequency/urgency
1.8
20.6
338
1971
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.5
20.5
132
539
F92.8
ICD-10 Finland
Other mixed disorders of conduct and emotions
5.3
20.3
41
78
IER01
NOMESCO Finland
Psychoeducation, group
3.4
20.3
75
226
P01
ICPC
Feeling anxious/nervous/tense
1.6
20.2
749
5387
R51.80
ICD-10 Finland
Headache
1.6
20.1
503
3295
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.3
20.0
76
233
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
19.8
427
2689
F84.8
ICD-10 Finland
Other pervasive developmental disorders
4.8
19.8
45
95
Z07
ICPC
Education problem
2.8
19.7
98
352
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
3.4
19.6
72
216
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
19.6
1806
15705
N05AD01
ATC
haloperidol; systemic
4.1
19.4
54
134
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.1
19.3
189
923
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
3.5
19.3
67
194
P74
ICPC
Anxiety disorder/anxiety state
1.9
19.3
256
1395
E66.8
ICD-10 Finland
Other obesity
2.4
19.2
132
556
F80.2
ICD-10 Finland
Receptive language disorder
3.4
19.1
69
205
N05BA06
ATC
lorazepam; systemic, sublingual
3.3
19.1
72
220
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.0
18.9
53
132
P12
ICPC
Bedwetting/enuresis
6.5
18.9
31
48
N05CD07
ATC
temazepam; oral
3.5
18.9
66
192
XA820, ,
NOMESCO Finland
6.0
18.8
33
55
IEY01
NOMESCO Finland
Psychoeducation, individual
3.5
18.7
63
179
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.7
18.7
104
396
R4120
NOMESCO Finland
Occupational therapy
2.2
18.5
154
705
C07AB07
ATC
bisoprolol; oral
1.7
18.5
373
2305
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
3.8
18.4
55
144
IEP03
NOMESCO Finland
Focused parental counselling
3.1
18.3
76
246
F92.0
ICD-10 Finland
Depressive conduct disorder
4.4
18.2
45
102
F61.0
ICD-10 Finland
Mixed personality disorders
3.6
18.1
61
173
N03AX12
ATC
[U] gabapentin; oral
2.1
18.1
182
898
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
4.1
18.0
50
124
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
18.0
605
4239
F90.1
ICD-10 Finland
Hyperkinetic conduct disorder
7.1
18.0
27
38
R35
ICD-10 Finland
Polyuria
2.7
17.9
100
381
F41.1
ICD-10 Finland
Generalized anxiety disorder
1.8
17.9
280
1606
F39
ICD-10 Finland
Unspecified mood [affective] disorder
2.6
17.9
102
393
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.5
17.8
62
180
ZXA10
NOMESCO Finland
Bilateral
1.8
17.6
318
1903
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
3.3
17.6
65
196
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
3.6
17.5
57
158
RS210, ,
NOMESCO Finland
5.3
17.5
35
66
F34.1
ICD-10 Finland
Dysthymia
2.5
17.5
111
451
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
3.2
17.5
69
217
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
17.5
437
2853
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.8
17.4
52
136
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
17.4
1880
16649
R4190
NOMESCO Finland
Nutritional therapy
2.0
17.3
207
1087
P03
ICPC
Feeling depressed
1.6
17.3
501
3388
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
17.2
900
6898
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
3.9
17.2
50
128
M79.7
ICD-10 Finland
Fibromyalgia
3.0
17.2
75
250
SPAT1229
SPAT
Assessment of need for aid
3.2
17.2
68
214
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.9
17.2
213
1133
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
17.2
130
572
H01AC01
ATC
somatropin; parenteral
3.2
16.9
67
211
F81.0
ICD-10 Finland
Specific reading disorder
3.3
16.9
63
191
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
2.3
16.8
130
577
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
4.6
16.8
40
88
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
16.8
293
1736
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
16.7
141
649
D01
ICPC
Abdominal pain/cramps general
1.6
16.7
474
3187
IEP99
NOMESCO Finland
Other psychiatric family intervention
3.0
16.6
74
250
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.8
16.5
84
306
IBB01
NOMESCO Finland
Psychiatric functioning capacity evaluation
4.5
16.3
40
90
WX002
NOMESCO Finland
Sedation and analgesia
1.8
16.3
249
1418
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.9
16.1
78
276
S18
ICPC
Laceration/cut
1.5
16.0
803
6085
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
2.7
15.9
83
306
F89
ICD-10 Finland
Unspecified disorder of psychological development
4.7
15.9
36
76
L28
ICPC
Limited function/disability (L)
1.9
15.8
200
1070
Z49.1
ICD-10 Finland
Extracorporeal dialysis
6.0
15.8
28
47
C03CA01
ATC
furosemide; systemic
2.1
15.8
148
711
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
15.8
276
1634
SFA30
NOMESCO Finland
Three-surface restoration
1.5
15.8
625
4515
T82
ICPC
Obesity
2.3
15.8
119
523
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
2.2
15.8
137
639
F80.1
ICD-10 Finland
Expressive language disorder
2.8
15.7
79
286
G04BD07
ATC
tolterodine; oral
4.4
15.6
39
89
R53
ICD-10 Finland
Malaise and fatigue
1.5
15.6
571
4055
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
15.6
636
4622
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
3.8
15.6
47
124
G47.3
ICD-10 Finland
Sleep apnoea
1.8
15.6
244
1399
P06
ICPC
Sleep disturbance
1.7
15.5
350
2221
U07
ICPC
Urine symptom/complaint other
2.1
15.5
156
771
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.0
15.5
67
223
N18.8
ICD-10 Finland
Other chronic renal failure
4.6
15.4
36
78
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
5.6
15.3
29
52
RD210, ,
NOMESCO Finland
2.4
15.3
109
467
B03XA01
ATC
erythropoietin; parenteral
6.2
15.3
26
42
G04BD12
ATC
mirabegron; oral
2.7
15.1
80
297
A03FA02
ATC
cisapride; oral, rectal
2.4
15.1
105
445
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.8
15.1
76
275
R50.9
ICD-10 Finland
Fever, unspecified
1.6
15.1
436
2938
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
15.0
374
2431
Z61.8
ICD-10 Finland
Other negative life events in childhood
4.5
14.9
36
80
R03AC02
ATC
salbutamol; inhalant
1.4
14.9
1236
10222
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
1.8
14.9
235
1350
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
14.8
182
964
J01MA12
ATC
levofloxacin; systemic
2.0
14.8
172
894
N06AX22
ATC
agomelatine; oral
2.6
14.8
87
341
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
3.2
14.8
59
187
D11
ICPC
Diarrhoea
1.6
14.8
403
2677
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.8
14.8
44
115
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.9
14.8
32
65
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.7
14.7
27
47
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
5.9
14.6
26
44
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.8
14.6
213
1195
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
2.2
14.5
126
587
F50.1
ICD-10 Finland
Atypical anorexia nervosa
3.5
14.5
49
140
R39.1
ICD-10 Finland
Other difficulties with micturition
3.5
14.5
49
140
N07BA03
ATC
varenicline; oral
2.6
14.4
83
322
P27
ICPC
Fear of mental disorder
2.7
14.4
77
288
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
2.9
14.4
68
238
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
2.9
14.4
68
238
ZY000
NOMESCO Finland
Hospital inpatient
2.8
14.4
72
260
IAB01, ,
SPAT
5.1
14.4
30
59
TK800
NOMESCO Finland
Hemodialysis
4.3
14.3
37
87
JDB10
NOMESCO Finland
Percutaneous gastrostomy
4.9
14.3
31
63
F31
ICD-10 Finland
Bipolar affective disorder
3.4
14.3
50
146
Z63.8
ICD-10 Finland
Other specified problems related to primary support group
4.3
14.3
36
83
UJF32
NOMESCO Finland
Coloscopy
1.7
14.3
253
1503
L04AD02
ATC
tacrolimus; systemic
3.5
14.2
49
142
Q62.7
ICD-10 Finland
Congenital vesico-uretero-renal reflux
4.8
14.0
31
64
N06AB08
ATC
fluvoxamine; oral
4.7
14.0
32
68
IEP02
NOMESCO Finland
Child-centred family therapy
2.8
14.0
69
247
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
2.1
14.0
139
683
127
Kela drug reimbursment
Transplant complication
3.2
14.0
55
173
N06AX03
ATC
mianserin; oral
3.0
14.0
60
199
N05BA12
ATC
alprazolam; oral
2.1
13.9
126
597
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
13.9
353
2303
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
13.9
288
1786
F50.8
ICD-10 Finland
Other eating disorders
4.0
13.8
39
98
ZXD05
NOMESCO Finland
Urgent procedure
1.5
13.8
542
3892
Z72.8
ICD-10 Finland
Other problems related to lifestyle
4.3
13.8
35
81
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.5
13.8
86
347
R03BA02
ATC
budesonide; inhalant
1.6
13.8
387
2586
D10
ICPC
Vomiting
1.6
13.7
313
1989
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
4.2
13.7
36
86
R33
ICD-10 Finland
Retention of urine
2.9
13.6
63
218
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
13.5
444
3070
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
3.5
13.5
46
132
F98.6
ICD-10 Finland
Cluttering
+∞
13.5
13
*
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
2.8
13.4
68
247
P19
ICPC
Drug abuse
2.9
13.4
63
220
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
13.4
427
2935
F93.1
ICD-10 Finland
Phobic anxiety disorder of childhood
4.9
13.4
29
59
A12AA04
ATC
calcium carbonate; oral
4.3
13.4
34
79
ZXY61
NOMESCO Finland
2-person team, special workers
5.4
13.3
26
48
SPAT1234
SPAT
Support of social functional capacity
2.5
13.3
81
323
R4140
NOMESCO Finland
Psychotherapy
4.0
13.3
37
92
A28
ICPC
Limited function/disability NOS
2.0
13.3
150
772
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
3.3
13.3
49
148
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
3.0
13.3
57
189
F41.00
ICD-10 Finland
Moderate panic disorder
2.6
13.2
74
284
P23
ICPC
Adolescent behaviour sympt/compl
2.7
13.1
68
250
N30.0
ICD-10 Finland
Acute cystitis
1.6
13.1
390
2638
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
2.3
13.0
94
406
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.7
12.9
266
1646
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
2.1
12.9
119
569
IDP99
NOMESCO Finland
Other psychotherapeutic family intervention
5.9
12.9
23
39
F50.2
ICD-10 Finland
Bulimia nervosa
3.5
12.9
43
122
F41.8
ICD-10 Finland
Other specified anxiety disorders
1.9
12.8
159
846
Z94.0
ICD-10 Finland
Kidney transplant status
3.6
12.8
41
113
SPAT1243
SPAT
Psychiatric/psychological examination
2.0
12.8
142
727
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
12.8
1015
8254
ICC01
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric outpatient clinic
3.2
12.8
49
152
RS140, ,
NOMESCO Finland
4.1
12.7
34
82
ZXA00
NOMESCO Finland
Right side
1.7
12.7
270
1683
P80
ICPC
Personality disorder
5.0
12.7
27
54
F95.2
ICD-10 Finland
Combined vocal and multiple motor tic disorder [de la Tourette]
5.0
12.7
27
54
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.8
12.7
38
100
R03BA05
ATC
fluticasone; inhalant
1.5
12.7
466
3297
J01DA01
ATC
[U] cefalexin
1.4
12.6
995
8078
TKC20
NOMESCO Finland
Catheterisation of bladder
2.6
12.6
72
279
N05CF02
ATC
zolpidem; oral
1.7
12.5
216
1274
P86
ICPC
Anorexia nervosa/bulimia
3.7
12.4
39
106
ICB03, ,
SPAT
4.6
12.4
29
63
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.3
12.4
97
434
A02BC02
ATC
pantoprazole; systemic
1.4
12.4
910
7295
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
3.2
12.4
48
150
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
3.3
12.4
47
145
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
12.3
232
1400
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
3.7
12.3
38
102
WX290
NOMESCO Finland
Other blockage of nerve
1.4
12.3
1339
11423
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
2.8
12.3
62
225
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
12.3
366
2475
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
3.2
12.2
49
156
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
3.4
12.2
44
131
SFC01
NOMESCO Finland
Additional procedure necessary for restorative treatment
1.5
12.1
432
3033
K02.1
ICD-10 Finland
Caries of dentine
1.4
12.1
1553
13586
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.2
12.1
97
438
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.1
12.1
112
536
R63.8
ICD-10 Finland
Other symptoms and signs concerning food and fluid intake
5.8
12.1
22
38
A97
ICPC
No disease
1.4
12.1
576
4281
L04AA06
ATC
mycophenolic acid; systemic
3.0
12.1
52
173
F59
ICD-10 Finland
Unspecified behavioural syndromes associated with physiological disturbances and physical factors
4.3
12.0
30
69
IHZ07, ,
SPAT
4.5
11.9
29
65
A11CC03
ATC
alfacalcidol; systemic
3.0
11.9
51
169
WX882
NOMESCO Finland
High dependency care
2.0
11.9
127
641
N06AX05
ATC
trazodone; oral
3.0
11.9
53
180
IEP04
NOMESCO Finland
Focused parenting intervention
4.1
11.8
32
78
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.9
11.8
150
804
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.3
11.8
90
398
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.5
11.8
489
3536
F98.12
ICD-10 Finland
Non-organic encopres with very loose stools
46.4
11.8
14
*
N06AA09
ATC
amitriptyline; systemic
2.7
11.8
63
236
N05AX13
ATC
paliperidone; systemic
4.3
11.7
30
70
K06.18
ICD-10 Finland
Another gingival hyperplasia
4.5
11.7
28
62
5901A
ICD-9 Finland
Infections of kidney, Acute pyelonephritis
4.6
11.7
27
58
J01MA02
ATC
ciprofloxacin; systemic
1.5
11.7
433
3063
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.4
11.6
78
327
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
3.6
11.6
37
102
R42
ICD-10 Finland
Dizziness and giddiness
1.6
11.5
310
2045
IFA01, ,
SPAT
4.9
11.5
25
51
J01CA08
ATC
pivmecillinam; oral
1.4
11.5
743
5815
L17
ICPC
Foot/toe symptom/complaint
1.4
11.5
646
4938
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.5
11.5
381
2635
R2110
NOMESCO Finland
Giving the first information
2.0
11.4
118
590
IHZ04, ,
SPAT
2.3
11.4
87
386
A29
ICPC
General symptom/complaint other
1.6
11.3
250
1572
R52.9
ICD-10 Finland
Pain, unspecified
1.7
11.3
204
1218
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
4.4
11.3
28
64
R4130
NOMESCO Finland
Speech therapy
2.4
11.2
74
307
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
11.2
157
870
R06.0
ICD-10 Finland
Dyspnoea
1.5
11.2
377
2615
D06
ICPC
Abdominal pain localized other
1.6
11.1
261
1667
ZXY81
NOMESCO Finland
Psychologist in multidisciplinary team
3.7
11.1
34
91
ICB01, ,
SPAT
3.0
11.1
47
155
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
11.1
266
1709
E66.9
ICD-10 Finland
Obesity, unspecified
2.2
11.1
93
429
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
11.0
547
4084
F41.09
ICD-10 Finland
UNS Panic Syndrome
2.0
11.0
122
624
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
3.4
11.0
39
115
Z35.7
ICD-10 Finland
Supervision of high-risk pregnancy due to social problems
4.4
11.0
27
61
TKC22
NOMESCO Finland
Catheterisation instruction
4.6
11.0
26
57
U01
ICPC
Dysuria/painful urination
1.7
11.0
214
1303
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.9
11.0
143
774
M54.5
ICD-10 Finland
Low back pain
1.4
10.9
662
5115
H02AB09
ATC
hydrocortisone; systemic
2.2
10.9
89
405
5640A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Constipation
13.8
10.9
18
13
A02BC01
ATC
omeprazole; systemic
1.5
10.9
372
2586
D09
ICPC
Nausea
1.6
10.8
260
1669
F91.3
ICD-10 Finland
Oppositional defiant disorder
5.7
10.8
20
35
N17
ICPC
Vertigo/dizziness
1.6
10.8
242
1527
K06.19
ICD-10 Finland
Gingival hyperplasia UNS
4.3
10.8
27
62
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
4.5
10.8
26
58
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
4.5
10.8
26
58
ZX199
NOMESCO Finland
Other rote
4.5
10.8
26
58
WX402
NOMESCO Finland
General anaesthesia
1.4
10.8
462
3358
N39.3
ICD-10 Finland
Stress incontinence
2.6
10.7
61
236
K03.66
ICD-10 Finland
Tooth plaque
1.6
10.7
279
1826
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
2.4
10.6
75
321
RS214, ,
NOMESCO Finland
4.2
10.6
28
67
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
3.2
10.6
41
128
TFC99
NOMESCO Finland
Catheterisation of heart with other procedure
3.6
10.6
34
94
IBZ06
NOMESCO Finland
Evaluation concerning developmental neuropsychiatry
2.6
10.6
60
232
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
10.5
356
2467
A04
ICPC
Weakness/tiredness general
1.4
10.5
471
3449
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.3
10.5
1102
9257
R1260
NOMESCO Finland
Evaluation of communicative skills
3.2
10.5
41
129
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
3.2
10.5
40
124
IEP01
NOMESCO Finland
Psychoeducation, family
3.3
10.5
39
119
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
3.8
10.5
31
81
K03.00
ICD-10 Finland
Approximal wear
1.7
10.4
189
1128
RL140, ,
NOMESCO Finland
3.5
10.4
35
100
IER03
NOMESCO Finland
Psychiatric disorder-specific group intervention
3.9
10.4
30
77
TJF80
NOMESCO Finland
Ostomy education
4.2
10.4
27
64
F98.11
ICD-10 Finland
Non-organic encopres leave feces in inappropriate places
+∞
10.4
10
*
RT160, ,
NOMESCO Finland
3.6
10.3
33
91
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.9
10.3
47
162
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
10.3
122
640
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
2.8
10.3
49
173
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
5.4
10.2
20
37
A03
ICPC
Fever
1.4
10.2
684
5361
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
3.2
10.2
39
121
U05
ICPC
Urination problems other
2.4
10.2
68
284
G04BD08
ATC
solifenacin; oral
2.9
10.2
47
163
IEV99, ,
SPAT
5.1
10.2
21
41
N05AE05
ATC
lurasidone; oral
3.9
10.1
29
74
N02AX02
ATC
tramadol; systemic, rectal
1.4
10.1
456
3341
ZXD20
NOMESCO Finland
Day surgery
1.7
10.1
199
1215
K04.0
ICD-10 Finland
Pulpitis
1.6
10.1
218
1363
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
10.1
152
861
F21
ICD-10 Finland
Schizotypal disorder
4.5
10.1
24
53
Z08
ICPC
Social welfare problem
3.2
10.1
39
122
AA400
NOMESCO Finland
Electroconvulsive therapy
4.0
10.1
28
70
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.5
10.0
63
256
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.4
10.0
498
3714
D12
ICPC
Constipation
2.3
10.0
74
324
P28
ICPC
Limited function/disability (P)
3.5
10.0
34
98
WX730
NOMESCO Finland
Conventional respirator
3.5
10.0
34
98
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.7
10.0
170
998
ZXE21
NOMESCO Finland
Procedure duration at least 3 but less than 4 hours
3.2
9.9
38
118
SGA01
NOMESCO Finland
Emergency treatment
1.5
9.9
354
2479
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
5.0
9.9
21
42
N01
ICPC
Headache
1.4
9.8
627
4872
E34.35
ICD-10 Finland
Abnormal growth retardation
2.5
9.8
60
241
P24
ICPC
Specific learning problem
2.2
9.8
84
391
T90
ICPC
Diabetes non-insulin dependent
1.8
9.8
138
766
C07AB02
ATC
metoprolol; systemic
1.9
9.8
133
730
RS220, ,
NOMESCO Finland
2.7
9.8
52
195
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.5
9.7
301
2046
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
3.0
9.7
41
135
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
9.7
1066
8977
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
9.7
211
1322
J01DB01
ATC
cefalexin; oral
1.4
9.6
1738
15705
Z04.6
ICD-10 Finland
General psychiatric examination, requested by authority
4.9
9.6
21
43
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
4.5
9.6
23
51
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
4.0
9.6
27
68
A02BA02
ATC
ranitidine; systemic
1.9
9.6
117
620
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.4
9.6
65
274
F42.2
ICD-10 Finland
Mixed obsessional thoughts and acts
2.4
9.6
62
256
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.7
9.5
179
1079
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.0
9.5
42
142
P11
ICPC
Eating problem in child
3.7
9.5
30
82
-60
ICPC
Result test/procedure
2.1
9.5
92
449
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.4
9.5
65
275
R74
ICPC
Upper respiratory infection acute
1.3
9.5
1155
9855
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
3.6
9.5
31
87
R5110, ,
SPAT
2.3
9.5
72
319
A05
ICPC
Feeling ill
1.5
9.5
381
2731
F81.1
ICD-10 Finland
Specific spelling disorder
5.0
9.4
20
40
R96
ICPC
Asthma
1.7
9.4
181
1099
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
4.4
9.4
23
52
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
2.7
9.4
49
182
Z71.8
ICD-10 Finland
Other specified counselling
1.3
9.4
866
7108
F98.40
ICD-10 Finland
Movement stereotypes do not hurt themselves
+∞
9.3
9
*
TKC50
NOMESCO Finland
Training of urinary bladder
17.4
9.3
14
8
SFA20
NOMESCO Finland
Two-surface restoration
1.3
9.3
1260
10894
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.0
9.3
93
459
N03AF02
ATC
oxcarbazepine; oral
2.1
9.3
87
419
N06AG02
ATC
moclobemide; oral
2.7
9.3
48
177
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.8
9.3
138
778
ZXY60
NOMESCO Finland
2-person team, nurses
3.1
9.3
38
123
ZXA05
NOMESCO Finland
Left side
1.6
9.3
238
1551
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
9.3
126
691
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.5
9.3
344
2426
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.1
9.3
81
380
N07BB01
ATC
disulfiram; oral
2.4
9.3
64
272
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
2.7
9.3
47
172
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
9.2
521
3963
S80.0
ICD-10 Finland
Contusion of knee
1.6
9.2
195
1213
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
2.4
9.2
63
267
N05AE04
ATC
ziprasidone; systemic
3.7
9.2
28
75
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
9.1
215
1374
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
2.6
9.1
52
202
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
1.7
9.1
166
993
F50.0
ICD-10 Finland
Anorexia nervosa
2.6
9.1
53
208
L03
ICPC
Low back symptom/complaint
1.4
9.1
614
4806
Z50.5
ICD-10 Finland
Speech therapy
2.1
9.1
82
390
H50.31
ICD-10 Finland
Intermittent exotropia
2.5
9.1
57
232
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.9
9.1
113
603
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
3.1
9.0
37
120
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
9.0
179
1096
H02AB04
ATC
methylprednisolone; systemic
1.7
9.0
151
883
R02
ICPC
Shortness of breath/dyspnoea
1.6
9.0
242
1595
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
1.6
9.0
215
1379
SFA10
NOMESCO Finland
One-surface restoration
1.3
9.0
1375
12066
N03AX11
ATC
topiramate; oral
2.2
8.9
71
321
A10BA02
ATC
metformin; oral
1.6
8.9
202
1279
ZXY03
NOMESCO Finland
Occupational therapist
4.0
8.9
25
63
X84
ICD-10 Finland
Intentional self-harm by unspecified means
4.0
8.9
25
63
S29
ICPC
Skin symptom/complaint other
1.4
8.8
437
3248
SPAT1281
SPAT
Other administrative function
1.6
8.8
191
1195
F43.20
ICD-10 Finland
Adaptation disorder with short-term depression
3.0
8.8
38
127
WX892
NOMESCO Finland
Monitored bed care
1.8
8.8
127
710
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
8.8
143
829
A99
ICPC
Disease/condition unspecnature/site
1.6
8.8
208
1331
AA1AD
NOMESCO Finland
CT of head and brain
1.5
8.8
262
1767
ZXY02
NOMESCO Finland
Neuropsychologist
4.2
8.8
23
55
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.1
8.8
76
356
T78.4
ICD-10 Finland
Allergy, unspecified
1.8
8.7
142
824
F28
ICD-10 Finland
Other nonorganic psychotic disorders
4.5
8.7
21
47
E66.00
ICD-10 Finland
Metabolic syndrome
2.3
8.7
62
268
R60.9
ICD-10 Finland
Oedema, unspecified
2.3
8.7
61
262
C09AA02
ATC
enalapril; systemic
1.9
8.6
102
535
137
Kela drug reimbursment
Uraemia requiring dialysis
4.0
8.6
24
60
XF602
NOMESCO Finland
Bloodpressure monitoring
3.1
8.6
35
113
F50.3
ICD-10 Finland
Atypical bulimia nervosa
3.4
8.6
30
88
Z00.0
ICD-10 Finland
General medical examination
1.4
8.6
459
3456
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.1
8.6
23
56
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
8.6
60
257
N06AA06
ATC
trimipramine; systemic
3.5
8.5
28
79
K52.2
ICD-10 Finland
Allergic and dietetic gastroenteritis and colitis
2.2
8.5
72
334
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.8
8.5
127
718
H03AA01
ATC
levothyroxine sodium; systemic
1.5
8.5
275
1886
N05AX15
ATC
cariprazine; oral
3.4
8.5
29
84
5990C
ICD-9 Finland
Other disorders of urethra and urinary tract, Urinary tract infection, site not specified[INFECTIO VIARUM URINARIUM RECIDIVANS]
10.0
8.5
16
16
H01
ICPC
Ear pain/earache
1.4
8.5
456
3438
U08
ICPC
Urinary retention
4.7
8.5
19
40
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
4.5
8.5
20
44
F41.3
ICD-10 Finland
Other mixed anxiety disorders
2.0
8.4
85
422
WW200
NOMESCO Finland
Immunization
2.3
8.4
60
259
SPAT1254
SPAT
Administration of medicine
1.4
8.4
434
3247
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
8.4
95
491
WX704
NOMESCO Finland
Intubation
1.8
8.4
128
728
RT420, ,
NOMESCO Finland
4.0
8.4
23
57
F95.9
ICD-10 Finland
Tic disorder, unspecified
4.0
8.4
23
57
T74.1
ICD-10 Finland
Physical abuse
2.1
8.4
75
356
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
8.4
161
978
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
8.3
267
1827
R78
ICPC
Acute bronchitis/bronchiolitis
2.9
8.3
37
126
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
1.3
8.3
722
5849
C08CA02
ATC
felodipine; oral
2.7
8.3
44
165
OAB43, ,
SPAT
0.8
8.3
711
8446
A08
ICPC
Swelling
2.3
8.3
59
255
F60.5
ICD-10 Finland
Anankastic personality disorder
2.9
8.3
38
132
G04BD11
ATC
fesoterodine; oral
4.8
8.2
18
37
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
3.4
8.2
28
81
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
8.2
314
2226
C08CA01
ATC
amlodipine; oral
1.6
8.2
184
1162
U13
ICPC
Bladder symptom/complaint other
2.4
8.2
52
213
F54
ICD-10 Finland
Psychological and behavioural factors associated with disorders or diseases classified elsewhere
3.2
8.2
32
101
T83
ICPC
Overweight
2.2
8.2
65
294
GAE10
NOMESCO Finland
Closure of previous incision of chest wall
4.0
8.2
23
58
ZXY49
NOMESCO Finland
Other health care provider
3.3
8.2
30
91
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
7.0
8.2
19
27
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.8
8.2
131
757
M79.6
ICD-10 Finland
Pain in limb
1.3
8.1
755
6174
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.6
8.1
179
1127
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
2.9
8.1
36
123
EB1VA, ,
NOMESCO Finland
1.5
8.0
312
2218
F84.10
ICD-10 Finland
Autism in atypical age
33.1
8.0
10
*
3004A
ICD-9 Finland
Neurotic disorders, Neurotic depression
33.1
8.0
10
*
N02BF01
ATC
gabapentin; oral
1.8
8.0
118
665
WZC00
NOMESCO Finland
Treatment plan or consultation
1.3
8.0
920
7732
W0A10
NOMESCO Finland
Mapping of psychosocial situation
4.5
8.0
19
42
ZXY58
NOMESCO Finland
2-person team, nurse-occupational therapist
4.5
8.0
19
42
Z93.1
ICD-10 Finland
Gastrostomy status
8.8
8.0
16
18
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.2
7.9
31
98
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
3.2
7.9
30
93
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
1.9
7.9
96
509
IHZ29, ,
SPAT
7.2
7.9
18
25
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
7.9
244
1658
UGC02
NOMESCO Finland
Rigid bronchoscopy
3.6
7.9
25
69
SPAT1097
SPAT
Recording of ECG
1.8
7.9
119
676
IEY17, ,
SPAT
12.9
7.8
13
10
J46
ICD-10 Finland
Status asthmaticus
2.5
7.8
46
182
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
7.8
229
1538
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.1
7.8
31
99
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.5
7.8
267
1852
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
7.8
158
973
A11
ICPC
Chest pain NOS
1.8
7.8
106
583
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
3.2
7.8
30
94
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.4
7.8
377
2789
SPAT1216
SPAT
Assessment of functional ability
1.7
7.8
156
959
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
2.1
7.7
73
354
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.6
7.7
204
1339
F91.0
ICD-10 Finland
Conduct disorder confined to the family context
6.9
7.7
18
26
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
1.6
7.7
195
1268
L04AA01
ATC
[U] ciclosporin
3.8
7.7
23
61
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.3
7.7
701
5709
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.0
7.7
75
369
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.6
867
7263
H52.0
ICD-10 Finland
Hypermetropia
2.0
7.6
83
424
101
Kela drug reimbursment
Anterior pituitary hypofunction
2.7
7.6
39
144
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.4
7.6
319
2300
U06
ICPC
Haematuria
2.9
7.6
35
122
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
7.6
530
4156
N30.2
ICD-10 Finland
Other chronic cystitis
4.3
7.6
19
44
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
7.5
1190
10378
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
7.5
255
1765
RT250, ,
NOMESCO Finland
4.5
7.5
18
40
F34.0
ICD-10 Finland
Cyclothymia
4.5
7.5
18
40
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
3.2
7.5
29
91
Z99.2
ICD-10 Finland
Dependence on renal dialysis
6.6
7.5
18
27
N03AF01
ATC
carbamazepine; oral, rectal
2.5
7.5
46
186
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.1
7.5
64
299
-69
ICPC
Other reason for encounter NEC
2.1
7.5
67
319
P01AB01
ATC
metronidazole; oral, rectal
1.3
7.4
556
4399
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.8
7.4
110
621
M35.7
ICD-10 Finland
Hypermobility syndrome
2.4
7.4
51
217
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
2.8
7.4
36
129
F32.1
ICD-10 Finland
Moderate depressive episode
1.5
7.4
212
1416
204
Kela drug reimbursment
Leukemia lymphatica
3.1
7.4
30
97
F32
ICD-10 Finland
Depressive episode
1.6
7.4
159
994
R21
ICPC
Throat symptom/complaint
1.3
7.4
913
7721
RL120, ,
NOMESCO Finland
79.5
7.4
8
*
IAA02
NOMESCO Finland
Consultation concerning further psychiatric treatment
3.2
7.4
28
87
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
3.2
7.4
28
87
B02AA02
ATC
tranexamic acid; systemic
1.6
7.4
194
1273
SGA03
NOMESCO Finland
Opening and preparing the root canals, complicated
1.6
7.4
182
1177
K04.08
ICD-10 Finland
Other specified pulpit
1.5
7.4
205
1362
F32.8
ICD-10 Finland
Other depressive episodes
2.2
7.4
60
275
Z72.2
ICD-10 Finland
Drug use
3.0
7.4
32
108
H13
ICPC
Plugged feeling ear
1.5
7.3
255
1774
K04.1
ICD-10 Finland
Necrosis of pulp
1.5
7.3
195
1283
N30.9
ICD-10 Finland
Cystitis, unspecified
1.7
7.3
125
736
G44.2
ICD-10 Finland
Tension-type headache
1.5
7.3
278
1968
D02
ICPC
Abdominal pain epigastric
1.7
7.3
145
889
F33
ICD-10 Finland
Recurrent depressive disorder
1.9
7.3
85
445
R3280, ,
ICD-10 Finland
+∞
7.3
7
*
S76
ICPC
Skin infection other
1.9
7.3
90
481
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
3.4
7.3
25
73
TLC02
NOMESCO Finland
Simple extraction of IUD
2.0
7.3
79
404
C02AC02
ATC
guanfacine; oral
8.3
7.3
15
18
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.9
7.3
88
467
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
3.2
7.2
28
88
M79.1
ICD-10 Finland
Myalgia
1.4
7.2
301
2166
N06AA04
ATC
clomipramine; systemic
3.2
7.2
27
83
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
2.7
7.2
36
131
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.7
7.2
124
731
Z61.5
ICD-10 Finland
Problems related to alleged sexual abuse of child by person outside primary support group
6.8
7.2
17
25
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.7
7.2
117
679
Z29
ICPC
Social problem NOS
2.0
7.2
80
412
G43.9
ICD-10 Finland
Migraine, unspecified
1.5
7.2
204
1361
F94.8
ICD-10 Finland
Other childhood disorders of social functioning
7.2
7.1
16
22
U71
ICPC
Cystitis/urinary infection other
1.7
7.1
138
841
SPAT1139
SPAT
Nutrition survey
2.2
7.1
58
266
S97
ICPC
Chronic ulcer skin
2.4
7.1
46
191
F44.5
ICD-10 Finland
Dissociative convulsions
19.9
7.1
10
5
Z31.5
ICD-10 Finland
Genetic counselling
1.6
7.1
162
1029
WZA90
NOMESCO Finland
Other medical or dental certificate
1.3
7.1
631
5112
U29
ICPC
Urinary symptom/complaint other
2.3
7.1
50
216
F20.0
ICD-10 Finland
Paranoid schizophrenia
4.5
7.1
17
38
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
4.5
7.1
17
38
SPAT1153
SPAT
Removal of sutures
1.4
7.1
345
2554
J45
ICD-10 Finland
Asthma
1.5
7.1
201
1342
N02BE01
ATC
paracetamol; systemic, rectal
1.3
7.0
1616
14690
M25.5
ICD-10 Finland
Pain in joint
1.3
7.0
549
4367
B03XA02
ATC
darbepoetin alfa; parenteral
3.5
7.0
23
65
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.4
7.0
44
180
1AB02, ,
NOMESCO Finland
6.0
7.0
18
30
ZXY52
NOMESCO Finland
2-person team, doctor-psychologist
3.1
7.0
28
90
ZXY13
NOMESCO Finland
Trainee psychologist, supervised
8.7
7.0
14
16
SPAT1283
SPAT
Restricted health certificate
1.3
7.0
705
5803
F43.21
ICD-10 Finland
Adaptation disorder with prolonged depression
3.2
7.0
27
85
A02BC05
ATC
esomeprazole; systemic
1.3
7.0
444
3428
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
3.3
7.0
25
75
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
7.0
100
560
Z61.7
ICD-10 Finland
Personal frightening experience in childhood
4.0
7.0
19
47
S01
ICPC
Pain/tenderness of skin
1.8
7.0
95
524
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
6.9
79
411
FM2CE, ,
NOMESCO Finland
1.9
6.9
87
468
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
6.9
69
343
IAZ99
NOMESCO Finland
Other psychiatric consultation
2.9
6.9
31
107
P10
ICPC
Stammering/stuttering/tic
7.5
6.8
15
20
188
Kela drug reimbursment
Psychosis requiring demanding treatment
7.5
6.8
15
20
J35.2
ICD-10 Finland
Hypertrophy of adenoids
1.5
6.8
200
1344
SPAT1310
SPAT
Counselling related to known health issue
1.3
6.8
735
6098
E34.31
ICD-10 Finland
Short stature, prenatal disorder
3.7
6.8
21
57
RT150, ,
NOMESCO Finland
2.7
6.8
35
130
S06.0
ICD-10 Finland
Concussion
1.4
6.8
286
2064
EMB30
NOMESCO Finland
Adenotomy
1.4
6.8
279
2005
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
10.8
6.7
12
11
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
6.7
80
422
R1270
NOMESCO Finland
Evaluation of the need for educational rehabilitation
9.2
6.7
13
14
ZYB01
NOMESCO Finland
Outreach service at unit of same specialty
9.2
6.7
13
14
ICZ04
NOMESCO Finland
Preparation of psychiatric treatment plan
3.4
6.7
23
67
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.5
6.7
211
1439
Z94.1
ICD-10 Finland
Heart transplant status
6.0
6.7
17
28
N28
ICPC
Limited function/disability (N)
3.3
6.7
24
72
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.7
67
333
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
1.9
6.7
76
395
N06BA02
ATC
dexamfetamine; oral
3.8
6.7
20
53
R63.4
ICD-10 Finland
Abnormal weight loss
2.1
6.7
59
280
Z02.7
ICD-10 Finland
Issue of medical certificate
1.6
6.7
155
989
WX290, ,
SPAT
1.8
6.6
102
583
J01FF01
ATC
clindamycin; systemic
1.4
6.6
348
2605
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
2.1
6.6
60
287
R1250
NOMESCO Finland
Evaluation of functional capability
2.4
6.6
44
185
A27
ICPC
Fear of other disease NOS
1.8
6.6
89
489
R05
ICD-10 Finland
Cough
1.3
6.6
431
3339
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
3.5
6.6
22
63
P98
ICPC
Psychosis NOS/other
3.1
6.6
26
83
F31.31
ICD-10 Finland
Bipolar disorder depressive episode with somatic syndrome
5.8
6.5
17
29
IAB13
NOMESCO Finland
Psychiatric sleep disorder consultation
5.4
6.5
18
33
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
12.1
6.5
11
9
SPAT1369
SPAT
Meeting with student welfare group of educational institution
2.4
6.5
41
168
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
6.5
217
1497
JN3AD
NOMESCO Finland
Abdominal CT examination
1.6
6.5
142
892
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
4.0
6.5
18
45
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
2.8
6.5
30
105
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
3.5
6.5
21
59
F22.0
ICD-10 Finland
Delusional disorder
3.5
6.5
21
59
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
3.5
6.5
21
59
H53.0
ICD-10 Finland
Amblyopia ex anopsia
2.2
6.5
53
244
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
6.5
97
551
R00.2
ICD-10 Finland
Palpitations
1.6
6.5
166
1084
A46
ICD-10 Finland
Erysipelas
1.7
6.4
113
672
IBA03
NOMESCO Finland
Psychotherapy evaluation
2.2
6.4
51
232
N06AA12
ATC
doxepin; systemic
2.6
6.4
35
134
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
2.9
6.4
28
95
R63.3
ICD-10 Finland
Feeding difficulties and mismanagement
6.1
6.4
16
26
XG413
NOMESCO Finland
Spirometry with oscillometry
2.6
6.4
36
140
IBB03
NOMESCO Finland
Assessment of vocational rehabilitation needs in a mental health context
3.0
6.4
27
90
SPAT1260
SPAT
Consultation of another employee
1.4
6.4
331
2474
F94.9
ICD-10 Finland
Childhood disorder of social functioning, unspecified
7.3
6.4
14
19
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
2.8
6.3
31
112
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
6.3
402
3099
P81
ICPC
Hyperkinetic disorder
1.9
6.3
80
431
L13
ICPC
Hip symptom/complaint
1.5
6.3
187
1259
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.5
6.3
166
1090
N02BF02
ATC
pregabalin; oral
1.8
6.3
93
526
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
3.2
6.3
24
75
ZX108
NOMESCO Finland
Inhalation
3.2
6.3
24
75
S11
ICPC
Skin infection post-traumatic
2.9
6.3
28
96
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.5
6.3
164
1075
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
1.9
6.3
76
404
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
2.7
6.3
33
124
J20
ICD-10 Finland
Acute bronchitis
1.5
6.3
173
1148
EBA00
NOMESCO Finland
Extraction of tooth
1.2
6.3
997
8637
P22
ICPC
Child behaviour symptom/complaint
1.8
6.3
95
542
Z49.2
ICD-10 Finland
Other dialysis
4.0
6.2
17
42
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
5.9
6.2
16
27
5937A
ICD-9 Finland
Other disorders of kidney and ureter, Vesicoureteric reflux
5.9
6.2
16
27
-1, ,
NOMESCO Finland
1.2
6.2
1050
9151
1603
FHL
Urodynamic research
+∞
6.2
6
*
L04AD01
ATC
ciclosporin; systemic
2.3
6.2
45
197
3094A
ICD-9 Finland
Adjustment reaction, With mixed disturbance of emotions and conduct
26.4
6.2
8
*
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
6.2
121
740
186
Kela drug reimbursment
Growth retardation associated with renal failure (growth hormone)
2.8
6.2
30
108
ZXE40
NOMESCO Finland
More than seven and less than nine hours
2.2
6.2
47
210
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.4
6.2
21
61
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
6.2
97
559
BE00A, ,
NOMESCO Finland
7.0
6.2
14
20
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
6.2
64
323
X14
ICPC
Vaginal discharge
1.7
6.1
104
612
K08.80
ICD-10 Finland
Toothache NOS
1.5
6.1
201
1382
Z01.7
ICD-10 Finland
Laboratory examination
1.4
6.1
312
2323
C03DA01
ATC
spironolactone; oral
1.7
6.1
96
553
N06AX17
ATC
milnacipran; oral
6.2
6.1
15
24
TK820
NOMESCO Finland
Peritoneal dialysis
5.3
6.1
17
32
G04BD09
ATC
trospium; oral
5.7
6.1
16
28
C09CA06
ATC
candesartan; oral
1.5
6.1
220
1543
R4110, ,
SPAT
1.6
6.1
153
995
L01
ICPC
Neck symptom/complaint
1.4
6.1
338
2554
F93.0
ICD-10 Finland
Separation anxiety disorder of childhood
8.5
6.0
12
14
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Psychiatry
26 [38004469]
26 [38004469]
1.6e+00
2.3e+00
2.7e+00
6.5e+00
3.0e+00
2.7e+00
1.9e+00
cases:10.78%
controls:2.40%
cases:13.40%
controls:1.51%
cases:8.05%
controls:0.57%
cases:17.79%
controls:0.03%
cases:11.03%
controls:0.61%
cases:18.75%
controls:1.51%
cases:23.06%
controls:4.13%
209
442
1729
18006
263
282
1699
18383
158
106
1804
18559
349
6
1613
18659
216
113
1743
18526
363
278
1573
18101
422
713
1408
16559
desmopressin; nasal, oral, parenteral, sublingual
H01BA02 [21602700]
H01BA02 [21602700]
2.4e+00
3.4e+00
3.3e+00
1.0e+50
4.3e+00
3.5e+00
2.9e+00
cases:7.48%
controls:0.72%
cases:9.43%
controls:0.35%
cases:2.29%
controls:0.09%
cases:1.53%
controls:0.00%
cases:6.18%
controls:0.09%
cases:10.85%
controls:0.37%
cases:12.13%
controls:0.74%
145
133
1793
18315
185
66
1777
18599
45
16
1917
18649
30
0
1932
18665
121
17
1838
18622
210
68
1726
18311
222
127
1608
17145
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
1.2e+00
1.9e+00
2.6e+00
5.6e+00
3.0e+00
2.4e+00
1.6e+00
cases:11.51%
controls:3.76%
cases:15.09%
controls:2.47%
cases:10.86%
controls:0.91%
cases:17.53%
controls:0.08%
cases:15.36%
controls:0.92%
cases:22.88%
controls:2.58%
cases:23.01%
controls:5.85%
223
693
1715
17755
296
461
1666
18204
213
169
1749
18496
344
15
1618
18650
301
171
1658
18468
443
474
1493
17905
421
1011
1409
16261
oxybutynin; oral, transdermal
G04BD04 [21602637]
G04BD04 [21602637]
2.9e+00
3.9e+00
—
1.0e+50
—
5.0e+00
4.2e+00
cases:2.32%
controls:0.14%
cases:2.96%
controls:0.06%
—
—
cases:0.71%
controls:0.00%
—
—
cases:6.25%
controls:0.04%
cases:5.63%
controls:0.09%
45
25
1893
18423
58
11
1904
18654
—
14
0
1948
18665
—
121
8
1815
18371
103
15
1727
17257
Nonorganic enuresis nocturna
F98.00 [2000502047]
F98.00 [2000502047]
2.4e+00
2.5e+00
—
1.0e+50
—
6.1e+00
4.5e+00
cases:0.31%
controls:0.03%
cases:0.41%
controls:0.03%
—
—
cases:14.32%
controls:0.00%
—
—
cases:11.00%
controls:0.03%
cases:8.74%
controls:0.10%
6
5
1932
18443
8
6
1954
18659
—
281
0
1681
18665
—
213
5
1723
18374
160
18
1670
17254
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
1.6e+00
2.5e+00
2.9e+00
1.0e+50
3.1e+00
2.8e+00
1.9e+00
cases:1.86%
controls:0.40%
cases:2.04%
controls:0.18%
cases:1.17%
controls:0.06%
cases:1.12%
controls:0.00%
cases:1.33%
controls:0.06%
cases:3.15%
controls:0.19%
cases:4.32%
controls:0.67%
36
73
1902
18375
40
33
1922
18632
23
12
1939
18653
22
0
1940
18665
26
11
1933
18628
61
35
1875
18344
79
116
1751
17156
Recurrent depressive disorder, current episode severe without psychotic symptoms
F33.2 [45547705]
F33.2 [45547705]
1.8e+00
2.5e+00
2.7e+00
—
2.3e+00
2.8e+00
2.3e+00
cases:0.98%
controls:0.16%
cases:1.07%
controls:0.09%
cases:0.46%
controls:0.03%
—
—
cases:0.46%
controls:0.05%
cases:1.29%
controls:0.08%
cases:3.01%
controls:0.30%
19
29
1919
18419
21
17
1941
18648
9
6
1953
18659
—
9
9
1950
18630
25
15
1911
18364
55
52
1775
17220
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
1.7e+00
2.2e+00
3.2e+00
—
3.0e+00
2.1e+00
1.6e+00
cases:4.18%
controls:0.81%
cases:3.21%
controls:0.35%
cases:1.99%
controls:0.08%
—
—
cases:1.63%
controls:0.09%
cases:4.03%
controls:0.50%
cases:7.81%
controls:1.73%
81
149
1857
18299
63
66
1899
18599
39
15
1923
18650
—
32
16
1927
18623
78
92
1858
18287
143
298
1687
16974
methylphenidate; oral
N06BA04 [21604757]
N06BA04 [21604757]
1.7e+00
1.9e+00
1.9e+00
—
3.0e+00
2.6e+00
1.9e+00
cases:3.30%
controls:0.65%
cases:4.54%
controls:0.69%
cases:2.40%
controls:0.35%
—
—
cases:6.28%
controls:0.34%
cases:11.00%
controls:0.89%
cases:13.06%
controls:2.13%
64
119
1874
18329
89
128
1873
18537
47
65
1915
18600
—
123
63
1836
18576
213
164
1723
18215
239
368
1591
16904
Anorexia nervosa
F50.0 [45562053]
F50.0 [45562053]
2.1e+00
2.5e+00
2.4e+00
—
2.4e+00
2.1e+00
1.6e+00
cases:0.52%
controls:0.07%
cases:0.71%
controls:0.06%
cases:0.41%
controls:0.04%
—
—
cases:0.46%
controls:0.04%
cases:0.77%
controls:0.09%
cases:1.15%
controls:0.24%
10
12
1928
18436
14
11
1948
18654
8
7
1954
18658
—
9
8
1950
18631
15
17
1921
18362
21
42
1809
17230
Other childhood emotional disorders
F93.89 [2000502046]
F93.89 [2000502046]
1.9e+00
2.3e+00
2.3e+00
—
2.4e+00
2.2e+00
1.6e+00
cases:1.50%
controls:0.22%
cases:1.63%
controls:0.17%
cases:0.82%
controls:0.09%
—
—
cases:0.92%
controls:0.08%
cases:2.07%
controls:0.22%
cases:2.73%
controls:0.54%
29
40
1909
18408
32
31
1930
18634
16
16
1946
18649
—
18
15
1941
18624
40
41
1896
18338
50
94
1780
17178
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
1.6e+00
2.3e+00
2.7e+00
1.0e+50
2.7e+00
2.1e+00
1.3e+00
cases:2.89%
controls:0.61%
cases:3.16%
controls:0.34%
cases:1.17%
controls:0.08%
cases:1.43%
controls:0.00%
cases:1.28%
controls:0.09%
cases:3.36%
controls:0.42%
cases:5.74%
controls:1.56%
56
112
1882
18336
62
63
1900
18602
23
15
1939
18650
28
0
1934
18665
25
16
1934
18623
65
77
1871
18302
105
270
1725
17002
Disturbance of activity and attention
F90.0 [45542870]
F90.0 [45542870]
1.7e+00
2.1e+00
2.2e+00
—
2.6e+00
2.4e+00
1.8e+00
cases:3.30%
controls:0.63%
cases:4.89%
controls:0.65%
cases:2.09%
controls:0.24%
—
—
cases:2.50%
controls:0.19%
cases:7.95%
controls:0.80%
cases:12.73%
controls:2.28%
64
117
1874
18331
96
122
1866
18543
41
45
1921
18620
—
49
36
1910
18603
154
147
1782
18232
233
393
1597
16879
duloxetine; oral
N06AX21 [21604749]
N06AX21 [21604749]
1.6e+00
2.0e+00
2.0e+00
—
2.8e+00
2.3e+00
1.7e+00
cases:1.65%
controls:0.34%
cases:1.38%
controls:0.18%
cases:0.36%
controls:0.05%
—
—
cases:0.61%
controls:0.04%
cases:1.81%
controls:0.18%
cases:2.68%
controls:0.50%
32
63
1906
18385
27
34
1935
18631
7
9
1955
18656
—
12
7
1947
18632
35
33
1901
18346
49
87
1781
17185
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
1.4e+00
2.0e+00
2.4e+00
1.0e+50
2.4e+00
2.4e+00
1.6e+00
cases:2.48%
controls:0.60%
cases:2.24%
controls:0.30%
cases:0.97%
controls:0.09%
cases:0.97%
controls:0.00%
cases:1.12%
controls:0.10%
cases:3.05%
controls:0.27%
cases:5.52%
controls:1.19%
48
110
1890
18338
44
56
1918
18609
19
16
1943
18649
19
0
1943
18665
22
19
1937
18620
59
50
1877
18329
101
206
1729
17066
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.7e+00
1.9e+00
2.3e+00
1.0e+50
1.9e+00
2.0e+00
2.1e+00
cases:1.44%
controls:0.26%
cases:1.33%
controls:0.19%
cases:0.61%
controls:0.06%
cases:0.56%
controls:0.00%
cases:0.56%
controls:0.08%
cases:1.50%
controls:0.20%
cases:3.01%
controls:0.38%
28
48
1910
18400
26
36
1936
18629
12
12
1950
18653
11
0
1951
18665
11
15
1948
18624
29
37
1907
18342
55
66
1775
17206
Unspecified urinary incontinence
R32 [45606803]
R32 [45606803]
2.6e+00
4.3e+00
—
1.0e+50
—
2.9e+00
2.0e+00
cases:0.98%
controls:0.07%
cases:2.75%
controls:0.04%
—
—
cases:0.25%
controls:0.00%
—
—
cases:1.50%
controls:0.08%
cases:1.64%
controls:0.23%
19
13
1919
18435
54
7
1908
18658
—
5
0
1957
18665
—
29
15
1907
18364
30
39
1800
17233
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
8.0e-01
1.5e+00
2.3e+00
1.0e+50
2.8e+00
2.3e+00
2.2e+00
cases:3.35%
controls:1.54%
cases:2.34%
controls:0.53%
cases:0.92%
controls:0.10%
cases:0.87%
controls:0.00%
cases:1.28%
controls:0.08%
cases:3.46%
controls:0.37%
cases:4.64%
controls:0.54%
65
284
1873
18164
46
99
1916
18566
18
18
1944
18647
17
0
1945
18665
25
14
1934
18625
67
68
1869
18311
85
94
1745
17178
Post-traumatic stress disorder
F43.1 [45595909]
F43.1 [45595909]
1.2e+00
2.4e+00
1.8e+00
—
2.1e+00
2.5e+00
1.9e+00
cases:0.62%
controls:0.18%
cases:0.97%
controls:0.09%
cases:0.36%
controls:0.06%
—
—
cases:0.36%
controls:0.04%
cases:1.08%
controls:0.09%
cases:2.08%
controls:0.32%
12
34
1926
18414
19
17
1943
18648
7
11
1955
18654
—
7
8
1952
18631
21
17
1915
18362
38
56
1792
17216
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
2.3e+00
3.4e+00
—
—
1.0e+50
3.6e+00
2.6e+00
cases:0.93%
controls:0.10%
cases:0.92%
controls:0.03%
—
—
—
—
cases:0.36%
controls:0.00%
cases:0.98%
controls:0.03%
cases:1.69%
controls:0.13%
18
18
1920
18430
18
6
1944
18659
—
—
7
0
1952
18639
19
5
1917
18374
31
23
1799
17249
bupropion; oral
N06AX12 [21604741]
N06AX12 [21604741]
1.7e+00
1.9e+00
1.9e+00
1.0e+50
2.0e+00
2.0e+00
2.1e+00
cases:1.86%
controls:0.35%
cases:2.04%
controls:0.30%
cases:0.56%
controls:0.09%
cases:0.41%
controls:0.00%
cases:0.61%
controls:0.08%
cases:2.22%
controls:0.29%
cases:4.21%
controls:0.54%
36
65
1902
18383
40
56
1922
18609
11
16
1951
18649
8
0
1954
18665
12
15
1947
18624
43
54
1893
18325
77
93
1753
17179
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
8.0e-01
1.2e+00
1.9e+00
1.0e+50
2.9e+00
2.2e+00
2.6e+00
cases:4.13%
controls:1.89%
cases:1.89%
controls:0.56%
cases:0.41%
controls:0.06%
cases:0.31%
controls:0.00%
cases:0.77%
controls:0.04%
cases:2.12%
controls:0.25%
cases:3.72%
controls:0.28%
80
349
1858
18099
37
104
1925
18561
8
12
1954
18653
6
0
1956
18665
15
8
1944
18631
41
46
1895
18333
68
48
1762
17224
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
1.6e+00
1.8e+00
2.3e+00
—
2.0e+00
2.0e+00
1.8e+00
cases:2.22%
controls:0.45%
cases:1.63%
controls:0.27%
cases:0.71%
controls:0.07%
—
—
cases:0.71%
controls:0.10%
cases:2.53%
controls:0.36%
cases:5.08%
controls:0.88%
43
83
1895
18365
32
50
1930
18615
14
13
1948
18652
—
14
19
1945
18620
49
67
1887
18312
93
152
1737
17120
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.2e+00
2.0e+00
2.0e+00
—
2.7e+00
2.0e+00
1.5e+00
cases:2.06%
controls:0.62%
cases:2.55%
controls:0.35%
cases:1.02%
controls:0.14%
—
—
cases:1.63%
controls:0.11%
cases:3.15%
controls:0.44%
cases:5.30%
controls:1.22%
40
114
1898
18334
50
65
1912
18600
20
27
1942
18638
—
32
21
1927
18618
61
80
1875
18299
97
211
1733
17061
Social phobias
F40.1 [45595907]
F40.1 [45595907]
1.9e+00
2.1e+00
1.5e+00
1.0e+50
2.4e+00
2.6e+00
2.3e+00
cases:0.83%
controls:0.12%
cases:0.97%
controls:0.12%
cases:0.25%
controls:0.06%
cases:0.82%
controls:0.00%
cases:0.46%
controls:0.04%
cases:1.50%
controls:0.11%
cases:2.73%
controls:0.27%
16
22
1922
18426
19
22
1943
18643
5
11
1957
18654
16
0
1946
18665
9
8
1950
18631
29
21
1907
18358
50
47
1780
17225
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.4e+00
1.8e+00
1.9e+00
—
2.2e+00
2.2e+00
1.8e+00
cases:4.95%
controls:1.26%
cases:4.64%
controls:0.81%
cases:1.63%
controls:0.24%
—
—
cases:1.68%
controls:0.19%
cases:6.56%
controls:0.81%
cases:10.49%
controls:1.87%
96
233
1842
18215
91
152
1871
18513
32
44
1930
18621
—
33
35
1926
18604
127
148
1809
18231
192
323
1638
16949
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
1.9e+00
1.8e+00
1.9e+00
—
1.9e+00
1.8e+00
2.2e+00
cases:0.72%
controls:0.11%
cases:0.71%
controls:0.12%
cases:0.56%
controls:0.09%
—
—
cases:0.61%
controls:0.10%
cases:0.83%
controls:0.14%
cases:1.42%
controls:0.16%
14
21
1924
18427
14
23
1948
18642
11
16
1951
18649
—
12
18
1947
18621
16
26
1920
18353
26
28
1804
17244
Mixed disorder of conduct and emotions, unspecified
F92.9 [45586263]
F92.9 [45586263]
2.0e+00
2.6e+00
—
—
2.5e+00
2.3e+00
1.8e+00
cases:0.72%
controls:0.10%
cases:0.71%
controls:0.05%
—
—
—
—
cases:0.41%
controls:0.03%
cases:0.83%
controls:0.08%
cases:0.93%
controls:0.15%
14
18
1924
18430
14
10
1948
18655
—
—
8
6
1951
18633
16
15
1920
18364
17
26
1813
17246
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.4e+00
2.1e+00
2.9e+00
—
1.9e+00
1.8e+00
1.2e+00
cases:6.35%
controls:1.69%
cases:7.34%
controls:0.96%
cases:3.77%
controls:0.23%
—
—
cases:1.58%
controls:0.25%
cases:5.11%
controls:0.87%
cases:8.91%
controls:2.76%
123
312
1815
18136
144
180
1818
18485
74
42
1888
18623
—
31
46
1928
18593
99
160
1837
18219
163
476
1667
16796
Other mixed disorders of conduct and emotions
F92.8 [45605519]
F92.8 [45605519]
2.6e+00
2.8e+00
—
—
—
2.6e+00
3.1e+00
cases:0.52%
controls:0.04%
cases:0.46%
controls:0.03%
—
—
—
—
—
—
cases:0.57%
controls:0.04%
cases:0.93%
controls:0.04%
10
7
1928
18441
9
5
1953
18660
—
—
—
11
8
1925
18371
17
7
1813
17265
Hospital outpatient
ZY010 [2001311599]
ZY010 [2001311599]
9.8e-01
1.3e+00
2.0e+00
—
2.2e+00
2.2e+00
2.4e+00
cases:2.48%
controls:0.95%
cases:2.09%
controls:0.56%
cases:1.02%
controls:0.14%
—
—
cases:1.33%
controls:0.16%
cases:2.69%
controls:0.32%
cases:4.92%
controls:0.48%
48
175
1890
18273
41
104
1921
18561
20
26
1942
18639
—
26
29
1933
18610
52
58
1884
18321
90
83
1740
17189
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
2.8e+00
2.4e+00
—
—
—
3.0e+00
2.8e+00
cases:0.72%
controls:0.04%
cases:0.71%
controls:0.06%
—
—
—
—
—
—
cases:1.24%
controls:0.07%
cases:1.53%
controls:0.10%
14
8
1924
18440
14
12
1948
18653
—
—
—
24
12
1912
18367
28
17
1802
17255
fluoxetine; oral
N06AB03 [21604711]
N06AB03 [21604711]
1.5e+00
1.8e+00
2.0e+00
—
1.9e+00
2.0e+00
1.5e+00
cases:2.89%
controls:0.65%
cases:2.80%
controls:0.46%
cases:0.87%
controls:0.12%
—
—
cases:0.77%
controls:0.11%
cases:3.05%
controls:0.42%
cases:5.30%
controls:1.20%
56
119
1882
18329
55
85
1907
18580
17
22
1945
18643
—
15
21
1944
18618
59
78
1877
18301
97
207
1733
17065
Generalized anxiety disorder
F41.1 [45571764]
F41.1 [45571764]
1.2e+00
1.7e+00
2.3e+00
1.0e+50
2.0e+00
2.0e+00
1.5e+00
cases:1.08%
controls:0.34%
cases:1.22%
controls:0.22%
cases:0.66%
controls:0.06%
cases:0.71%
controls:0.00%
cases:0.61%
controls:0.09%
cases:1.60%
controls:0.23%
cases:3.01%
controls:0.67%
21
62
1917
18386
24
41
1938
18624
13
12
1949
18653
14
0
1948
18665
12
16
1947
18623
31
42
1905
18337
55
116
1775
17156
Asperger syndrome
F84.5 [45576562]
F84.5 [45576562]
2.1e+00
2.5e+00
—
1.0e+50
—
3.2e+00
2.5e+00
cases:0.52%
controls:0.07%
cases:0.61%
controls:0.05%
—
—
cases:0.76%
controls:0.00%
—
—
cases:1.60%
controls:0.07%
cases:2.51%
controls:0.22%
10
12
1928
18436
12
9
1950
18656
—
15
0
1947
18665
—
31
12
1905
18367
46
38
1784
17234
Other developmental disorders of scholastic skills
F81.8 [45542868]
F81.8 [45542868]
2.7e+00
2.5e+00
—
1.0e+50
—
3.1e+00
1.8e+00
cases:0.57%
controls:0.04%
cases:0.46%
controls:0.04%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.83%
controls:0.04%
cases:0.98%
controls:0.16%
11
7
1927
18441
9
7
1953
18658
—
7
0
1955
18665
—
16
7
1920
18372
18
28
1812
17244
Outpatient Visit
OP [9202]
OP [9202]
1.5e-01
4.0e-01
7.9e-01
5.4e+00
1.6e+00
1.1e+00
5.0e-01
cases:64.76%
controls:61.23%
cases:56.63%
controls:46.75%
cases:24.52%
controls:12.85%
cases:59.68%
controls:0.64%
cases:41.55%
controls:12.72%
cases:71.80%
controls:45.98%
cases:78.14%
controls:68.35%
1255
11295
683
7153
1111
8725
851
9940
481
2398
1481
16267
1171
120
791
18545
814
2371
1145
16268
1390
8451
546
9928
1430
11805
400
5467
vortioxetine; oral
N06AX26 [44819158]
N06AX26 [44819158]
1.6e+00
1.9e+00
1.6e+00
—
2.4e+00
2.1e+00
1.7e+00
cases:1.24%
controls:0.25%
cases:1.22%
controls:0.18%
cases:0.31%
controls:0.06%
—
—
cases:0.66%
controls:0.06%
cases:1.50%
controls:0.18%
cases:2.84%
controls:0.53%
24
46
1914
18402
24
33
1938
18632
6
12
1956
18653
—
13
11
1946
18628
29
34
1907
18345
52
91
1778
17181
Procedure duration 60 to 89 minutes
ZXE11 [2001311402]
ZXE11 [2001311402]
8.1e-01
8.5e-01
1.5e+00
—
2.1e+00
1.9e+00
2.4e+00
cases:2.99%
controls:1.35%
cases:1.94%
controls:0.84%
cases:0.66%
controls:0.15%
—
—
cases:0.77%
controls:0.09%
cases:2.12%
controls:0.32%
cases:3.99%
controls:0.36%
58
249
1880
18199
38
156
1924
18509
13
28
1949
18637
—
15
17
1944
18622
41
58
1895
18321
73
62
1757
17210
Uroflowmetry
44856007 [4261340]
44856007 [4261340]
1.4e+00
2.5e+00
—
1.0e+50
—
3.5e+00
2.2e+00
cases:1.70%
controls:0.43%
cases:1.33%
controls:0.11%
—
—
cases:3.92%
controls:0.00%
—
—
cases:3.98%
controls:0.12%
cases:3.55%
controls:0.41%
33
80
1905
18368
26
20
1936
18645
—
77
0
1885
18665
—
77
22
1859
18357
65
70
1765
17202
Fibromyalgia
M79.7 [45553272]
M79.7 [45553272]
2.5e+00
2.7e+00
—
—
—
2.3e+00
2.3e+00
cases:0.83%
controls:0.07%
cases:0.46%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.93%
controls:0.10%
16
13
1922
18435
9
6
1953
18659
—
—
—
7
7
1929
18372
17
17
1813
17255
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
1.7e+00
2.0e+00
—
—
—
3.1e+00
2.8e+00
cases:1.19%
controls:0.22%
cases:0.46%
controls:0.06%
—
—
—
—
—
—
cases:1.50%
controls:0.07%
cases:3.28%
controls:0.21%
23
40
1915
18408
9
12
1953
18653
—
—
—
29
12
1907
18367
60
36
1770
17236
atomoxetine; oral
N06BA09 [21604762]
N06BA09 [21604762]
2.8e+00
1.7e+00
—
—
—
3.3e+00
1.8e+00
cases:0.52%
controls:0.03%
cases:0.41%
controls:0.08%
—
—
—
—
—
—
cases:1.19%
controls:0.04%
cases:1.58%
controls:0.27%
10
6
1928
18442
8
14
1954
18651
—
—
—
23
8
1913
18371
29
46
1801
17226
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
1.1e+00
1.7e+00
1.8e+00
—
1.8e+00
1.7e+00
1.3e+00
cases:2.43%
controls:0.80%
cases:1.78%
controls:0.34%
cases:0.66%
controls:0.11%
—
—
cases:0.61%
controls:0.10%
cases:1.55%
controls:0.28%
cases:2.62%
controls:0.72%
47
148
1891
18300
35
63
1927
18602
13
20
1949
18645
—
12
19
1947
18620
30
51
1906
18328
48
125
1782
17147
Hyperkinetic disorder, unspecified
F90.9 [45533124]
F90.9 [45533124]
2.1e+00
2.0e+00
—
—
2.4e+00
1.8e+00
1.1e+00
cases:0.72%
controls:0.09%
cases:0.71%
controls:0.10%
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.57%
controls:0.10%
cases:0.82%
controls:0.27%
14
17
1924
18431
14
18
1948
18647
—
—
6
5
1953
18634
11
18
1925
18361
15
47
1815
17225
Depressive conduct disorder
F92.0 [45581477]
F92.0 [45581477]
3.0e+00
—
—
1.0e+50
1.0e+50
3.3e+00
3.0e+00
cases:0.52%
controls:0.03%
—
—
—
—
cases:0.25%
controls:0.00%
cases:0.31%
controls:0.00%
cases:0.72%
controls:0.03%
cases:1.04%
controls:0.05%
10
5
1928
18443
—
—
5
0
1957
18665
6
0
1953
18639
14
5
1922
18374
19
9
1811
17263
Other bipolar affective disorders
F31.8 [45586237]
F31.8 [45586237]
1.8e+00
1.8e+00
—
—
—
2.5e+00
3.1e+00
cases:0.46%
controls:0.08%
cases:0.46%
controls:0.08%
—
—
—
—
—
—
cases:0.72%
controls:0.06%
cases:1.48%
controls:0.07%
9
14
1929
18434
9
14
1953
18651
—
—
—
14
11
1922
18368
27
12
1803
17260
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.9e+00
2.5e+00
—
—
1.9e+00
2.6e+00
2.1e+00
cases:0.77%
controls:0.11%
cases:0.51%
controls:0.04%
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.98%
controls:0.07%
cases:1.97%
controls:0.24%
15
21
1923
18427
10
8
1952
18657
—
—
5
7
1954
18632
19
13
1917
18366
36
41
1794
17231
Ultrasound measurement of residual urine
KC1EE [2001305918]
KC1EE [2001305918]
1.0e+00
2.3e+00
—
1.0e+50
—
3.5e+00
2.2e+00
cases:1.08%
controls:0.39%
cases:0.87%
controls:0.09%
—
—
cases:2.55%
controls:0.00%
—
—
cases:3.00%
controls:0.10%
cases:2.79%
controls:0.32%
21
72
1917
18376
17
16
1945
18649
—
50
0
1912
18665
—
58
18
1878
18361
51
56
1779
17216
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
1.8e+00
2.3e+00
—
—
—
2.3e+00
2.6e+00
cases:0.62%
controls:0.10%
cases:0.61%
controls:0.06%
—
—
—
—
—
—
cases:0.72%
controls:0.08%
cases:1.09%
controls:0.08%
12
19
1926
18429
12
12
1950
18653
—
—
—
14
14
1922
18365
20
14
1810
17258
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
1.2e+00
1.7e+00
1.6e+00
—
1.4e+00
1.5e+00
1.5e+00
cases:4.23%
controls:1.31%
cases:2.91%
controls:0.56%
cases:0.76%
controls:0.16%
—
—
cases:0.71%
controls:0.17%
cases:3.00%
controls:0.69%
cases:7.10%
controls:1.74%
82
242
1856
18206
57
104
1905
18561
15
29
1947
18636
—
14
32
1945
18607
58
127
1878
18252
130
300
1700
16972
Paediatric neurology
421 [44777781]
421 [44777781]
4.3e-01
5.1e-01
8.1e-01
4.2e+00
1.4e+00
8.0e-01
6.7e-01
cases:10.42%
controls:7.01%
cases:7.24%
controls:4.48%
cases:2.19%
controls:0.99%
cases:3.57%
controls:0.05%
cases:3.57%
controls:0.92%
cases:8.21%
controls:3.87%
cases:11.04%
controls:5.97%
202
1294
1736
17154
142
836
1820
17829
43
184
1919
18481
70
10
1892
18655
70
171
1889
18468
159
712
1777
17667
202
1031
1628
16241
Recurrent depression, mild episode without somatic syndrome
F33.00 [2000501982]
F33.00 [2000501982]
2.2e+00
2.1e+00
—
—
—
2.3e+00
2.3e+00
cases:0.67%
controls:0.08%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
cases:0.57%
controls:0.06%
cases:1.09%
controls:0.12%
13
14
1925
18434
8
9
1954
18656
—
—
—
11
11
1925
18368
20
20
1810
17252
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
1.9e+00
2.3e+00
—
1.0e+50
—
2.6e+00
2.0e+00
cases:1.19%
controls:0.17%
cases:1.12%
controls:0.11%
—
—
cases:0.56%
controls:0.00%
—
—
cases:1.14%
controls:0.09%
cases:2.13%
controls:0.30%
23
32
1915
18416
22
21
1940
18644
—
11
0
1951
18665
—
22
16
1914
18363
39
52
1791
17220
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
1.8e+00
1.7e+00
—
—
—
3.0e+00
2.2e+00
cases:0.62%
controls:0.10%
cases:0.41%
controls:0.08%
—
—
—
—
—
—
cases:0.83%
controls:0.04%
cases:1.58%
controls:0.17%
12
19
1926
18429
8
14
1954
18651
—
—
—
16
8
1920
18371
29
30
1801
17242
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
1.9e+00
2.3e+00
—
—
—
2.3e+00
2.2e+00
cases:0.41%
controls:0.07%
cases:0.41%
controls:0.04%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.60%
controls:0.06%
8
12
1930
18436
8
8
1954
18657
—
—
—
7
7
1929
18372
11
11
1819
17261
Eating disorder, unspecified
F50.9 [45547713]
F50.9 [45547713]
1.8e+00
2.3e+00
—
—
—
2.6e+00
1.8e+00
cases:0.67%
controls:0.11%
cases:0.71%
controls:0.08%
—
—
—
—
—
—
cases:1.03%
controls:0.08%
cases:1.64%
controls:0.28%
13
20
1925
18428
14
14
1948
18651
—
—
—
20
14
1916
18365
30
48
1800
17224
Specific reading disorder
F81.0 [45542866]
F81.0 [45542866]
2.0e+00
2.4e+00
—
1.0e+50
—
2.1e+00
2.0e+00
cases:0.46%
controls:0.07%
cases:0.41%
controls:0.04%
—
—
cases:0.41%
controls:0.00%
—
—
cases:0.46%
controls:0.05%
cases:1.26%
controls:0.18%
9
12
1929
18436
8
7
1954
18658
—
8
0
1954
18665
—
9
10
1927
18369
23
31
1807
17241
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.5e+00
1.9e+00
—
—
—
1.8e+00
2.2e+00
cases:0.77%
controls:0.07%
cases:0.41%
controls:0.06%
—
—
—
—
—
—
cases:0.52%
controls:0.08%
cases:1.31%
controls:0.15%
15
12
1923
18436
8
12
1954
18653
—
—
—
10
15
1926
18364
24
26
1806
17246
Mental disorder, not otherwise specified
F99 [45605525]
F99 [45605525]
1.2e+00
3.5e+00
—
—
—
3.1e+00
1.7e+00
cases:0.26%
controls:0.08%
cases:1.07%
controls:0.03%
—
—
—
—
—
—
cases:0.88%
controls:0.04%
cases:0.87%
controls:0.17%
5
14
1933
18434
21
6
1941
18659
—
—
—
17
7
1919
18372
16
29
1814
17243
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
1.3e+00
1.6e+00
1.5e+00
—
1.5e+00
1.1e+00
1.2e+00
cases:3.56%
controls:0.96%
cases:2.55%
controls:0.54%
cases:0.71%
controls:0.16%
—
—
cases:0.66%
controls:0.14%
cases:1.70%
controls:0.56%
cases:4.15%
controls:1.27%
69
177
1869
18271
50
101
1912
18564
14
29
1948
18636
—
13
27
1946
18612
33
103
1903
18276
76
220
1754
17052
lisdexamfetamine; oral
N06BA12 [40252237]
N06BA12 [40252237]
1.6e+00
1.4e+00
—
—
3.0e+00
2.8e+00
2.5e+00
cases:0.31%
controls:0.07%
cases:0.36%
controls:0.09%
—
—
—
—
cases:0.61%
controls:0.03%
cases:1.70%
controls:0.11%
cases:3.28%
controls:0.29%
6
12
1932
18436
7
17
1955
18648
—
—
12
6
1947
18633
33
20
1903
18359
60
50
1770
17222
Other therapy enhancing rehabilitation
R4160 [2001310240]
R4160 [2001310240]
7.9e-01
1.6e+00
—
1.0e+50
2.6e+00
2.4e+00
1.6e+00
cases:1.14%
controls:0.52%
cases:0.87%
controls:0.18%
—
—
cases:0.31%
controls:0.00%
cases:0.51%
controls:0.04%
cases:1.60%
controls:0.15%
cases:2.13%
controls:0.46%
22
96
1916
18352
17
33
1945
18632
—
6
0
1956
18665
10
7
1949
18632
31
28
1905
18351
39
79
1791
17193
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
1.5e+00
1.9e+00
1.2e+00
—
1.3e+00
1.8e+00
1.6e+00
cases:3.10%
controls:0.70%
cases:2.45%
controls:0.39%
cases:0.46%
controls:0.14%
—
—
cases:0.66%
controls:0.18%
cases:2.53%
controls:0.42%
cases:5.30%
controls:1.07%
60
129
1878
18319
48
73
1914
18592
9
27
1953
18638
—
13
34
1946
18605
49
77
1887
18302
97
185
1733
17087
Constipation, unspecified
K59.09 [2000502926]
K59.09 [2000502926]
7.5e-01
1.2e+00
1.8e+00
1.0e+50
3.0e+00
1.9e+00
1.2e+00
cases:1.29%
controls:0.61%
cases:0.76%
controls:0.24%
cases:0.25%
controls:0.04%
cases:0.46%
controls:0.00%
cases:0.56%
controls:0.03%
cases:1.39%
controls:0.22%
cases:1.64%
controls:0.50%
25
113
1913
18335
15
44
1947
18621
5
8
1957
18657
9
0
1953
18665
11
5
1948
18634
27
40
1909
18339
30
87
1800
17185
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
1.1e+00
1.4e+00
2.3e+00
—
1.6e+00
1.5e+00
1.6e+00
cases:1.60%
controls:0.56%
cases:1.27%
controls:0.31%
cases:0.46%
controls:0.05%
—
—
cases:0.36%
controls:0.08%
cases:1.19%
controls:0.27%
cases:2.30%
controls:0.47%
31
104
1907
18344
25
58
1937
18607
9
9
1953
18656
—
7
14
1952
18625
23
49
1913
18330
42
82
1788
17190
Psychological disorders other
P99 [2002000880]
P99 [2002000880]
2.0e+00
2.2e+00
—
—
—
1.7e+00
2.0e+00
cases:0.67%
controls:0.09%
cases:0.56%
controls:0.06%
—
—
—
—
—
—
cases:0.41%
controls:0.08%
cases:1.53%
controls:0.22%
13
17
1925
18431
11
12
1951
18653
—
—
—
8
14
1928
18365
28
38
1802
17234
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
1.1e+00
1.2e+00
1.3e+00
—
1.8e+00
1.3e+00
1.0e+00
cases:4.33%
controls:1.43%
cases:2.65%
controls:0.80%
cases:0.82%
controls:0.22%
—
—
cases:0.97%
controls:0.17%
cases:3.15%
controls:0.85%
cases:6.01%
controls:2.26%
84
264
1854
18184
52
149
1910
18516
16
41
1946
18624
—
19
31
1940
18608
61
156
1875
18223
110
391
1720
16881
Other rehabilitation service
R5599 [2001310270]
R5599 [2001310270]
1.7e+00
2.0e+00
—
—
—
2.1e+00
2.1e+00
cases:0.77%
controls:0.15%
cases:0.46%
controls:0.06%
—
—
—
—
—
—
cases:0.77%
controls:0.10%
cases:1.58%
controls:0.20%
15
27
1923
18421
9
12
1953
18653
—
—
—
15
18
1921
18361
29
35
1801
17237
Mixed obsessional thoughts and acts
F42.2 [45542850]
F42.2 [45542850]
2.1e+00
2.4e+00
—
—
—
3.1e+00
2.2e+00
cases:0.26%
controls:0.03%
cases:0.36%
controls:0.03%
—
—
—
—
—
—
cases:0.62%
controls:0.03%
cases:0.98%
controls:0.11%
5
6
1933
18442
7
6
1955
18659
—
—
—
12
5
1924
18374
18
19
1812
17253
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 [21604305]
N02BA01 [21604305]
9.8e-01
1.3e+00
2.4e+00
—
1.9e+00
1.8e+00
1.2e+00
cases:0.93%
controls:0.35%
cases:0.71%
controls:0.20%
cases:0.41%
controls:0.04%
—
—
cases:0.26%
controls:0.04%
cases:0.77%
controls:0.13%
cases:0.93%
controls:0.28%
18
65
1920
18383
14
37
1948
18628
8
7
1954
18658
—
5
7
1954
18632
15
23
1921
18356
17
48
1813
17224
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
7.9e-01
9.3e-01
1.3e+00
—
2.0e+00
1.3e+00
1.4e+00
cases:6.55%
controls:3.07%
cases:3.11%
controls:1.25%
cases:0.61%
controls:0.17%
—
—
cases:1.23%
controls:0.17%
cases:3.87%
controls:1.07%
cases:7.65%
controls:2.10%
127
567
1811
17881
61
234
1901
18431
12
31
1950
18634
—
24
32
1935
18607
75
196
1861
18183
140
362
1690
16910
Procedure duration 90 to 119 minutes
ZXE13 [2001311404]
ZXE13 [2001311404]
1.1e+00
9.0e-01
—
1.0e+50
1.7e+00
1.6e+00
2.2e+00
cases:2.22%
controls:0.73%
cases:0.92%
controls:0.38%
—
—
cases:0.25%
controls:0.00%
cases:0.41%
controls:0.08%
cases:1.03%
controls:0.20%
cases:2.51%
controls:0.27%
43
135
1895
18313
18
70
1944
18595
—
5
0
1957
18665
8
14
1951
18625
20
37
1916
18342
46
47
1784
17225
2-person team, doctor-nurse
ZXY51 [2001311525]
ZXY51 [2001311525]
1.6e+00
1.2e+00
—
—
—
2.6e+00
3.3e+00
cases:0.52%
controls:0.10%
cases:0.25%
controls:0.08%
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:1.09%
controls:0.04%
10
19
1928
18429
5
15
1957
18650
—
—
—
7
5
1929
18374
20
7
1810
17265
Buprenorphine [Presence] in Urine by Screen method
93494-3 [1001926]
93494-3 [1001926]
8.4e-01
2.0e+00
2.7e+00
—
—
1.3e+00
1.4e+00
cases:0.93%
controls:0.40%
cases:1.48%
controls:0.20%
cases:0.41%
controls:0.03%
—
—
—
—
cases:0.83%
controls:0.22%
cases:3.17%
controls:0.80%
18
74
1920
18374
29
37
1933
18628
8
5
1954
18660
—
—
16
40
1920
18339
58
138
1772
17134
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.2e+00
2.3e+00
—
—
—
2.3e+00
1.8e+00
cases:0.98%
controls:0.31%
cases:0.51%
controls:0.05%
—
—
—
—
—
—
cases:0.88%
controls:0.09%
cases:2.19%
controls:0.38%
19
57
1919
18391
10
10
1952
18655
—
—
—
17
17
1919
18362
40
66
1790
17206
Cocaine [Presence] in Urine
3397-7 [3016879]
3397-7 [3016879]
7.5e-01
2.0e+00
2.8e+00
—
—
1.2e+00
1.3e+00
cases:0.98%
controls:0.47%
cases:1.68%
controls:0.23%
cases:0.46%
controls:0.03%
—
—
—
—
cases:0.88%
controls:0.26%
cases:3.50%
controls:0.96%
19
86
1919
18362
33
42
1929
18623
9
5
1953
18660
—
—
17
48
1919
18331
64
165
1766
17107
Receptive language disorder
F80.2 [45576561]
F80.2 [45576561]
1.3e+00
1.5e+00
—
—
1.8e+00
1.3e+00
1.4e+00
cases:1.03%
controls:0.29%
cases:0.87%
controls:0.19%
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.88%
controls:0.23%
cases:1.26%
controls:0.30%
20
54
1918
18394
17
35
1945
18630
—
—
7
11
1952
18628
17
43
1919
18336
23
52
1807
17220
Faecal incontinence
R15 [45573014]
R15 [45573014]
2.2e+00
2.8e+00
—
—
—
—
2.4e+00
cases:0.52%
controls:0.06%
cases:0.51%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.06%
10
11
1928
18437
10
6
1952
18659
—
—
—
—
12
10
1818
17262
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
6.6e-01
1.2e+00
1.3e+00
1.0e+50
2.1e+00
1.9e+00
1.4e+00
cases:5.78%
controls:3.08%
cases:3.52%
controls:1.07%
cases:0.51%
controls:0.14%
cases:0.46%
controls:0.00%
cases:0.87%
controls:0.10%
cases:3.77%
controls:0.58%
cases:4.64%
controls:1.22%
112
569
1826
17879
69
199
1893
18466
10
27
1952
18638
9
0
1953
18665
17
19
1942
18620
73
106
1863
18273
85
211
1745
17061
Benzodiazepines [Presence] in Urine
3390-2 [3000764]
3390-2 [3000764]
7.3e-01
2.0e+00
2.8e+00
—
—
1.2e+00
1.2e+00
cases:0.98%
controls:0.48%
cases:1.68%
controls:0.23%
cases:0.46%
controls:0.03%
—
—
—
—
cases:0.88%
controls:0.27%
cases:3.61%
controls:1.07%
19
88
1919
18360
33
43
1929
18622
9
5
1953
18660
—
—
17
49
1919
18330
66
184
1764
17088
Opiates [Presence] in Urine
3879-4 [3027008]
3879-4 [3027008]
7.0e-01
2.0e+00
2.8e+00
—
—
1.2e+00
1.3e+00
cases:0.98%
controls:0.49%
cases:1.68%
controls:0.23%
cases:0.46%
controls:0.03%
—
—
—
—
cases:0.88%
controls:0.27%
cases:3.61%
controls:1.06%
19
90
1919
18358
33
43
1929
18622
9
5
1953
18660
—
—
17
50
1919
18329
66
183
1764
17089
Inpatient Hospital
21 [8717]
21 [8717]
4.1e-02
2.6e-01
4.0e-01
5.1e+00
1.0e+00
5.8e-01
3.1e-01
cases:31.53%
controls:30.65%
cases:12.59%
controls:10.01%
cases:2.09%
controls:1.40%
cases:7.19%
controls:0.05%
cases:3.73%
controls:1.36%
cases:14.62%
controls:8.75%
cases:28.14%
controls:22.25%
611
5654
1327
12794
247
1868
1715
16797
41
262
1921
18403
141
9
1821
18656
73
253
1886
18386
283
1608
1653
16771
515
3843
1315
13429
Cannabinoids [Presence] in Urine
3427-2 [3028300]
3427-2 [3028300]
7.0e-01
2.0e+00
2.8e+00
—
—
1.2e+00
1.2e+00
cases:0.98%
controls:0.49%
cases:1.68%
controls:0.23%
cases:0.46%
controls:0.03%
—
—
—
—
cases:0.88%
controls:0.27%
cases:3.61%
controls:1.08%
19
90
1919
18358
33
43
1929
18622
9
5
1953
18660
—
—
17
50
1919
18329
66
186
1764
17086
General evaluation of the need for rehabilitation
R1100 [2001310172]
R1100 [2001310172]
1.2e+00
1.8e+00
—
—
—
2.1e+00
2.0e+00
cases:1.70%
controls:0.51%
cases:0.76%
controls:0.12%
—
—
—
—
—
—
cases:0.88%
controls:0.11%
cases:1.86%
controls:0.24%
33
94
1905
18354
15
23
1947
18642
—
—
—
17
20
1919
18359
34
42
1796
17230
Lower urinary tract urodynamic studies
252896003 [4099392]
252896003 [4099392]
1.8e+00
2.6e+00
—
1.0e+50
—
—
2.8e+00
cases:0.46%
controls:0.08%
cases:0.36%
controls:0.03%
—
—
cases:0.36%
controls:0.00%
—
—
—
—
cases:0.93%
controls:0.06%
9
14
1929
18434
7
5
1955
18660
—
7
0
1955
18665
—
—
17
10
1813
17262
Other specified urinary incontinence
N39.4 [45577525]
N39.4 [45577525]
1.3e+00
1.8e+00
—
—
—
2.0e+00
2.0e+00
cases:0.57%
controls:0.16%
cases:0.56%
controls:0.09%
—
—
—
—
—
—
cases:0.67%
controls:0.09%
cases:1.09%
controls:0.14%
11
29
1927
18419
11
17
1951
18648
—
—
—
13
16
1923
18363
20
25
1810
17247
Neurology
13 [38004458]
13 [38004458]
9.0e-01
1.1e+00
1.6e+00
—
1.6e+00
1.2e+00
7.9e-01
cases:6.09%
controls:2.56%
cases:3.77%
controls:1.31%
cases:1.12%
controls:0.24%
—
—
cases:1.28%
controls:0.26%
cases:4.60%
controls:1.43%
cases:8.52%
controls:4.04%
118
473
1820
17975
74
245
1888
18420
22
44
1940
18621
—
25
48
1934
18591
89
262
1847
18117
156
698
1674
16574
Procedure duration 10 to 19 minutes
ZXE02 [2001311396]
ZXE02 [2001311396]
9.2e-01
1.0e+00
—
—
2.1e+00
2.3e+00
2.7e+00
cases:0.88%
controls:0.35%
cases:0.51%
controls:0.18%
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.83%
controls:0.09%
cases:1.69%
controls:0.11%
17
65
1921
18383
10
34
1952
18631
—
—
7
8
1952
18631
16
16
1920
18363
31
19
1799
17253
Psychiatric treatment plan, standard
ICB01 [2001304098]
ICB01 [2001304098]
1.4e+00
8.3e-01
—
—
2.3e+00
1.8e+00
1.6e+00
cases:1.08%
controls:0.27%
cases:0.61%
controls:0.27%
—
—
—
—
cases:0.31%
controls:0.03%
cases:1.91%
controls:0.31%
cases:3.44%
controls:0.74%
21
50
1917
18398
12
50
1950
18615
—
—
6
6
1953
18633
37
57
1899
18322
63
127
1767
17145
Bipolar affective disorder, currently in remission
F31.7 [45581457]
F31.7 [45581457]
1.9e+00
2.4e+00
—
—
—
—
2.8e+00
cases:0.52%
controls:0.08%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.82%
controls:0.05%
10
15
1928
18433
6
5
1956
18660
—
—
—
—
15
9
1815
17263
Stress incontinence
N39.3 [45539046]
N39.3 [45539046]
1.6e+00
2.2e+00
—
1.0e+50
—
2.0e+00
1.3e+00
cases:0.57%
controls:0.12%
cases:0.51%
controls:0.06%
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.36%
controls:0.05%
cases:0.66%
controls:0.18%
11
22
1927
18426
10
11
1952
18654
—
6
0
1956
18665
—
7
9
1929
18370
12
31
1818
17241
Dysthymia
F34.1 [45586238]
F34.1 [45586238]
1.7e+00
1.5e+00
2.3e+00
—
—
2.2e+00
1.5e+00
cases:0.77%
controls:0.14%
cases:0.51%
controls:0.11%
cases:0.25%
controls:0.03%
—
—
—
—
cases:0.83%
controls:0.09%
cases:1.04%
controls:0.23%
15
25
1923
18423
10
21
1952
18644
5
5
1957
18660
—
—
16
17
1920
18362
19
40
1811
17232
Profession-specific psychiatric evaluation
IBZ01 [2001304075]
IBZ01 [2001304075]
1.7e+00
1.4e+00
—
—
—
1.9e+00
1.9e+00
cases:0.93%
controls:0.17%
cases:0.82%
controls:0.20%
—
—
—
—
—
—
cases:1.14%
controls:0.18%
cases:2.73%
controls:0.41%
18
32
1920
18416
16
38
1946
18627
—
—
—
22
33
1914
18346
50
70
1780
17202
paroxetine; oral
N06AB05 [21604713]
N06AB05 [21604713]
1.5e+00
1.6e+00
—
—
—
2.1e+00
1.7e+00
cases:0.98%
controls:0.22%
cases:0.56%
controls:0.12%
—
—
—
—
—
—
cases:0.72%
controls:0.09%
cases:1.31%
controls:0.24%
19
41
1919
18407
11
22
1951
18643
—
—
—
14
17
1922
18362
24
41
1806
17231
Amphetamines [Presence] in Urine
3349-8 [3027944]
3349-8 [3027944]
7.3e-01
1.9e+00
2.6e+00
—
—
1.2e+00
1.2e+00
cases:0.98%
controls:0.48%
cases:1.43%
controls:0.22%
cases:0.36%
controls:0.03%
—
—
—
—
cases:0.83%
controls:0.26%
cases:3.44%
controls:1.08%
19
88
1919
18360
28
41
1934
18624
7
5
1955
18660
—
—
16
47
1920
18332
63
187
1767
17085
Nonorganic insomnia
F51.0 [45552492]
F51.0 [45552492]
8.0e-01
1.1e+00
—
—
2.4e+00
1.1e+00
1.4e+00
cases:1.55%
controls:0.70%
cases:0.92%
controls:0.31%
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.72%
controls:0.24%
cases:3.39%
controls:0.89%
30
130
1908
18318
18
57
1944
18608
—
—
6
5
1953
18634
14
45
1922
18334
62
154
1768
17118
Schizophrenia, unspecified
F20.9 [45576533]
F20.9 [45576533]
2.3e+00
2.3e+00
—
—
—
—
2.2e+00
cases:0.46%
controls:0.05%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
—
—
cases:1.09%
controls:0.12%
9
9
1929
18439
6
6
1956
18659
—
—
—
—
20
21
1810
17251
Pediatric Medicine
37 [38004477]
37 [38004477]
-1.5e-01
-1.4e-01
-1.4e-01
4.9e+00
1.1e+00
4.7e-01
2.5e-01
cases:34.16%
controls:37.62%
cases:21.97%
controls:24.44%
cases:5.71%
controls:6.49%
cases:27.27%
controls:0.29%
cases:17.30%
controls:6.37%
cases:31.92%
controls:22.60%
cases:34.81%
controls:29.42%
662
6940
1276
11508
431
4561
1531
14104
112
1211
1850
17454
535
54
1427
18611
339
1188
1620
17451
618
4154
1318
14225
637
5082
1193
12190
Other depressive episodes
F32.8 [45571759]
F32.8 [45571759]
2.2e+00
2.7e+00
—
—
—
—
1.8e+00
cases:0.46%
controls:0.05%
cases:0.41%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.66%
controls:0.11%
9
10
1929
18438
8
5
1954
18660
—
—
—
—
12
19
1818
17253
Mild depressive episode without somatic syndrome
F32.00 [2000501978]
F32.00 [2000501978]
1.7e+00
1.6e+00
—
1.0e+50
—
2.0e+00
1.4e+00
cases:1.08%
controls:0.20%
cases:0.51%
controls:0.11%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.88%
controls:0.13%
cases:1.58%
controls:0.39%
21
37
1917
18411
10
20
1952
18645
—
7
0
1955
18665
—
17
23
1919
18356
29
67
1801
17205
Atypical anorexia nervosa
F50.1 [45586245]
F50.1 [45586245]
2.3e+00
2.8e+00
—
—
—
1.9e+00
1.6e+00
cases:0.36%
controls:0.04%
cases:0.51%
controls:0.03%
—
—
—
—
—
—
cases:0.26%
controls:0.04%
cases:0.82%
controls:0.17%
7
7
1931
18441
10
6
1952
18659
—
—
—
5
7
1931
18372
15
30
1815
17242
Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine
331 [2001600292]
331 [2001600292]
1.8e+00
2.0e+00
—
—
—
2.6e+00
2.1e+00
cases:0.46%
controls:0.08%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.98%
controls:0.07%
cases:2.51%
controls:0.31%
9
14
1929
18434
6
8
1956
18657
—
—
—
19
13
1917
18366
46
53
1784
17219
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
2.0e+00
—
-1.0e+50
—
—
2.4e+00
2.2e+00
cases:0.62%
controls:0.08%
—
—
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.46%
controls:0.04%
cases:0.66%
controls:0.08%
12
15
1926
18433
—
0
5
1962
18660
—
—
9
8
1927
18371
12
13
1818
17259
Recurrent depressive disorder, currently in remission
F33.4 [45533100]
F33.4 [45533100]
1.5e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.9e+00
cases:0.41%
controls:0.09%
cases:0.56%
controls:0.06%
—
—
cases:0.41%
controls:0.00%
—
—
cases:0.93%
controls:0.08%
cases:1.64%
controls:0.26%
8
17
1930
18431
11
12
1951
18653
—
8
0
1954
18665
—
18
15
1918
18364
30
45
1800
17227
Child-centred family therapy
IEP02 [2001304194]
IEP02 [2001304194]
1.0e+00
1.1e+00
—
—
2.3e+00
1.9e+00
1.2e+00
cases:0.72%
controls:0.25%
cases:0.61%
controls:0.21%
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.93%
controls:0.14%
cases:1.26%
controls:0.37%
14
47
1924
18401
12
40
1950
18625
—
—
6
6
1953
18633
18
25
1918
18354
23
64
1807
17208
Diagnostic and symptom-mapping evaluation
IBA01 [2001304043]
IBA01 [2001304043]
1.4e+00
1.6e+00
—
—
—
2.2e+00
1.3e+00
cases:0.67%
controls:0.17%
cases:0.66%
controls:0.13%
—
—
—
—
—
—
cases:0.93%
controls:0.10%
cases:1.64%
controls:0.47%
13
31
1925
18417
13
25
1949
18640
—
—
—
18
19
1918
18360
30
82
1800
17190
Feeling anxious/nervous/tense
P01 [2002000798]
P01 [2002000798]
7.8e-01
1.3e+00
2.3e+00
—
1.6e+00
1.3e+00
8.3e-01
cases:2.32%
controls:1.07%
cases:1.83%
controls:0.52%
cases:0.82%
controls:0.09%
—
—
cases:0.41%
controls:0.09%
cases:1.86%
controls:0.52%
cases:5.96%
controls:2.69%
45
198
1893
18250
36
97
1926
18568
16
16
1946
18649
—
8
16
1951
18623
36
95
1900
18284
109
465
1721
16807
acetylsalicylic acid; oral
B01AC06 [21600991]
B01AC06 [21600991]
9.2e-01
1.0e+00
1.9e+00
—
1.4e+00
1.5e+00
1.1e+00
cases:1.08%
controls:0.43%
cases:0.76%
controls:0.27%
cases:0.46%
controls:0.07%
—
—
cases:0.26%
controls:0.06%
cases:0.83%
controls:0.18%
cases:0.98%
controls:0.34%
21
80
1917
18368
15
51
1947
18614
9
13
1953
18652
—
5
12
1954
18627
16
34
1920
18345
18
58
1812
17214
Moderate depressive episode
F32.1 [45552478]
F32.1 [45552478]
1.0e+00
2.1e+00
—
1.0e+50
2.3e+00
2.0e+00
1.3e+00
cases:0.77%
controls:0.28%
cases:0.76%
controls:0.10%
—
—
cases:0.36%
controls:0.00%
cases:0.26%
controls:0.03%
cases:0.93%
controls:0.13%
cases:1.69%
controls:0.47%
15
51
1923
18397
15
18
1947
18647
—
7
0
1955
18665
5
5
1954
18634
18
23
1918
18356
31
82
1799
17190
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
1.1e+00
1.4e+00
1.3e+00
—
1.5e+00
1.8e+00
2.0e+00
cases:1.19%
controls:0.38%
cases:1.12%
controls:0.29%
cases:0.31%
controls:0.08%
—
—
cases:0.41%
controls:0.09%
cases:1.65%
controls:0.27%
cases:3.99%
controls:0.55%
23
70
1915
18378
22
54
1940
18611
6
15
1956
18650
—
8
17
1951
18622
32
49
1904
18330
73
95
1757
17177
UNS Panic Syndrome
F41.09 [2000501997]
F41.09 [2000501997]
1.3e+00
2.0e+00
—
—
—
1.8e+00
1.2e+00
cases:0.77%
controls:0.21%
cases:0.61%
controls:0.08%
—
—
—
—
—
—
cases:0.46%
controls:0.08%
cases:1.04%
controls:0.32%
15
38
1923
18410
12
15
1950
18650
—
—
—
9
14
1927
18365
19
56
1811
17216
Other stressful life events affecting family and household
Z63.7 [45537662]
Z63.7 [45537662]
5.9e-01
9.9e-01
1.9e+00
1.0e+50
1.7e+00
1.1e+00
6.5e-01
cases:1.81%
controls:1.01%
cases:1.43%
controls:0.54%
cases:0.61%
controls:0.10%
cases:0.56%
controls:0.00%
cases:0.56%
controls:0.10%
cases:1.34%
controls:0.45%
cases:1.80%
controls:0.95%
35
186
1903
18262
28
100
1934
18565
12
18
1950
18647
11
0
1951
18665
11
19
1948
18620
26
83
1910
18296
33
164
1797
17108
Childhood emotional disorder, unspecified
F93.9 [45538091]
F93.9 [45538091]
1.4e+00
2.4e+00
—
—
—
2.4e+00
1.5e+00
cases:0.46%
controls:0.12%
cases:0.56%
controls:0.05%
—
—
—
—
—
—
cases:0.62%
controls:0.05%
cases:0.77%
controls:0.17%
9
22
1929
18426
11
10
1951
18655
—
—
—
12
10
1924
18369
14
30
1816
17242
Moderate panic disorder
F41.00 [2000501994]
F41.00 [2000501994]
1.9e+00
2.3e+00
—
—
—
2.4e+00
2.0e+00
cases:0.46%
controls:0.07%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:0.82%
controls:0.12%
9
13
1929
18435
5
5
1957
18660
—
—
—
7
6
1929
18373
15
20
1815
17252
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.7e-01
4.6e-01
9.5e-01
2.6e+00
1.1e+00
5.8e-01
5.9e-01
cases:14.09%
controls:12.10%
cases:12.08%
controls:7.99%
cases:3.62%
controls:1.44%
cases:1.22%
controls:0.09%
cases:3.78%
controls:1.33%
cases:11.83%
controls:7.00%
cases:24.59%
controls:15.28%
273
2233
1665
16215
237
1491
1725
17174
71
268
1891
18397
24
17
1938
18648
74
247
1885
18392
229
1286
1707
17093
450
2640
1380
14632
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-9.0e-01
-5.4e-01
—
—
2.4e+00
2.3e+00
3.0e+00
cases:8.10%
controls:17.77%
cases:3.87%
controls:6.49%
—
—
—
—
cases:0.31%
controls:0.03%
cases:3.31%
controls:0.35%
cases:11.86%
controls:0.69%
157
3278
1781
15170
76
1211
1886
17454
—
—
6
5
1953
18634
64
64
1872
18315
217
119
1613
17153
Obsessive-compulsive disorder, unspecified
F42.9 [45600745]
F42.9 [45600745]
2.1e+00
2.3e+00
—
—
—
2.6e+00
1.5e+00
cases:0.31%
controls:0.04%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:0.55%
controls:0.12%
6
7
1932
18441
5
5
1957
18660
—
—
—
7
5
1929
18374
10
21
1820
17251
Methadone [Presence] in Urine by Screen method
19550-3 [3028707]
19550-3 [3028707]
9.5e-01
2.5e+00
—
—
—
1.8e+00
1.9e+00
cases:0.67%
controls:0.26%
cases:1.48%
controls:0.12%
—
—
—
—
—
—
cases:0.72%
controls:0.13%
cases:2.90%
controls:0.43%
13
48
1925
18400
29
23
1933
18642
—
—
—
14
23
1922
18356
53
74
1777
17198
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.6e-01
4.5e-01
9.5e-01
2.6e+00
1.0e+00
5.7e-01
5.9e-01
cases:13.93%
controls:12.10%
cases:11.88%
controls:7.95%
cases:3.62%
controls:1.43%
cases:1.22%
controls:0.09%
cases:3.68%
controls:1.36%
cases:11.73%
controls:7.00%
cases:24.54%
controls:15.28%
270
2233
1668
16215
233
1483
1729
17182
71
266
1891
18399
24
17
1938
18648
72
254
1887
18385
227
1286
1709
17093
449
2639
1381
14633
alprazolam; oral
N05BA12 [21604577]
N05BA12 [21604577]
1.7e+00
1.6e+00
—
—
—
1.6e+00
1.3e+00
cases:1.29%
controls:0.25%
cases:0.76%
controls:0.15%
—
—
—
—
—
—
cases:0.62%
controls:0.13%
cases:1.31%
controls:0.37%
25
46
1913
18402
15
28
1947
18637
—
—
—
12
23
1924
18356
24
64
1806
17208
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
9.5e-01
1.3e+00
1.2e+00
—
1.3e+00
1.6e+00
1.1e+00
cases:3.51%
controls:1.39%
cases:2.65%
controls:0.75%
cases:0.61%
controls:0.19%
—
—
cases:0.71%
controls:0.20%
cases:3.56%
controls:0.77%
cases:6.72%
controls:2.33%
68
257
1870
18191
52
140
1910
18525
12
36
1950
18629
—
14
38
1945
18601
69
142
1867
18237
123
402
1707
16870
Bedwetting/enuresis
P12 [2002000809]
P12 [2002000809]
1.6e+00
2.4e+00
—
—
—
—
2.1e+00
cases:0.46%
controls:0.10%
cases:0.31%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.33%
controls:0.04%
9
18
1929
18430
6
5
1956
18660
—
—
—
—
6
7
1824
17265
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
1.2e+00
1.9e+00
—
—
—
1.9e+00
1.1e+00
cases:1.34%
controls:0.40%
cases:1.12%
controls:0.17%
—
—
—
—
—
—
cases:1.03%
controls:0.16%
cases:2.90%
controls:1.00%
26
73
1912
18375
22
32
1940
18633
—
—
—
20
29
1916
18350
53
172
1777
17100
Other disorders of psychological development
F88 [45538087]
F88 [45538087]
1.7e+00
1.3e+00
—
—
—
2.2e+00
2.3e+00
cases:0.52%
controls:0.10%
cases:0.36%
controls:0.10%
—
—
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.04%
controls:0.11%
10
18
1928
18430
7
18
1955
18647
—
—
—
11
12
1925
18367
19
19
1811
17253
Dedicated profession-specific psychiatric intervention, individual
IEY05 [2001304224]
IEY05 [2001304224]
1.0e+00
1.4e+00
—
—
1.3e+00
1.8e+00
1.8e+00
cases:0.72%
controls:0.25%
cases:0.76%
controls:0.19%
—
—
—
—
cases:0.41%
controls:0.11%
cases:1.24%
controls:0.21%
cases:3.11%
controls:0.53%
14
47
1924
18401
15
35
1947
18630
—
—
8
21
1951
18618
24
38
1912
18341
57
91
1773
17181
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
4.6e-01
9.1e-01
1.6e+00
—
1.6e+00
7.4e-01
7.1e-01
cases:3.51%
controls:2.25%
cases:2.24%
controls:0.91%
cases:0.61%
controls:0.12%
—
—
cases:0.56%
controls:0.11%
cases:1.91%
controls:0.92%
cases:5.30%
controls:2.68%
68
416
1870
18032
44
170
1918
18495
12
23
1950
18642
—
11
21
1948
18618
37
169
1899
18210
97
463
1733
16809
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
2.8e-01
4.2e-01
9.0e-01
2.3e+00
1.1e+00
5.7e-01
8.0e-01
cases:7.69%
controls:5.95%
cases:4.94%
controls:3.29%
cases:1.53%
controls:0.63%
cases:0.41%
controls:0.04%
cases:1.48%
controls:0.51%
cases:4.44%
controls:2.56%
cases:10.55%
controls:5.01%
149
1097
1789
17351
97
614
1865
18051
30
117
1932
18548
8
8
1954
18657
29
95
1930
18544
86
470
1850
17909
193
866
1637
16406
Procedure duration 50 to 59 minutes
ZXE06 [2001311400]
ZXE06 [2001311400]
1.1e+00
1.2e+00
1.7e+00
1.0e+50
1.6e+00
1.5e+00
2.2e+00
cases:2.17%
controls:0.74%
cases:1.22%
controls:0.36%
cases:0.25%
controls:0.05%
cases:0.25%
controls:0.00%
cases:0.36%
controls:0.07%
cases:1.03%
controls:0.22%
cases:2.84%
controls:0.33%
42
136
1896
18312
24
68
1938
18597
5
9
1957
18656
5
0
1957
18665
7
13
1952
18626
20
41
1916
18338
52
57
1778
17215
propranolol; oral, parenteral
C07AA05 [21601670]
C07AA05 [21601670]
4.9e-01
9.5e-01
1.1e+00
—
1.6e+00
8.3e-01
9.8e-01
cases:3.20%
controls:1.98%
cases:2.70%
controls:1.06%
cases:0.71%
controls:0.24%
—
—
cases:0.82%
controls:0.16%
cases:2.32%
controls:1.03%
cases:6.56%
controls:2.58%
62
366
1876
18082
53
198
1909
18467
14
44
1948
18621
—
16
30
1943
18609
45
189
1891
18190
120
445
1710
16827
Other specified anxiety disorders
F41.8 [45595908]
F41.8 [45595908]
1.5e+00
2.3e+00
—
1.0e+50
—
2.2e+00
9.4e-01
cases:0.52%
controls:0.11%
cases:0.41%
controls:0.04%
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.62%
controls:0.07%
cases:0.77%
controls:0.30%
10
21
1928
18427
8
8
1954
18657
—
7
0
1955
18665
—
12
13
1924
18366
14
52
1816
17220
Therapeutic discussion
SPAT1240 [2001700341]
SPAT1240 [2001700341]
9.2e-01
1.3e+00
1.8e+00
—
1.4e+00
1.1e+00
7.5e-01
cases:2.48%
controls:1.00%
cases:1.38%
controls:0.39%
cases:0.66%
controls:0.11%
—
—
cases:0.36%
controls:0.09%
cases:1.39%
controls:0.45%
cases:3.77%
controls:1.82%
48
184
1890
18264
27
72
1935
18593
13
20
1949
18645
—
7
17
1952
18622
27
82
1909
18297
69
314
1761
16958
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.8e+00
1.8e+00
—
—
—
1.9e+00
2.1e+00
cases:1.08%
controls:0.17%
cases:0.31%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.08%
cases:1.75%
controls:0.21%
21
32
1917
18416
6
9
1956
18656
—
—
—
10
14
1926
18365
32
36
1798
17236
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.8e-01
3.7e-01
9.7e-01
2.3e+00
1.2e+00
6.0e-01
8.5e-01
cases:7.38%
controls:5.69%
cases:4.49%
controls:3.13%
cases:1.53%
controls:0.58%
cases:0.41%
controls:0.04%
cases:1.48%
controls:0.45%
cases:4.29%
controls:2.40%
cases:10.11%
controls:4.58%
143
1050
1795
17398
88
584
1874
18081
30
109
1932
18556
8
8
1954
18657
29
84
1930
18555
83
442
1853
17937
185
791
1645
16481
buspirone; oral
N05BE01 [21604601]
N05BE01 [21604601]
2.5e+00
—
—
—
—
—
3.4e+00
cases:0.57%
controls:0.05%
—
—
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.03%
11
9
1927
18439
—
—
—
—
—
19
6
1811
17266
aripiprazole; oral, parenteral
N05AX12 [21604562]
N05AX12 [21604562]
1.4e+00
1.2e+00
8.7e-01
—
1.3e+00
1.4e+00
1.9e+00
cases:1.34%
controls:0.33%
cases:0.87%
controls:0.27%
cases:0.25%
controls:0.11%
—
—
cases:0.36%
controls:0.10%
cases:1.08%
controls:0.28%
cases:3.66%
controls:0.57%
26
61
1912
18387
17
50
1945
18615
5
20
1957
18645
—
7
18
1952
18621
21
52
1915
18327
67
98
1763
17174
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
F81.9 [45581474]
2.0e+00
2.0e+00
—
—
—
2.6e+00
1.2e+00
cases:0.31%
controls:0.04%
cases:0.36%
controls:0.05%
—
—
—
—
—
—
cases:0.52%
controls:0.04%
cases:0.82%
controls:0.24%
6
8
1932
18440
7
9
1955
18656
—
—
—
10
7
1926
18372
15
42
1815
17230
Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
21573-1 [3003031]
21573-1 [3003031]
5.0e-01
1.7e+00
1.9e+00
—
2.3e+00
1.1e+00
1.1e+00
cases:1.29%
controls:0.79%
cases:1.53%
controls:0.29%
cases:0.36%
controls:0.05%
—
—
cases:0.26%
controls:0.03%
cases:0.98%
controls:0.32%
cases:3.55%
controls:1.23%
25
145
1913
18303
30
54
1932
18611
7
10
1955
18655
—
5
5
1954
18634
19
58
1917
18321
65
212
1765
17060
Psychiatric monitoring contact
IGY02 [2001304322]
IGY02 [2001304322]
7.1e-01
1.1e+00
—
—
2.2e+00
1.3e+00
1.2e+00
cases:0.83%
controls:0.41%
cases:0.87%
controls:0.29%
—
—
—
—
cases:0.46%
controls:0.05%
cases:1.24%
controls:0.35%
cases:2.51%
controls:0.76%
16
75
1922
18373
17
55
1945
18610
—
—
9
10
1950
18629
24
65
1912
18314
46
131
1784
17141
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
2.9e-01
1.2e+00
—
—
1.8e+00
1.2e+00
1.5e+00
cases:2.17%
controls:1.63%
cases:1.33%
controls:0.42%
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.93%
controls:0.27%
cases:1.75%
controls:0.40%
42
300
1896
18148
26
79
1936
18586
—
—
7
11
1952
18628
18
50
1918
18329
32
69
1798
17203
sertraline; oral
N06AB06 [21604714]
N06AB06 [21604714]
1.5e+00
1.4e+00
1.3e+00
—
1.2e+00
1.3e+00
1.4e+00
cases:2.68%
controls:0.59%
cases:1.78%
controls:0.44%
cases:0.51%
controls:0.14%
—
—
cases:0.46%
controls:0.14%
cases:2.12%
controls:0.57%
cases:5.63%
controls:1.45%
52
108
1886
18340
35
83
1927
18582
10
27
1952
18638
—
9
27
1950
18612
41
105
1895
18274
103
251
1727
17021
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
6.0e-01
9.2e-01
1.2e+00
—
1.5e+00
1.4e+00
1.2e+00
cases:2.01%
controls:1.12%
cases:1.68%
controls:0.68%
cases:0.46%
controls:0.14%
—
—
cases:0.66%
controls:0.14%
cases:2.07%
controls:0.51%
cases:3.22%
controls:0.99%
39
206
1899
18242
33
126
1929
18539
9
27
1953
18638
—
13
27
1946
18612
40
94
1896
18285
59
171
1771
17101
Procedure duration 120 to 149 minutes
ZXE15 [2001311406]
ZXE15 [2001311406]
1.1e+00
6.0e-01
—
—
—
1.7e+00
2.8e+00
cases:1.08%
controls:0.35%
cases:0.41%
controls:0.23%
—
—
—
—
—
—
cases:0.41%
controls:0.08%
cases:1.15%
controls:0.07%
21
64
1917
18384
8
42
1954
18623
—
—
—
8
14
1928
18365
21
12
1809
17260
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
6.2e-01
1.2e+00
1.7e+00
—
1.2e+00
9.8e-01
1.1e+00
cases:3.41%
controls:1.86%
cases:1.99%
controls:0.64%
cases:0.66%
controls:0.12%
—
—
cases:0.46%
controls:0.14%
cases:1.76%
controls:0.67%
cases:4.04%
controls:1.39%
66
343
1872
18105
39
119
1923
18546
13
22
1949
18643
—
9
26
1950
18613
34
123
1902
18256
74
240
1756
17032
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
2.8e-01
2.6e-01
7.3e-01
2.6e+00
1.4e+00
6.8e-01
8.4e-01
cases:3.41%
controls:2.61%
cases:2.45%
controls:1.90%
cases:0.82%
controls:0.40%
cases:0.36%
controls:0.03%
cases:1.17%
controls:0.28%
cases:2.53%
controls:1.30%
cases:4.32%
controls:1.92%
66
481
1872
17967
48
355
1914
18310
16
74
1946
18591
7
5
1955
18660
23
53
1936
18586
49
239
1887
18140
79
331
1751
16941
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
3.8e-01
8.9e-01
1.6e+00
—
2.0e+00
1.1e+00
2.8e-01
cases:4.64%
controls:3.21%
cases:3.52%
controls:1.47%
cases:1.12%
controls:0.24%
—
—
cases:1.48%
controls:0.21%
cases:4.24%
controls:1.46%
cases:6.12%
controls:4.70%
90
593
1848
17855
69
275
1893
18390
22
44
1940
18621
—
29
39
1930
18600
82
268
1854
18111
112
811
1718
16461
Participation in compiling a psychiatric treatment plan
ICZ03 [2001304119]
ICZ03 [2001304119]
1.2e+00
1.1e+00
—
1.0e+50
—
1.7e+00
1.6e+00
cases:1.14%
controls:0.36%
cases:0.87%
controls:0.30%
—
—
cases:0.51%
controls:0.00%
—
—
cases:1.76%
controls:0.32%
cases:3.22%
controls:0.69%
22
66
1916
18382
17
56
1945
18609
—
10
0
1952
18665
—
34
59
1902
18320
59
120
1771
17152
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.3e-01
4.0e-01
7.0e-01
2.6e+00
8.0e-01
4.9e-01
4.4e-01
cases:14.55%
controls:12.99%
cases:13.10%
controls:9.16%
cases:3.62%
controls:1.84%
cases:1.17%
controls:0.09%
cases:3.68%
controls:1.68%
cases:13.22%
controls:8.52%
cases:25.03%
controls:17.63%
282
2397
1656
16051
257
1710
1705
16955
71
343
1891
18322
23
16
1939
18649
72
313
1887
18326
256
1565
1680
16814
458
3045
1372
14227
Psychiatric network contact
IGV01 [2001304319]
IGV01 [2001304319]
1.7e+00
1.1e+00
—
—
—
1.8e+00
2.0e+00
cases:0.62%
controls:0.11%
cases:0.41%
controls:0.14%
—
—
—
—
—
—
cases:0.88%
controls:0.15%
cases:1.69%
controls:0.24%
12
20
1926
18428
8
26
1954
18639
—
—
—
17
28
1919
18351
31
42
1799
17230
Personality disorder, unspecified
F60.9 [45538076]
F60.9 [45538076]
2.5e+00
—
—
—
—
—
2.9e+00
cases:0.46%
controls:0.04%
—
—
—
—
—
—
—
—
—
—
cases:0.87%
controls:0.05%
9
7
1929
18441
—
—
—
—
—
16
8
1814
17264
Expressive language disorder
F80.1 [45595921]
F80.1 [45595921]
5.1e-01
8.5e-01
2.4e+00
1.0e+50
2.3e+00
3.7e-01
8.0e-01
cases:1.19%
controls:0.72%
cases:0.97%
controls:0.42%
cases:0.46%
controls:0.04%
cases:0.36%
controls:0.00%
cases:0.56%
controls:0.06%
cases:0.67%
controls:0.46%
cases:1.26%
controls:0.57%
23
132
1915
18316
19
78
1943
18587
9
8
1953
18657
7
0
1955
18665
11
11
1948
18628
13
85
1923
18294
23
98
1807
17174
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.1e-01
4.0e-01
6.5e-01
3.0e+00
7.8e-01
3.3e-01
3.0e-01
cases:7.89%
controls:6.47%
cases:6.32%
controls:4.32%
cases:1.68%
controls:0.89%
cases:0.82%
controls:0.04%
cases:1.74%
controls:0.80%
cases:6.30%
controls:4.60%
cases:12.84%
controls:9.87%
153
1194
1785
17254
124
806
1838
17859
33
166
1929
18499
16
8
1946
18657
34
150
1925
18489
122
845
1814
17534
235
1705
1595
15567
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 [3030306]
51485-1 [3030306]
6.3e-01
8.2e-01
1.6e+00
1.0e+50
1.2e+00
6.0e-01
5.7e-01
cases:2.89%
controls:1.56%
cases:2.34%
controls:1.05%
cases:0.76%
controls:0.16%
cases:0.31%
controls:0.00%
cases:0.66%
controls:0.20%
cases:2.07%
controls:1.15%
cases:3.83%
controls:2.20%
56
287
1882
18161
46
196
1916
18469
15
30
1947
18635
6
0
1956
18665
13
37
1946
18602
40
211
1896
18168
70
380
1760
16892
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 [3029879]
51486-9 [3029879]
6.4e-01
7.7e-01
1.6e+00
1.0e+50
1.2e+00
6.4e-01
5.4e-01
cases:3.04%
controls:1.63%
cases:2.29%
controls:1.07%
cases:0.76%
controls:0.16%
cases:0.31%
controls:0.00%
cases:0.66%
controls:0.20%
cases:2.12%
controls:1.13%
cases:3.77%
controls:2.24%
59
300
1879
18148
45
200
1917
18465
15
30
1947
18635
6
0
1956
18665
13
38
1946
18601
41
207
1895
18172
69
387
1761
16885
mirabegron; oral
G04BD12 [43534790]
G04BD12 [43534790]
1.1e+00
1.5e+00
1.6e+00
—
1.7e+00
1.4e+00
1.3e+00
cases:0.88%
controls:0.29%
cases:0.61%
controls:0.13%
cases:0.36%
controls:0.07%
—
—
cases:0.31%
controls:0.05%
cases:0.57%
controls:0.14%
cases:0.71%
controls:0.19%
17
54
1921
18394
12
25
1950
18640
7
13
1955
18652
—
6
10
1953
18629
11
26
1925
18353
13
33
1817
17239
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.1e+00
1.7e+00
—
—
—
1.3e+00
1.3e+00
cases:0.88%
controls:0.30%
cases:0.82%
controls:0.15%
—
—
—
—
—
—
cases:0.62%
controls:0.17%
cases:1.04%
controls:0.30%
17
56
1921
18392
16
28
1946
18637
—
—
—
12
32
1924
18347
19
51
1811
17221
Bipolar affective disorder
F31 [45595902]
F31 [45595902]
2.5e+00
—
—
—
—
2.3e+00
2.8e+00
cases:0.52%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.77%
controls:0.05%
10
8
1928
18440
—
—
—
—
5
5
1931
18374
14
8
1816
17264
Bipolar affective disorder, current episode mixed
F31.6 [45571757]
F31.6 [45571757]
2.1e+00
—
—
—
—
1.0e+50
3.1e+00
cases:0.41%
controls:0.05%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.00%
cases:0.77%
controls:0.03%
8
9
1930
18439
—
—
—
—
9
0
1927
18379
14
6
1816
17266
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 [3007220]
2157-6 [3007220]
5.0e-01
6.5e-01
1.2e+00
—
2.4e+00
1.4e+00
9.7e-01
cases:2.94%
controls:1.80%
cases:1.38%
controls:0.72%
cases:0.25%
controls:0.08%
—
—
cases:0.46%
controls:0.04%
cases:2.17%
controls:0.55%
cases:4.37%
controls:1.70%
57
332
1881
18116
27
135
1935
18530
5
14
1957
18651
—
9
8
1950
18631
42
102
1894
18277
80
294
1750
16978
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
4.3e-01
7.1e-01
1.4e+00
1.0e+50
1.3e+00
6.3e-01
7.1e-01
cases:5.26%
controls:3.50%
cases:3.57%
controls:1.79%
cases:1.07%
controls:0.26%
cases:0.31%
controls:0.00%
cases:0.92%
controls:0.26%
cases:2.63%
controls:1.42%
cases:6.34%
controls:3.22%
102
645
1836
17803
70
335
1892
18330
21
48
1941
18617
6
0
1956
18665
18
48
1941
18591
51
261
1885
18118
116
556
1714
16716
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.0e-01
2.9e-01
8.5e-01
2.5e+00
7.5e-01
4.2e-01
3.3e-01
cases:16.31%
controls:13.70%
cases:11.42%
controls:8.81%
cases:3.57%
controls:1.55%
cases:1.07%
controls:0.09%
cases:2.91%
controls:1.40%
cases:11.73%
controls:8.04%
cases:23.55%
controls:18.09%
316
2527
1622
15921
224
1645
1738
17020
70
290
1892
18375
21
16
1941
18649
57
261
1902
18378
227
1477
1709
16902
431
3124
1399
14148
trimethoprim; oral, parenteral
J01EA01 [21602931]
J01EA01 [21602931]
7.2e-01
1.1e+00
1.4e+00
—
1.2e+00
1.2e+00
7.9e-01
cases:4.44%
controls:2.21%
cases:2.29%
controls:0.79%
cases:0.56%
controls:0.14%
—
—
cases:0.46%
controls:0.14%
cases:2.38%
controls:0.73%
cases:6.34%
controls:2.98%
86
407
1852
18041
45
148
1917
18517
11
27
1951
18638
—
9
26
1950
18613
46
134
1890
18245
116
515
1714
16757
Constipation
K59.0 [45557663]
K59.0 [45557663]
1.3e+00
1.6e+00
—
1.0e+50
—
2.3e+00
8.3e-01
cases:1.39%
controls:0.38%
cases:0.82%
controls:0.17%
—
—
cases:0.31%
controls:0.00%
—
—
cases:1.03%
controls:0.11%
cases:1.09%
controls:0.48%
27
71
1911
18377
16
32
1946
18633
—
6
0
1956
18665
—
20
20
1916
18359
20
83
1810
17189
Other hyperkinetic disorders
F90.8 [45586262]
F90.8 [45586262]
—
—
—
—
—
2.9e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.03%
cases:1.09%
controls:0.13%
—
—
—
—
—
10
5
1926
18374
20
22
1810
17250
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
4.3e-01
6.7e-01
1.4e+00
1.0e+50
1.2e+00
6.0e-01
7.3e-01
cases:5.42%
controls:3.60%
cases:3.57%
controls:1.86%
cases:1.12%
controls:0.27%
cases:0.31%
controls:0.00%
cases:0.92%
controls:0.27%
cases:2.69%
controls:1.49%
cases:6.39%
controls:3.20%
105
665
1833
17783
70
347
1892
18318
22
51
1940
18614
6
0
1956
18665
18
51
1941
18588
52
273
1884
18106
117
553
1713
16719
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
7.1e-01
8.7e-01
7.1e-01
1.0e+50
1.6e+00
1.1e+00
7.7e-01
cases:5.73%
controls:2.89%
cases:3.67%
controls:1.57%
cases:0.51%
controls:0.25%
cases:0.41%
controls:0.00%
cases:0.92%
controls:0.19%
cases:3.51%
controls:1.16%
cases:5.36%
controls:2.54%
111
533
1827
17915
72
293
1890
18372
10
47
1952
18618
8
0
1954
18665
18
36
1941
18603
68
213
1868
18166
98
439
1732
16833
nitrofurantoin; oral
J01XE01 [21603058]
J01XE01 [21603058]
1.0e+00
1.3e+00
1.4e+00
—
—
1.8e+00
1.0e+00
cases:2.63%
controls:0.99%
cases:1.43%
controls:0.41%
cases:0.25%
controls:0.06%
—
—
—
—
cases:1.76%
controls:0.30%
cases:3.28%
controls:1.20%
51
182
1887
18266
28
77
1934
18588
5
12
1957
18653
—
—
34
55
1902
18324
60
208
1770
17064
agomelatine; oral
N06AX22 [21604750]
N06AX22 [21604750]
1.5e+00
1.7e+00
—
—
—
1.4e+00
1.8e+00
cases:0.52%
controls:0.11%
cases:0.46%
controls:0.09%
—
—
—
—
—
—
cases:0.26%
controls:0.07%
cases:1.09%
controls:0.17%
10
21
1928
18427
9
16
1953
18649
—
—
—
5
12
1931
18367
20
30
1810
17242
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
1.7e-01
4.1e-01
6.0e-01
2.6e+00
6.2e-01
4.0e-01
4.3e-01
cases:14.19%
controls:12.20%
cases:12.59%
controls:8.68%
cases:3.21%
controls:1.78%
cases:0.76%
controls:0.06%
cases:3.01%
controls:1.64%
cases:11.93%
controls:8.35%
cases:24.21%
controls:17.13%
275
2251
1663
16197
247
1621
1715
17044
63
333
1899
18332
15
11
1947
18654
59
306
1900
18333
231
1534
1705
16845
443
2959
1387
14313
Psychiatric treatment plan, permanent discontinuation
ICC04 [2001304105]
ICC04 [2001304105]
1.4e+00
—
—
—
—
2.1e+00
1.5e+00
cases:0.67%
controls:0.16%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.10%
cases:1.75%
controls:0.41%
13
30
1925
18418
—
—
—
—
17
19
1919
18360
32
71
1798
17201
Psychosocial counselling and guidance
SPAT1307 [2001700408]
SPAT1307 [2001700408]
1.1e+00
1.7e+00
—
—
—
1.3e+00
8.8e-01
cases:2.27%
controls:0.76%
cases:1.38%
controls:0.25%
—
—
—
—
—
—
cases:1.03%
controls:0.28%
cases:3.11%
controls:1.32%
44
141
1894
18307
27
47
1935
18618
—
—
—
20
52
1916
18327
57
228
1773
17044
Drugs identified in Urine by Screen method Nominal
12286-1 [3011288]
12286-1 [3011288]
7.4e-01
2.2e+00
—
—
—
1.3e+00
1.5e+00
cases:0.67%
controls:0.32%
cases:1.58%
controls:0.18%
—
—
—
—
—
—
cases:0.72%
controls:0.20%
cases:3.01%
controls:0.68%
13
59
1925
18389
31
34
1931
18631
—
—
—
14
36
1922
18343
55
118
1775
17154
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
7.7e-01
1.1e+00
1.5e+00
—
7.3e-01
8.9e-01
7.5e-01
cases:3.97%
controls:1.88%
cases:2.09%
controls:0.71%
cases:0.56%
controls:0.13%
—
—
cases:0.26%
controls:0.12%
cases:1.60%
controls:0.66%
cases:4.43%
controls:2.14%
77
347
1861
18101
41
133
1921
18532
11
24
1951
18641
—
5
23
1954
18616
31
122
1905
18257
81
369
1749
16903
Other psychiatric treatment contact
IGY99 [2001304323]
IGY99 [2001304323]
1.2e+00
1.1e+00
—
—
1.2e+00
1.1e+00
1.6e+00
cases:1.08%
controls:0.32%
cases:0.82%
controls:0.28%
—
—
—
—
cases:0.36%
controls:0.11%
cases:0.88%
controls:0.29%
cases:2.79%
controls:0.60%
21
59
1917
18389
16
52
1946
18613
—
—
7
21
1952
18618
17
54
1919
18325
51
104
1779
17168
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.1e-01
4.8e-01
4.4e-01
2.0e+00
7.5e-01
6.1e-01
6.0e-01
cases:88.03%
controls:85.64%
cases:74.87%
controls:64.81%
cases:33.23%
controls:24.21%
cases:8.26%
controls:1.18%
cases:39.92%
controls:23.91%
cases:77.84%
controls:65.71%
cases:92.57%
controls:87.22%
1706
15799
232
2649
1469
12096
493
6569
652
4518
1310
14147
162
221
1800
18444
782
4456
1177
14183
1507
12077
429
6302
1694
15065
136
2207
Cystoscopy
UKC02 [2001306005]
UKC02 [2001306005]
1.2e+00
1.2e+00
—
1.0e+50
—
2.2e+00
1.5e+00
cases:1.39%
controls:0.43%
cases:0.46%
controls:0.14%
—
—
cases:0.82%
controls:0.00%
—
—
cases:1.03%
controls:0.12%
cases:1.26%
controls:0.27%
27
79
1911
18369
9
27
1953
18638
—
16
0
1946
18665
—
20
22
1916
18357
23
47
1807
17225
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 [3029287]
50554-5 [3029287]
4.3e-01
6.3e-01
1.4e+00
1.0e+50
1.0e+00
6.0e-01
7.3e-01
cases:6.19%
controls:4.12%
cases:3.98%
controls:2.16%
cases:1.22%
controls:0.29%
cases:0.31%
controls:0.00%
cases:0.92%
controls:0.33%
cases:3.10%
controls:1.72%
cases:7.76%
controls:3.89%
120
760
1818
17688
78
403
1884
18262
24
55
1938
18610
6
0
1956
18665
18
62
1941
18577
60
316
1876
18063
142
672
1688
16600
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
8.6e-01
1.3e+00
—
—
2.0e+00
1.9e+00
8.4e-01
cases:1.81%
controls:0.78%
cases:0.87%
controls:0.24%
—
—
—
—
cases:0.31%
controls:0.04%
cases:1.03%
controls:0.16%
cases:1.91%
controls:0.83%
35
143
1903
18305
17
45
1945
18620
—
—
6
8
1953
18631
20
30
1916
18349
35
144
1795
17128
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
4.5e-01
6.4e-01
1.3e+00
1.0e+50
1.2e+00
5.4e-01
6.5e-01
cases:6.45%
controls:4.22%
cases:4.38%
controls:2.35%
cases:1.33%
controls:0.35%
cases:0.31%
controls:0.00%
cases:1.23%
controls:0.38%
cases:3.41%
controls:2.01%
cases:8.69%
controls:4.72%
125
778
1813
17670
86
439
1876
18226
26
66
1936
18599
6
0
1956
18665
24
70
1935
18569
66
370
1870
18009
159
816
1671
16456
Congenital vesico-uretero-renal reflux
Q62.7 [45568071]
Q62.7 [45568071]
1.4e+00
2.0e+00
—
—
—
2.5e+00
2.2e+00
cases:0.46%
controls:0.11%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.41%
controls:0.03%
cases:0.38%
controls:0.04%
9
21
1929
18427
6
8
1956
18657
—
—
—
8
6
1928
18373
7
7
1823
17265
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.1e+00
1.3e+00
—
—
—
1.0e+00
1.4e+00
cases:2.01%
controls:0.69%
cases:1.02%
controls:0.28%
—
—
—
—
—
—
cases:0.88%
controls:0.32%
cases:2.62%
controls:0.68%
39
127
1899
18321
20
52
1942
18613
—
—
—
17
58
1919
18321
48
118
1782
17154
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.1e+00
1.3e+00
—
—
—
1.0e+00
1.4e+00
cases:2.01%
controls:0.69%
cases:1.02%
controls:0.28%
—
—
—
—
—
—
cases:0.88%
controls:0.32%
cases:2.62%
controls:0.68%
39
127
1899
18321
20
52
1942
18613
—
—
—
17
58
1919
18321
48
118
1782
17154
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.1e+00
1.3e+00
—
—
—
1.0e+00
1.4e+00
cases:2.01%
controls:0.69%
cases:1.02%
controls:0.28%
—
—
—
—
—
—
cases:0.88%
controls:0.32%
cases:2.62%
controls:0.68%
39
127
1899
18321
20
52
1942
18613
—
—
—
17
58
1919
18321
48
118
1782
17154
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.1e+00
1.3e+00
—
—
—
1.0e+00
1.4e+00
cases:2.01%
controls:0.69%
cases:1.02%
controls:0.28%
—
—
—
—
—
—
cases:0.88%
controls:0.32%
cases:2.62%
controls:0.68%
39
127
1899
18321
20
52
1942
18613
—
—
—
17
58
1919
18321
48
118
1782
17154
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.1e+00
1.3e+00
—
—
—
1.0e+00
1.4e+00
cases:2.01%
controls:0.69%
cases:1.02%
controls:0.28%
—
—
—
—
—
—
cases:0.88%
controls:0.32%
cases:2.62%
controls:0.68%
39
127
1899
18321
20
52
1942
18613
—
—
—
17
58
1919
18321
48
118
1782
17154
Hemoglobin [Presence] in Urine by Test strip
5794-3 [3011397]
5794-3 [3011397]
3.9e-01
6.7e-01
1.3e+00
—
1.3e+00
8.8e-01
6.4e-01
cases:2.73%
controls:1.88%
cases:2.34%
controls:1.22%
cases:0.61%
controls:0.17%
—
—
cases:0.77%
controls:0.21%
cases:3.10%
controls:1.31%
cases:6.67%
controls:3.61%
53
346
1885
18102
46
227
1916
18438
12
31
1950
18634
—
15
40
1944
18599
60
241
1876
18138
122
624
1708
16648
Otolaryngology
4 [38004449]
4 [38004449]
6.9e-02
-6.2e-02
1.6e-01
3.7e+00
6.8e-01
1.8e-01
2.9e-01
cases:15.38%
controls:14.49%
cases:4.94%
controls:5.25%
cases:0.92%
controls:0.78%
cases:1.12%
controls:0.03%
cases:1.63%
controls:0.84%
cases:5.58%
controls:4.69%
cases:13.11%
controls:10.18%
298
2674
1640
15774
97
979
1865
17686
18
146
1944
18519
22
5
1940
18660
32
156
1927
18483
108
862
1828
17517
240
1759
1590
15513
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
1.3e+00
1.2e+00
—
—
—
1.4e+00
8.4e-01
cases:2.22%
controls:0.64%
cases:1.17%
controls:0.34%
—
—
—
—
—
—
cases:1.08%
controls:0.28%
cases:1.97%
controls:0.86%
43
118
1895
18330
23
64
1939
18601
—
—
—
21
52
1915
18327
36
148
1794
17124
Congenital stenosis of aortic valve
Q23.0 [45587449]
Q23.0 [45587449]
2.1e+00
2.1e+00
—
—
—
—
2.6e+00
cases:0.31%
controls:0.04%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.03%
6
7
1932
18441
5
6
1957
18659
—
—
—
—
7
5
1823
17267
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.1e+00
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:2.12%
controls:0.72%
cases:1.07%
controls:0.33%
—
—
—
—
—
—
cases:0.93%
controls:0.35%
cases:2.68%
controls:0.69%
41
133
1897
18315
21
61
1941
18604
—
—
—
18
64
1918
18315
49
119
1781
17153
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.1e+00
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:2.12%
controls:0.72%
cases:1.07%
controls:0.33%
—
—
—
—
—
—
cases:0.93%
controls:0.35%
cases:2.68%
controls:0.69%
41
133
1897
18315
21
61
1941
18604
—
—
—
18
64
1918
18315
49
119
1781
17153
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.1e+00
1.2e+00
—
—
—
9.9e-01
1.4e+00
cases:2.12%
controls:0.72%
cases:1.07%
controls:0.33%
—
—
—
—
—
—
cases:0.93%
controls:0.35%
cases:2.68%
controls:0.69%
41
133
1897
18315
21
61
1941
18604
—
—
—
18
64
1918
18315
49
119
1781
17153
Mixed personality disorders
F61.0 [2000502024]
F61.0 [2000502024]
1.8e+00
—
—
1.0e+50
—
—
2.8e+00
cases:0.36%
controls:0.06%
—
—
—
—
cases:0.36%
controls:0.00%
—
—
—
—
cases:0.87%
controls:0.05%
7
11
1931
18437
—
—
7
0
1955
18665
—
—
16
9
1814
17263
Kidney transplant status
Z94.0 [45566477]
Z94.0 [45566477]
1.1e+00
1.2e+00
7.5e-01
—
7.8e-01
1.1e+00
1.3e+00
cases:0.77%
controls:0.27%
cases:0.87%
controls:0.26%
cases:0.41%
controls:0.19%
—
—
cases:0.41%
controls:0.19%
cases:0.77%
controls:0.27%
cases:0.93%
controls:0.27%
15
49
1923
18399
17
49
1945
18616
8
36
1954
18629
—
8
35
1951
18604
15
49
1921
18330
17
46
1813
17226
Remote contact by phone
ZYC01 [2001311579]
ZYC01 [2001311579]
9.1e-01
9.5e-01
-1.0e+50
—
1.7e+00
1.7e+00
2.0e+00
cases:1.03%
controls:0.42%
cases:0.66%
controls:0.26%
cases:0.00%
controls:0.05%
—
—
cases:0.36%
controls:0.06%
cases:0.98%
controls:0.18%
cases:2.13%
controls:0.30%
20
77
1918
18371
13
48
1949
18617
0
9
1962
18656
—
7
12
1952
18627
19
34
1917
18345
39
52
1791
17220
Non-organic diurnal enuresis
F98.01 [2000502048]
F98.01 [2000502048]
—
—
—
1.0e+50
1.0e+50
1.0e+50
4.6e+00
—
—
—
—
—
—
cases:5.56%
controls:0.00%
cases:2.40%
controls:0.00%
cases:5.01%
controls:0.00%
cases:3.72%
controls:0.04%
—
—
—
109
0
1853
18665
47
0
1912
18639
97
0
1839
18379
68
7
1762
17265
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
8.2e-01
1.3e+00
—
—
—
1.4e+00
1.1e+00
cases:1.65%
controls:0.74%
cases:0.82%
controls:0.23%
—
—
—
—
—
—
cases:0.57%
controls:0.15%
cases:1.91%
controls:0.64%
32
136
1906
18312
16
43
1946
18622
—
—
—
11
27
1925
18352
35
111
1795
17161
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
7.3e-01
1.2e+00
—
—
1.7e+00
1.3e+00
1.3e+00
cases:2.17%
controls:1.05%
cases:1.43%
controls:0.42%
—
—
—
—
cases:0.26%
controls:0.05%
cases:1.24%
controls:0.35%
cases:1.80%
controls:0.51%
42
194
1896
18254
28
78
1934
18587
—
—
5
9
1954
18630
24
64
1912
18315
33
88
1797
17184
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
6.6e-02
3.0e-01
5.7e-01
2.4e+00
6.8e-01
3.4e-01
2.6e-01
cases:18.37%
controls:17.41%
cases:17.84%
controls:13.86%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.16%
controls:2.69%
cases:17.51%
controls:13.13%
cases:29.95%
controls:24.79%
356
3211
1582
15237
350
2587
1612
16078
104
572
1858
18093
29
26
1933
18639
101
501
1858
18138
339
2414
1597
15965
548
4281
1282
12991
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
6.8e-02
3.0e-01
5.7e-01
2.4e+00
6.8e-01
3.3e-01
2.6e-01
cases:18.37%
controls:17.37%
cases:17.84%
controls:13.87%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.16%
controls:2.68%
cases:17.41%
controls:13.13%
cases:29.95%
controls:24.79%
356
3204
1582
15244
350
2588
1612
16077
104
572
1858
18093
29
26
1933
18639
101
499
1858
18140
337
2413
1599
15966
548
4282
1282
12990
Psychiatric family contact
IGP01 [2001304317]
IGP01 [2001304317]
8.5e-01
1.1e+00
—
—
1.6e+00
2.0e+00
1.5e+00
cases:0.57%
controls:0.24%
cases:0.71%
controls:0.24%
—
—
—
—
cases:0.31%
controls:0.06%
cases:1.55%
controls:0.22%
cases:2.19%
controls:0.51%
11
45
1927
18403
14
45
1948
18620
—
—
6
12
1953
18627
30
41
1906
18338
40
88
1790
17184
CICLOSPORIN - yes
CICLOSPORIN-1 [2002330221]
CICLOSPORIN-1 [2002330221]
2.3e+00
1.5e+00
—
—
—
2.3e+00
1.6e+00
cases:0.52%
controls:0.05%
cases:0.25%
controls:0.06%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.27%
controls:0.06%
10
10
1928
18438
5
11
1957
18654
—
—
—
7
7
1929
18372
5
10
1825
17262
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
7.1e-02
3.1e-01
5.7e-01
2.4e+00
6.7e-01
3.3e-01
2.5e-01
cases:18.37%
controls:17.33%
cases:17.89%
controls:13.83%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.10%
controls:2.68%
cases:17.41%
controls:13.12%
cases:29.78%
controls:24.76%
356
3197
1582
15251
351
2581
1611
16084
104
572
1858
18093
29
26
1933
18639
100
499
1859
18140
337
2412
1599
15967
545
4276
1285
12996
Hypoplastic left heart syndrome
Q23.4 [45568057]
Q23.4 [45568057]
1.8e+00
2.3e+00
—
—
—
2.3e+00
—
cases:0.26%
controls:0.04%
cases:0.36%
controls:0.04%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
—
—
5
8
1933
18440
7
7
1955
18658
—
—
—
7
7
1929
18372
—
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
7.1e-02
3.0e-01
5.7e-01
2.4e+00
6.7e-01
3.3e-01
2.5e-01
cases:18.37%
controls:17.32%
cases:17.84%
controls:13.82%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.10%
controls:2.68%
cases:17.41%
controls:13.11%
cases:29.78%
controls:24.75%
356
3196
1582
15252
350
2580
1612
16085
104
572
1858
18093
29
26
1933
18639
100
499
1859
18140
337
2410
1599
15969
545
4274
1285
12998
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
7.0e-02
3.0e-01
5.7e-01
2.4e+00
6.7e-01
3.3e-01
2.5e-01
cases:18.37%
controls:17.34%
cases:17.84%
controls:13.83%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.10%
controls:2.68%
cases:17.41%
controls:13.11%
cases:29.78%
controls:24.75%
356
3199
1582
15249
350
2581
1612
16084
104
572
1858
18093
29
26
1933
18639
100
499
1859
18140
337
2410
1599
15969
545
4275
1285
12997
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
7.2e-02
3.0e-01
5.7e-01
2.4e+00
6.7e-01
3.4e-01
2.6e-01
cases:18.37%
controls:17.31%
cases:17.74%
controls:13.82%
cases:5.30%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.10%
controls:2.68%
cases:17.41%
controls:13.10%
cases:29.78%
controls:24.68%
356
3193
1582
15255
348
2580
1614
16085
104
572
1858
18093
29
26
1933
18639
100
499
1859
18140
337
2407
1599
15972
545
4263
1285
13009
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
F43.22 [2000502003]
1.2e+00
1.3e+00
1.9e+00
—
2.3e+00
1.9e+00
1.4e+00
cases:0.62%
controls:0.18%
cases:0.41%
controls:0.11%
cases:0.25%
controls:0.04%
—
—
cases:0.26%
controls:0.03%
cases:0.52%
controls:0.08%
cases:1.15%
controls:0.30%
12
34
1926
18414
8
20
1954
18645
5
7
1957
18658
—
5
5
1954
18634
10
14
1926
18365
21
51
1809
17221
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
6.7e-02
3.0e-01
5.6e-01
2.4e+00
6.7e-01
3.3e-01
2.6e-01
cases:18.32%
controls:17.33%
cases:17.74%
controls:13.83%
cases:5.25%
controls:3.06%
cases:1.48%
controls:0.14%
cases:5.10%
controls:2.68%
cases:17.41%
controls:13.10%
cases:29.78%
controls:24.69%
355
3197
1583
15251
348
2581
1614
16084
103
572
1859
18093
29
26
1933
18639
100
499
1859
18140
337
2408
1599
15971
545
4265
1285
13007
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
9.2e-01
3.4e-01
—
—
—
2.2e+00
2.3e+00
cases:0.52%
controls:0.21%
cases:0.25%
controls:0.18%
—
—
—
—
—
—
cases:1.45%
controls:0.16%
cases:3.39%
controls:0.36%
10
38
1928
18410
5
34
1957
18631
—
—
—
28
30
1908
18349
62
63
1768
17209
Bulimia nervosa
F50.2 [45581464]
F50.2 [45581464]
2.1e+00
—
—
—
—
2.6e+00
1.8e+00
cases:0.26%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.03%
cases:0.55%
controls:0.09%
5
6
1933
18442
—
—
—
—
7
5
1929
18374
10
15
1820
17257
Recurrent depressive disorder
F33 [45576542]
F33 [45576542]
—
—
—
—
—
2.3e+00
2.2e+00
—
—
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.03%
cases:0.71%
controls:0.08%
—
—
—
—
—
6
6
1930
18373
13
14
1817
17258
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
1.3e+00
1.9e+00
—
—
—
1.3e+00
1.2e+00
cases:0.83%
controls:0.23%
cases:0.61%
controls:0.09%
—
—
—
—
—
—
cases:0.36%
controls:0.10%
cases:0.82%
controls:0.24%
16
42
1922
18406
12
17
1950
18648
—
—
—
7
18
1929
18361
15
42
1815
17230
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
3.4e-01
5.9e-01
1.1e+00
—
1.3e+00
4.9e-01
5.4e-01
cases:11.61%
controls:8.55%
cases:8.66%
controls:4.99%
cases:2.09%
controls:0.69%
—
—
cases:1.84%
controls:0.50%
cases:7.28%
controls:4.60%
cases:19.89%
controls:12.60%
225
1577
1713
16871
170
932
1792
17733
41
128
1921
18537
—
36
94
1923
18545
141
846
1795
17533
364
2176
1466
15096
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
9.8e-02
2.7e-01
5.1e-01
2.1e+00
7.9e-01
4.1e-01
2.9e-01
cases:15.58%
controls:14.34%
cases:14.02%
controls:11.04%
cases:3.82%
controls:2.33%
cases:1.02%
controls:0.12%
cases:4.29%
controls:2.00%
cases:14.05%
controls:9.83%
cases:23.99%
controls:19.07%
302
2645
1636
15803
275
2061
1687
16604
75
435
1887
18230
20
23
1942
18642
84
373
1875
18266
272
1806
1664
16573
439
3294
1391
13978
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
1.1e+00
1.4e+00
—
—
—
1.1e+00
7.7e-01
cases:1.75%
controls:0.61%
cases:0.87%
controls:0.23%
—
—
—
—
—
—
cases:0.88%
controls:0.28%
cases:2.30%
controls:1.07%
34
112
1904
18336
17
42
1945
18623
—
—
—
17
52
1919
18327
42
185
1788
17087
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.1e-01
3.1e-01
4.0e-01
2.4e+00
8.6e-01
4.4e-01
3.1e-01
cases:14.76%
controls:13.41%
cases:13.71%
controls:10.42%
cases:3.47%
controls:2.36%
cases:1.22%
controls:0.11%
cases:4.44%
controls:1.93%
cases:13.74%
controls:9.30%
cases:22.24%
controls:17.34%
286
2474
1652
15974
269
1945
1693
16720
68
440
1894
18225
24
21
1938
18644
87
359
1872
18280
266
1709
1670
16670
407
2995
1423
14277
Education problem
Z07 [2002001463]
Z07 [2002001463]
—
2.5e+00
—
—
—
1.0e+50
1.8e+00
—
—
cases:0.46%
controls:0.04%
—
—
—
—
—
—
cases:0.26%
controls:0.00%
cases:0.98%
controls:0.16%
—
9
7
1953
18658
—
—
—
5
0
1931
18379
18
28
1812
17244
Conduct disorder, unspecified
F91.9 [45533125]
F91.9 [45533125]
2.3e+00
1.0e+50
—
—
1.0e+50
—
2.0e+00
cases:0.31%
controls:0.03%
cases:0.51%
controls:0.00%
—
—
—
—
cases:0.36%
controls:0.00%
—
—
cases:0.71%
controls:0.09%
6
6
1932
18442
10
0
1952
18665
—
—
7
0
1952
18639
—
13
16
1817
17256
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
4.0e-01
5.1e-01
2.3e-01
—
1.7e+00
1.0e+00
6.5e-01
cases:10.53%
controls:7.33%
cases:5.71%
controls:3.50%
cases:0.66%
controls:0.53%
—
—
cases:2.40%
controls:0.45%
cases:7.85%
controls:2.93%
cases:12.30%
controls:6.83%
204
1353
1734
17095
112
654
1850
18011
13
98
1949
18567
—
47
83
1912
18556
152
539
1784
17840
225
1179
1605
16093
Other mixed anxiety disorders
F41.3 [45605492]
F41.3 [45605492]
1.6e+00
—
—
—
—
2.7e+00
1.6e+00
cases:0.31%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.41%
controls:0.03%
cases:0.66%
controls:0.14%
6
12
1932
18436
—
—
—
—
8
5
1928
18374
12
24
1818
17248
Emergency Room Visit
ER [9203]
ER [9203]
3.5e-01
5.9e-01
1.1e+00
—
1.0e+00
6.2e-01
5.4e-01
cases:36.07%
controls:28.48%
cases:16.82%
controls:10.04%
cases:3.47%
controls:1.15%
—
—
cases:3.01%
controls:1.08%
cases:16.22%
controls:9.46%
cases:38.31%
controls:26.59%
699
5254
1239
13194
330
1874
1632
16791
68
215
1894
18450
—
59
201
1900
18438
314
1738
1622
16641
701
4593
1129
12679
Urology
34 [38004474]
34 [38004474]
7.7e-01
1.1e+00
—
—
1.0e+00
1.5e+00
8.8e-01
cases:2.12%
controls:0.99%
cases:1.22%
controls:0.42%
—
—
—
—
cases:0.26%
controls:0.09%
cases:1.76%
controls:0.39%
cases:2.84%
controls:1.20%
41
182
1897
18266
24
78
1938
18587
—
—
5
17
1954
18622
34
71
1902
18308
52
208
1778
17064
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
3.7e-01
3.1e-01
4.2e-01
2.1e+00
8.2e-01
4.4e-01
5.0e-01
cases:8.77%
controls:6.26%
cases:6.27%
controls:4.66%
cases:1.73%
controls:1.15%
cases:0.41%
controls:0.05%
cases:1.99%
controls:0.89%
cases:6.20%
controls:4.10%
cases:10.87%
controls:6.90%
170
1154
1768
17294
123
869
1839
17796
34
214
1928
18451
8
9
1954
18656
39
165
1920
18474
120
753
1816
17626
199
1192
1631
16080
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
6.2e-01
1.1e+00
1.2e+00
—
—
1.3e+00
1.2e+00
cases:3.66%
controls:2.00%
cases:1.63%
controls:0.53%
cases:0.25%
controls:0.08%
—
—
—
—
cases:1.50%
controls:0.40%
cases:3.88%
controls:1.24%
71
369
1867
18079
32
98
1930
18567
5
14
1957
18651
—
—
29
74
1907
18305
71
215
1759
17057
Urinary tract ultrasound examination
KH1AE [2001306329]
KH1AE [2001306329]
4.9e-01
1.4e+00
—
1.0e+50
—
1.6e+00
1.3e+00
cases:0.88%
controls:0.54%
cases:0.56%
controls:0.13%
—
—
cases:0.66%
controls:0.00%
—
—
cases:0.46%
controls:0.10%
cases:1.31%
controls:0.38%
17
99
1921
18349
11
25
1951
18640
—
13
0
1949
18665
—
9
18
1927
18361
24
65
1806
17207
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
4.1e-01
6.6e-01
1.4e+00
1.0e+50
1.1e+00
4.9e-01
7.0e-01
cases:5.78%
controls:3.91%
cases:3.87%
controls:2.04%
cases:1.17%
controls:0.29%
cases:0.31%
controls:0.00%
cases:0.92%
controls:0.31%
cases:2.74%
controls:1.70%
cases:7.32%
controls:3.78%
112
721
1826
17727
76
380
1886
18285
23
55
1939
18610
6
0
1956
18665
18
58
1941
18581
53
312
1883
18067
134
653
1696
16619
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
9.2e-01
1.2e+00
9.8e-01
—
1.1e+00
1.2e+00
9.5e-01
cases:2.68%
controls:1.08%
cases:1.68%
controls:0.53%
cases:0.36%
controls:0.13%
—
—
cases:0.31%
controls:0.11%
cases:1.86%
controls:0.57%
cases:3.39%
controls:1.34%
52
200
1886
18248
33
98
1929
18567
7
25
1955
18640
—
6
20
1953
18619
36
105
1900
18274
62
232
1768
17040
Focused parental counselling
IEP03 [2001304195]
IEP03 [2001304195]
7.2e-01
1.3e+00
—
—
1.7e+00
1.6e+00
1.2e+00
cases:0.62%
controls:0.30%
cases:0.76%
controls:0.20%
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.98%
controls:0.19%
cases:1.26%
controls:0.36%
12
56
1926
18392
15
38
1947
18627
—
—
7
12
1952
18627
19
35
1917
18344
23
63
1807
17209
Unspecified mood [affective] disorder
F39 [45591137]
F39 [45591137]
1.5e+00
2.2e+00
—
—
—
—
2.1e+00
cases:0.41%
controls:0.09%
cases:0.46%
controls:0.05%
—
—
—
—
—
—
—
—
cases:1.04%
controls:0.13%
8
17
1930
18431
9
10
1953
18655
—
—
—
—
19
23
1811
17249
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
3.1e-01
5.8e-01
1.2e+00
—
1.2e+00
4.5e-01
4.7e-01
cases:13.47%
controls:10.23%
cases:10.60%
controls:6.23%
cases:2.60%
controls:0.80%
—
—
cases:2.25%
controls:0.69%
cases:9.19%
controls:6.06%
cases:22.51%
controls:15.37%
261
1887
1677
16561
208
1162
1754
17503
51
149
1911
18516
—
44
128
1915
18511
178
1114
1758
17265
412
2654
1418
14618
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
3.5e-01
6.9e-01
1.3e+00
—
1.1e+00
6.9e-01
5.0e-01
cases:4.39%
controls:3.12%
cases:3.57%
controls:1.83%
cases:0.92%
controls:0.26%
—
—
cases:0.92%
controls:0.32%
cases:3.77%
controls:1.93%
cases:9.29%
controls:5.82%
85
575
1853
17873
70
341
1892
18324
18
49
1944
18616
—
18
59
1941
18580
73
355
1863
18024
170
1006
1660
16266
General Practice
1 [38004446]
1 [38004446]
5.3e-01
6.1e-01
1.0e+00
—
1.0e+00
7.3e-01
3.4e-01
cases:10.78%
controls:6.65%
cases:3.98%
controls:2.20%
cases:0.76%
controls:0.28%
—
—
cases:0.77%
controls:0.28%
cases:4.91%
controls:2.42%
cases:10.82%
controls:7.98%
209
1227
1729
17221
78
411
1884
18254
15
53
1947
18612
—
15
53
1944
18586
95
445
1841
17934
198
1378
1632
15894
mianserin; oral
N06AX03 [21604732]
N06AX03 [21604732]
1.6e+00
—
—
—
—
—
2.6e+00
cases:0.46%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.05%
9
18
1929
18430
—
—
—
—
—
13
9
1817
17263
Pain general/multiple sites
A01 [2002000142]
A01 [2002000142]
1.4e+00
1.6e+00
—
—
—
8.0e-01
1.2e+00
cases:1.08%
controls:0.27%
cases:0.51%
controls:0.11%
—
—
—
—
—
—
cases:0.36%
controls:0.16%
cases:1.69%
controls:0.50%
21
50
1917
18398
10
20
1952
18645
—
—
—
7
30
1929
18349
31
87
1799
17185
Hyperkinetic disorders
F90 [45581476]
F90 [45581476]
1.4e+00
—
—
—
—
2.2e+00
2.0e+00
cases:0.26%
controls:0.07%
—
—
—
—
—
—
—
—
cases:0.52%
controls:0.06%
cases:0.93%
controls:0.13%
5
12
1933
18436
—
—
—
—
10
11
1926
18368
17
22
1813
17250
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
2.3e-01
6.8e-01
1.3e+00
1.0e+50
1.0e+00
4.8e-01
6.2e-01
cases:8.82%
controls:7.17%
cases:6.37%
controls:3.33%
cases:1.78%
controls:0.48%
cases:0.31%
controls:0.00%
cases:1.33%
controls:0.48%
cases:4.91%
controls:3.10%
cases:14.10%
controls:8.11%
171
1323
1767
17125
125
621
1837
18044
35
89
1927
18576
6
0
1956
18665
26
90
1933
18549
95
569
1841
17810
258
1401
1572
15871
Other psychiatric family intervention
IEP99 [2001304203]
IEP99 [2001304203]
1.4e+00
1.2e+00
-1.0e+50
—
—
2.1e+00
2.0e+00
cases:0.41%
controls:0.10%
cases:0.36%
controls:0.11%
cases:0.00%
controls:0.03%
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.04%
controls:0.14%
8
19
1930
18429
7
20
1955
18645
0
6
1962
18659
—
—
11
13
1925
18366
19
24
1811
17248
Extensive initial psychiatric evaluation
IBA04 [2001304046]
IBA04 [2001304046]
1.5e+00
1.6e+00
—
1.0e+50
1.0e+50
1.2e+00
1.1e+00
cases:0.83%
controls:0.19%
cases:0.82%
controls:0.17%
—
—
cases:0.66%
controls:0.00%
cases:0.41%
controls:0.00%
cases:0.31%
controls:0.09%
cases:1.64%
controls:0.58%
16
35
1922
18413
16
32
1946
18633
—
13
0
1949
18665
8
0
1951
18639
6
17
1930
18362
30
100
1800
17172
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
1.0e+00
7.5e-01
5.5e-01
—
6.1e-01
1.2e+00
1.1e+00
cases:3.30%
controls:1.24%
cases:1.38%
controls:0.65%
cases:0.31%
controls:0.18%
—
—
cases:0.26%
controls:0.14%
cases:2.22%
controls:0.66%
cases:4.26%
controls:1.45%
64
229
1874
18219
27
122
1935
18543
6
33
1956
18632
—
5
26
1954
18613
43
121
1893
18258
78
250
1752
17022
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
8.7e-01
8.4e-01
9.6e-01
—
9.9e-01
1.0e+00
1.3e+00
cases:1.81%
controls:0.76%
cases:1.07%
controls:0.47%
cases:0.46%
controls:0.18%
—
—
cases:0.46%
controls:0.17%
cases:1.29%
controls:0.47%
cases:2.84%
controls:0.75%
35
141
1903
18307
21
87
1941
18578
9
33
1953
18632
—
9
32
1950
18607
25
87
1911
18292
52
130
1778
17142
Recurrent depressive disorder, current episode moderate
F33.1 [45576543]
F33.1 [45576543]
1.2e+00
2.2e+00
—
—
—
1.6e+00
1.9e+00
cases:0.41%
controls:0.12%
cases:0.46%
controls:0.05%
—
—
—
—
—
—
cases:0.26%
controls:0.05%
cases:1.37%
controls:0.21%
8
23
1930
18425
9
10
1953
18655
—
—
—
5
10
1931
18369
25
36
1805
17236
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.2e-01
3.3e-01
7.4e-01
2.3e+00
4.8e-01
3.5e-01
3.3e-01
cases:15.33%
controls:13.89%
cases:11.26%
controls:8.37%
cases:3.06%
controls:1.48%
cases:0.71%
controls:0.08%
cases:1.89%
controls:1.18%
cases:10.33%
controls:7.52%
cases:22.57%
controls:17.37%
297
2562
1641
15886
221
1563
1741
17102
60
277
1902
18388
14
14
1948
18651
37
220
1922
18419
200
1383
1736
16996
413
3000
1417
14272
Psychoeducation, group
IER01 [2001304205]
IER01 [2001304205]
2.4e+00
—
—
—
—
2.3e+00
1.6e+00
cases:0.36%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.26%
controls:0.03%
cases:0.87%
controls:0.18%
7
6
1931
18442
—
—
—
—
5
5
1931
18374
16
31
1814
17241
Bipolar disorder Depressive episode without somatic syndrome
F31.30 [2000501976]
F31.30 [2000501976]
1.4e+00
2.0e+00
—
—
—
2.3e+00
1.7e+00
cases:0.26%
controls:0.07%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
cases:0.36%
controls:0.04%
cases:0.66%
controls:0.12%
5
12
1933
18436
6
8
1956
18657
—
—
—
7
7
1929
18372
12
20
1818
17252
Adolescent behaviour sympt/compl
P23 [2002000818]
P23 [2002000818]
2.4e+00
2.1e+00
—
—
—
—
1.5e+00
cases:0.62%
controls:0.05%
cases:0.25%
controls:0.03%
—
—
—
—
—
—
—
—
cases:0.71%
controls:0.16%
12
10
1926
18438
5
6
1957
18659
—
—
—
—
13
27
1817
17245
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
-1.8e-01
-1.4e-01
3.2e-01
3.1e+00
8.0e-01
1.6e-01
1.6e-02
cases:12.18%
controls:14.22%
cases:6.68%
controls:7.58%
cases:1.63%
controls:1.18%
cases:1.89%
controls:0.09%
cases:2.35%
controls:1.07%
cases:8.52%
controls:7.34%
cases:14.54%
controls:14.34%
236
2623
1702
15825
131
1414
1831
17251
32
221
1930
18444
37
16
1925
18649
46
199
1913
18440
165
1349
1771
17030
266
2476
1564
14796
Specific developmental disorder of motor function
F82 [45605516]
F82 [45605516]
9.2e-01
6.6e-01
—
—
1.6e+00
1.5e+00
1.5e+00
cases:1.24%
controls:0.50%
cases:0.56%
controls:0.29%
—
—
—
—
cases:0.31%
controls:0.06%
cases:1.08%
controls:0.25%
cases:1.75%
controls:0.39%
24
92
1914
18356
11
54
1951
18611
—
—
6
12
1953
18627
21
46
1915
18333
32
68
1798
17204
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
4.7e-01
6.4e-01
1.3e+00
—
1.1e+00
7.8e-01
7.2e-01
cases:6.55%
controls:4.19%
cases:3.82%
controls:2.06%
cases:0.97%
controls:0.27%
—
—
cases:0.56%
controls:0.19%
cases:3.87%
controls:1.81%
cases:11.04%
controls:5.72%
127
773
1811
17675
75
384
1887
18281
19
51
1943
18614
—
11
36
1948
18603
75
332
1861
18047
202
988
1628
16284
Other chronic pain
R52.2 [45568139]
R52.2 [45568139]
2.3e+00
—
—
—
—
—
1.6e+00
cases:0.31%
controls:0.03%
—
—
—
—
—
—
—
—
—
—
cases:0.44%
controls:0.09%
6
6
1932
18442
—
—
—
—
—
8
15
1822
17257
Outpatient Hospital
22 [8756]
22 [8756]
3.1e-02
7.6e-02
-2.9e-01
2.9e+00
6.0e-01
5.0e-01
4.6e-01
cases:21.41%
controls:20.89%
cases:7.19%
controls:6.70%
cases:0.76%
controls:1.02%
cases:1.27%
controls:0.07%
cases:1.63%
controls:0.90%
cases:8.88%
controls:5.60%
cases:20.27%
controls:13.84%
415
3854
1523
14594
141
1250
1821
17415
15
191
1947
18474
25
13
1937
18652
32
168
1927
18471
172
1029
1764
17350
371
2391
1459
14881
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 [40771025]
68438-1 [40771025]
5.1e-01
5.6e-01
1.0e+00
—
1.1e+00
3.1e-01
5.8e-01
cases:5.99%
controls:3.67%
cases:4.18%
controls:2.44%
cases:0.97%
controls:0.34%
—
—
cases:0.97%
controls:0.31%
cases:3.41%
controls:2.52%
cases:9.89%
controls:5.81%
116
677
1822
17771
82
455
1880
18210
19
64
1943
18601
—
19
58
1940
18581
66
464
1870
17915
181
1003
1649
16269
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
-1.5e-01
6.4e-02
4.1e-01
3.0e+00
4.2e-01
1.1e-01
7.9e-02
cases:40.61%
controls:44.30%
cases:38.74%
controls:37.22%
cases:21.00%
controls:15.00%
cases:14.53%
controls:0.85%
cases:21.44%
controls:15.17%
cases:41.27%
controls:38.73%
cases:57.10%
controls:55.16%
787
8173
1151
10275
760
6948
1202
11717
412
2799
1550
15866
285
158
1677
18507
420
2828
1539
15811
799
7118
1137
11261
1045
9527
785
7745
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 [45587505]
R29.8 [45587505]
9.8e-01
1.4e+00
—
—
—
1.5e+00
6.0e-01
cases:1.19%
controls:0.45%
cases:0.66%
controls:0.17%
—
—
—
—
—
—
cases:0.67%
controls:0.16%
cases:0.98%
controls:0.54%
23
83
1915
18365
13
31
1949
18634
—
—
—
13
29
1923
18350
18
94
1812
17178
Psychiatric pharmacotherapy plan, not specified
IFA01 [2001304251]
IFA01 [2001304251]
8.3e-01
—
—
—
—
1.9e+00
1.9e+00
cases:0.31%
controls:0.14%
—
—
—
—
—
—
—
—
cases:0.88%
controls:0.13%
cases:2.13%
controls:0.32%
6
25
1932
18423
—
—
—
—
17
24
1919
18355
39
56
1791
17216
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.1e-01
4.6e-01
7.3e-01
—
9.1e-01
6.0e-01
6.5e-01
cases:9.44%
controls:6.50%
cases:6.12%
controls:3.96%
cases:1.58%
controls:0.77%
—
—
cases:1.48%
controls:0.60%
cases:6.56%
controls:3.70%
cases:14.75%
controls:8.26%
183
1199
1755
17249
120
739
1842
17926
31
144
1931
18521
—
29
112
1930
18527
127
680
1809
17699
270
1426
1560
15846
Ultrasound examination transplanted kidney
KA2AE [2001305644]
KA2AE [2001305644]
1.2e+00
1.8e+00
—
—
—
1.9e+00
1.2e+00
cases:0.46%
controls:0.15%
cases:0.46%
controls:0.08%
—
—
—
—
—
—
cases:0.41%
controls:0.06%
cases:0.38%
controls:0.12%
9
27
1929
18421
9
14
1953
18651
—
—
—
8
11
1928
18368
7
20
1823
17252
Inpatient Visit
IP [9201]
IP [9201]
1.8e-01
6.8e-01
-8.9e-02
—
1.7e+00
7.4e-01
6.2e-01
cases:5.68%
controls:4.76%
cases:3.21%
controls:1.66%
cases:0.25%
controls:0.28%
—
—
cases:1.02%
controls:0.19%
cases:2.94%
controls:1.43%
cases:5.46%
controls:3.02%
110
879
1828
17569
63
309
1899
18356
5
52
1957
18613
—
20
35
1939
18604
57
262
1879
18117
100
521
1730
16751
Moderate depressive episode with somatic syndrome
F32.11 [2000501981]
F32.11 [2000501981]
1.3e+00
2.0e+00
—
—
—
1.8e+00
1.7e+00
cases:0.52%
controls:0.14%
cases:0.41%
controls:0.05%
—
—
—
—
—
—
cases:0.31%
controls:0.05%
cases:0.82%
controls:0.15%
10
26
1928
18422
8
10
1954
18655
—
—
—
6
9
1930
18370
15
26
1815
17246
Obstetrics / Gynecology
16 [38004461]
16 [38004461]
1.5e-01
2.0e-01
7.0e-02
3.0e+00
5.8e-01
4.0e-01
3.6e-01
cases:8.31%
controls:7.25%
cases:3.87%
controls:3.18%
cases:0.82%
controls:0.76%
cases:0.82%
controls:0.04%
cases:0.97%
controls:0.55%
cases:4.86%
controls:3.29%
cases:12.95%
controls:9.44%
161
1338
1777
17110
76
594
1886
18071
16
142
1946
18523
16
8
1946
18657
19
102
1940
18537
94
605
1842
17774
237
1630
1593
15642
Evaluation concerning developmental neuropsychiatry
IBZ06 [2001304080]
IBZ06 [2001304080]
—
—
—
—
—
2.1e+00
1.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.05%
cases:0.60%
controls:0.13%
—
—
—
—
—
9
10
1927
18369
11
23
1819
17249
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
1.2e+00
2.1e+00
—
—
—
—
1.6e+00
cases:0.36%
controls:0.11%
cases:0.31%
controls:0.04%
—
—
—
—
—
—
—
—
cases:0.77%
controls:0.16%
7
21
1931
18427
6
7
1956
18658
—
—
—
—
14
28
1816
17244
Feeling ill
A05 [2002000146]
A05 [2002000146]
6.1e-01
1.2e+00
—
—
—
1.0e+00
8.0e-01
cases:2.06%
controls:1.13%
cases:1.48%
controls:0.45%
—
—
—
—
—
—
cases:1.55%
controls:0.56%
cases:4.59%
controls:2.12%
40
209
1898
18239
29
84
1933
18581
—
—
—
30
103
1906
18276
84
366
1746
16906
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.7e-01
5.6e-01
1.2e+00
—
9.1e-01
4.3e-01
5.8e-01
cases:9.39%
controls:7.31%
cases:6.47%
controls:3.82%
cases:1.89%
controls:0.60%
—
—
cases:1.38%
controls:0.56%
cases:5.06%
controls:3.36%
cases:13.83%
controls:8.26%
182
1348
1756
17100
127
713
1835
17952
37
112
1925
18553
—
27
104
1932
18535
98
618
1838
17761
253
1426
1577
15846
Anxiety disorder/anxiety state
P74 [2002000868]
P74 [2002000868]
1.2e+00
1.5e+00
—
—
—
1.3e+00
9.0e-01
cases:0.77%
controls:0.24%
cases:0.56%
controls:0.12%
—
—
—
—
—
—
cases:0.52%
controls:0.15%
cases:1.58%
controls:0.65%
15
44
1923
18404
11
23
1951
18642
—
—
—
10
27
1926
18352
29
112
1801
17160
Ventricular septal defect NOS
Q21.09 [2000503269]
Q21.09 [2000503269]
1.8e+00
1.2e+00
—
—
—
—
1.8e+00
cases:0.36%
controls:0.06%
cases:0.25%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.06%
7
11
1931
18437
5
15
1957
18650
—
—
—
—
7
11
1823
17261
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
2.3e-01
4.4e-01
1.0e+00
—
9.0e-01
6.4e-01
5.7e-01
cases:7.38%
controls:5.97%
cases:4.89%
controls:3.19%
cases:1.22%
controls:0.44%
—
—
cases:0.92%
controls:0.38%
cases:4.55%
controls:2.44%
cases:10.60%
controls:6.29%
143
1102
1795
17346
96
596
1866
18069
24
82
1938
18583
—
18
70
1941
18569
88
448
1848
17931
194
1087
1636
16185
Glucose [Presence] in Urine by Test strip
25428-4 [3009261]
25428-4 [3009261]
3.0e-01
5.0e-01
1.1e+00
—
9.5e-01
5.2e-01
4.7e-01
cases:5.31%
controls:3.98%
cases:3.72%
controls:2.29%
cases:1.07%
controls:0.35%
—
—
cases:0.97%
controls:0.38%
cases:4.03%
controls:2.43%
cases:10.66%
controls:6.94%
103
734
1835
17714
73
427
1889
18238
21
65
1941
18600
—
19
70
1940
18569
78
446
1858
17933
195
1199
1635
16073
Constipation caused by slow bowel passage (SCT)
K59.00 [2000502924]
K59.00 [2000502924]
8.5e-01
9.8e-01
—
1.0e+50
—
2.3e+00
1.3e+00
cases:0.57%
controls:0.24%
cases:0.36%
controls:0.13%
—
—
cases:0.51%
controls:0.00%
—
—
cases:1.14%
controls:0.11%
cases:0.98%
controls:0.28%
11
45
1927
18403
7
25
1955
18640
—
10
0
1952
18665
—
22
21
1914
18358
18
48
1812
17224
Nitrite [Presence] in Urine by Test strip
5802-4 [3021601]
5802-4 [3021601]
3.3e-01
4.9e-01
1.1e+00
—
9.4e-01
5.2e-01
5.0e-01
cases:5.26%
controls:3.84%
cases:3.67%
controls:2.27%
cases:1.02%
controls:0.34%
—
—
cases:0.97%
controls:0.38%
cases:3.98%
controls:2.41%
cases:10.77%
controls:6.85%
102
709
1836
17739
72
424
1890
18241
20
64
1942
18601
—
19
71
1940
18568
77
443
1859
17936
197
1183
1633
16089
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
1.6e-01
1.1e+00
—
—
—
1.1e+00
1.3e+00
cases:0.77%
controls:0.66%
cases:0.66%
controls:0.22%
—
—
—
—
—
—
cases:0.72%
controls:0.24%
cases:2.57%
controls:0.69%
15
122
1923
18326
13
41
1949
18624
—
—
—
14
45
1922
18334
47
119
1783
17153
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
3.3e-01
5.1e-01
1.1e+00
—
9.3e-01
5.2e-01
4.7e-01
cases:5.37%
controls:3.92%
cases:3.72%
controls:2.27%
cases:1.02%
controls:0.34%
—
—
cases:0.97%
controls:0.39%
cases:4.03%
controls:2.43%
cases:10.71%
controls:6.96%
104
723
1834
17725
73
424
1889
18241
20
64
1942
18601
—
19
72
1940
18567
78
447
1858
17932
196
1202
1634
16070
Specific (isolated) phobias
F40.2 [45586240]
F40.2 [45586240]
—
—
—
—
—
2.1e+00
1.4e+00
—
—
—
—
—
—
—
—
—
—
cases:0.31%
controls:0.04%
cases:0.55%
controls:0.13%
—
—
—
—
—
6
7
1930
18372
10
23
1820
17249
Observation for suspected disease or condition, unspecified
Z03.9 [45552062]
Z03.9 [45552062]
2.0e-01
8.1e-01
1.8e+00
—
1.9e+00
6.3e-01
7.1e-01
cases:3.46%
controls:2.86%
cases:1.94%
controls:0.87%
cases:0.25%
controls:0.04%
—
—
cases:0.41%
controls:0.06%
cases:1.24%
controls:0.66%
cases:3.93%
controls:1.97%
67
528
1871
17920
38
162
1924
18503
5
8
1957
18657
—
8
11
1951
18628
24
122
1912
18257
72
341
1758
16931
Observation for suspected nervous system disorder
Z03.3 [45609903]
Z03.3 [45609903]
8.5e-02
4.6e-01
2.4e+00
—
—
1.0e+00
5.4e-02
cases:1.03%
controls:0.95%
cases:0.41%
controls:0.26%
cases:0.31%
controls:0.03%
—
—
—
—
cases:0.83%
controls:0.30%
cases:1.04%
controls:0.98%
20
175
1918
18273
8
48
1954
18617
6
5
1956
18660
—
—
16
55
1920
18324
19
170
1811
17102
Systematic individual therapy, cognitive-behavioural
IDY03 [2001304164]
IDY03 [2001304164]
1.3e+00
1.6e+00
—
—
—
1.8e+00
7.6e-01
cases:0.52%
controls:0.15%
cases:0.66%
controls:0.13%
—
—
—
—
—
—
cases:0.72%
controls:0.13%
cases:0.98%
controls:0.46%
10
27
1928
18421
13
24
1949
18641
—
—
—
14
23
1922
18356
18
80
1812
17192
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.1e-02
1.8e-01
5.6e-01
2.0e+00
5.8e-01
2.1e-01
1.1e-01
cases:20.64%
controls:20.47%
cases:22.22%
controls:19.32%
cases:9.02%
controls:5.36%
cases:2.19%
controls:0.29%
cases:9.04%
controls:5.27%
cases:23.04%
controls:19.45%
cases:34.37%
controls:31.95%
400
3776
1538
14672
436
3607
1526
15058
177
1001
1785
17664
43
54
1919
18611
177
982
1782
17657
446
3575
1490
14804
629
5518
1201
11754
Clinic/Center
261Q00000X [38004207]
261Q00000X [38004207]
3.8e-02
—
—
—
—
1.9e+00
1.5e+00
cases:0.31%
controls:0.30%
—
—
—
—
—
—
—
—
cases:0.62%
controls:0.09%
cases:1.26%
controls:0.29%
6
55
1932
18393
—
—
—
—
12
17
1924
18362
23
50
1807
17222
Mixed disorder of scholastic skills
F81.3 [45605515]
F81.3 [45605515]
—
1.6e+00
—
—
—
1.9e+00
1.5e+00
—
—
cases:0.36%
controls:0.07%
—
—
—
—
—
—
cases:0.62%
controls:0.10%
cases:1.42%
controls:0.31%
—
7
13
1955
18652
—
—
—
12
18
1924
18361
26
54
1804
17218
Observation for suspected mental and behavioural disorders
Z03.2 [45552060]
Z03.2 [45552060]
1.3e+00
2.1e+00
—
—
—
1.6e+00
5.8e-01
cases:0.77%
controls:0.22%
cases:0.71%
controls:0.09%
—
—
—
—
—
—
cases:0.36%
controls:0.08%
cases:0.71%
controls:0.40%
15
40
1923
18408
14
17
1948
18648
—
—
—
7
14
1929
18365
13
69
1817
17203
Catheterisation of heart with other procedure
TFC99 [2001303401]
TFC99 [2001303401]
1.4e+00
—
—
—
—
—
1.9e+00
cases:0.62%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.38%
controls:0.06%
12
28
1926
18420
—
—
—
—
—
7
10
1823
17262
Cortisol [Moles/volume] in Serum or Plasma
14675-3 [3036481]
14675-3 [3036481]
6.2e-01
9.5e-01
1.3e+00
—
—
9.2e-01
7.8e-01
cases:2.43%
controls:1.32%
cases:1.94%
controls:0.76%
cases:0.36%
controls:0.10%
—
—
—
—
cases:1.29%
controls:0.52%
cases:2.73%
controls:1.27%
47
243
1891
18205
38
141
1924
18524
7
18
1955
18647
—
—
25
95
1911
18284
50
219
1780
17053
Choriogonadotropin [Units/volume] in Urine
25372-4 [3023511]
25372-4 [3023511]
4.9e-01
—
—
—
—
2.2e+00
1.1e+00
cases:0.62%
controls:0.38%
—
—
—
—
—
—
—
—
cases:0.57%
controls:0.07%
cases:1.80%
controls:0.60%
12
70
1926
18378
—
—
—
—
11
12
1925
18367
33
104
1797
17168
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
5.7e-01
5.5e-01
1.9e+00
—
—
8.3e-01
7.6e-01
cases:2.48%
controls:1.42%
cases:0.82%
controls:0.47%
cases:0.36%
controls:0.05%
—
—
—
—
cases:0.93%
controls:0.41%
cases:1.91%
controls:0.90%
48
262
1890
18186
16
88
1946
18577
7
10
1955
18655
—
—
18
75
1918
18304
35
156
1795
17116
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.9e-01
5.4e-01
1.1e+00
—
1.1e+00
7.0e-01
5.0e-01
cases:5.37%
controls:3.71%
cases:2.55%
controls:1.49%
cases:0.66%
controls:0.23%
—
—
cases:0.61%
controls:0.21%
cases:2.84%
controls:1.43%
cases:8.09%
controls:5.08%
104
684
1834
17764
50
279
1912
18386
13
42
1949
18623
—
12
39
1947
18600
55
263
1881
18116
148
877
1682
16395
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
3.1e-01
5.4e-01
9.0e-01
—
6.4e-01
3.7e-01
4.5e-01
cases:18.89%
controls:14.55%
cases:9.79%
controls:5.96%
cases:2.14%
controls:0.88%
—
—
cases:1.79%
controls:0.95%
cases:8.42%
controls:5.99%
cases:22.73%
controls:15.74%
366
2684
1572
15764
192
1113
1770
17552
42
165
1920
18500
—
35
177
1924
18462
163
1101
1773
17278
416
2718
1414
14554
Accelerated psychiatric treatment contact
IGY01 [2001304321]
IGY01 [2001304321]
9.0e-01
—
—
—
—
1.7e+00
1.5e+00
cases:0.52%
controls:0.21%
—
—
—
—
—
—
—
—
cases:0.98%
controls:0.18%
cases:2.08%
controls:0.48%
10
39
1928
18409
—
—
—
—
19
33
1917
18346
38
83
1792
17189
Diplopia
H53.2 [45576792]
H53.2 [45576792]
1.8e+00
—
—
—
—
—
1.4e+00
cases:0.36%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.55%
controls:0.14%
7
11
1931
18437
—
—
—
—
—
10
24
1820
17248
Feeling depressed
P03 [2002000800]
P03 [2002000800]
1.2e+00
1.4e+00
—
—
—
5.2e-01
6.4e-01
cases:2.53%
controls:0.80%
cases:1.22%
controls:0.32%
—
—
—
—
—
—
cases:0.57%
controls:0.34%
cases:3.17%
controls:1.70%
49
148
1889
18300
24
59
1938
18606
—
—
—
11
62
1925
18317
58
293
1772
16979
Fear of other disease NOS
A27 [2002000161]
A27 [2002000161]
5.7e-01
—
—
—
—
1.8e+00
1.4e+00
cases:0.41%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.36%
controls:0.06%
cases:0.87%
controls:0.23%
8
43
1930
18405
—
—
—
—
7
11
1929
18368
16
39
1814
17233
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
4.4e-01
6.9e-01
5.4e-01
1.0e+50
8.6e-01
4.9e-01
6.6e-01
cases:7.64%
controls:5.06%
cases:5.25%
controls:2.71%
cases:0.82%
controls:0.48%
cases:0.25%
controls:0.00%
cases:1.23%
controls:0.52%
cases:4.03%
controls:2.50%
cases:12.90%
controls:7.10%
148
933
1790
17515
103
505
1859
18160
16
89
1946
18576
5
0
1957
18665
24
97
1935
18542
78
460
1858
17919
236
1226
1594
16046
Anankastic personality disorder
F60.5 [45591150]
F60.5 [45591150]
—
1.0e+50
—
—
1.0e+50
—
3.1e+00
—
—
cases:0.31%
controls:0.00%
—
—
—
—
cases:0.31%
controls:0.00%
—
—
cases:0.66%
controls:0.03%
—
6
0
1956
18665
—
—
6
0
1953
18639
—
12
5
1818
17267
Other psychiatric network intervention
IEV99 [2001304218]
IEV99 [2001304218]
1.5e+00
—
—
—
—
1.6e+00
1.5e+00
cases:0.36%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.46%
controls:0.09%
cases:0.87%
controls:0.20%
7
15
1931
18433
—
—
—
—
9
17
1927
18362
16
34
1814
17238
Spirometry with oscillometry
XG413 [2001303854]
XG413 [2001303854]
1.0e+00
9.1e-01
—
—
—
2.1e+00
—
cases:0.72%
controls:0.25%
cases:0.31%
controls:0.12%
—
—
—
—
—
—
cases:0.46%
controls:0.06%
—
—
14
47
1924
18401
6
23
1956
18642
—
—
—
9
11
1927
18368
—
Pulmonary Disease
29 [38004472]
29 [38004472]
5.4e-01
7.3e-01
8.0e-01
—
9.3e-01
1.1e+00
7.4e-01
cases:2.79%
controls:1.64%
cases:1.78%
controls:0.87%
cases:0.36%
controls:0.16%
—
—
cases:0.46%
controls:0.18%
cases:2.43%
controls:0.83%
cases:4.21%
controls:2.06%
54
303
1884
18145
35
162
1927
18503
7
30
1955
18635
—
9
34
1950
18605
47
153
1889
18226
77
355
1753
16917
Standard MRI examination of brain with high intensity magnet
AA1BG [2001300112]
AA1BG [2001300112]
4.7e-01
7.2e-01
—
—
—
1.5e+00
1.5e+00
cases:1.29%
controls:0.81%
cases:0.41%
controls:0.20%
—
—
—
—
—
—
cases:0.77%
controls:0.17%
cases:2.24%
controls:0.49%
25
149
1913
18299
8
37
1954
18628
—
—
—
15
31
1921
18348
41
84
1789
17188
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
7.6e-01
1.1e+00
—
—
—
1.4e+00
9.3e-01
cases:1.34%
controls:0.63%
cases:0.56%
controls:0.19%
—
—
—
—
—
—
cases:0.67%
controls:0.17%
cases:1.15%
controls:0.46%
26
117
1912
18331
11
36
1951
18629
—
—
—
13
31
1923
18348
21
79
1809
17193
Delayed milestone
R62.0 [45597195]
R62.0 [45597195]
2.2e-01
4.5e-01
—
—
—
1.6e+00
1.5e+00
cases:1.91%
controls:1.54%
cases:0.71%
controls:0.46%
—
—
—
—
—
—
cases:0.83%
controls:0.17%
cases:0.93%
controls:0.21%
37
285
1901
18163
14
85
1948
18580
—
—
—
16
32
1920
18347
17
36
1813
17236
Weakness/tiredness general
A04 [2002000145]
A04 [2002000145]
5.5e-01
1.1e+00
—
—
—
1.0e+00
9.3e-01
cases:1.81%
controls:1.05%
cases:0.92%
controls:0.31%
—
—
—
—
—
—
cases:0.77%
controls:0.28%
cases:3.88%
controls:1.57%
35
193
1903
18255
18
57
1944
18608
—
—
—
15
51
1921
18328
71
272
1759
17000
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
R1230 [2001310176]
1.1e+00
9.9e-01
—
—
—
1.2e+00
7.8e-01
cases:0.88%
controls:0.29%
cases:0.46%
controls:0.17%
—
—
—
—
—
—
cases:0.77%
controls:0.24%
cases:1.53%
controls:0.71%
17
54
1921
18394
9
32
1953
18633
—
—
—
15
45
1921
18334
28
122
1802
17150
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1036
6718
1.94
51.79
16.4
8.8
1.22
1.22
mmol/l
0.46
999
6332
1107
7455
1.89
48.25
13.6
8.4
1.22
1.22
mmol/l
0.11
992
6678
776
4688
1.95
46.73
3.1
2.7
2.37
2.37
mmol/l
0.06
730
4365
927
5987
1.88
45.21
7.3
6.0
37.92
38.09
g/l
0.43
871
5658
327
1452
2.43
43.13
1.7
1.6
1158.48
1136.78
nmol/l
0.17
270
1123
786
4887
1.89
42.58
4.6
4.0
8.14
8.81
mmol/l
2.37
726
4508
1536
11743
1.85
42.15
8.0
6.5
89.53
85.94
u/l
1.38
1477
11129
859
5511
1.86
42.03
2.0
1.7
95.69
97.78
pmol/l
0.71
510
3073
602
3489
1.95
39.90
2.2
1.7
1.44
1.36
%
3.73
556
3178
1306
9653
1.76
38.53
9.1
5.6
6.05
6.07
mmol/l
0.06
1224
8746
1137
8086
1.76
38.32
3.7
2.9
67.05
68.66
nmol/l
1.30
1087
7707
1049
7352
1.74
36.71
6.6
6.1
12.29
13.51
umol/l
0.88
986
6836
592
3495
1.90
36.69
1.7
1.5
19.81
19.23
nmol/l
0.16
544
3142
1854
15352
1.93
36.04
5.1
4.1
14.48
14.41
pmol/l
0.60
1759
14100
602
3595
1.88
35.90
3.8
2.9
10.54
8.17
e6/l
1.64
542
3211
834
5513
1.77
35.54
5.4
3.5
18.07
60.46
e6/l
2.40
638
4005
572
3410
1.87
34.04
2.8
2.3
188.47
259.37
u/l
1.16
554
3272
2041
17592
2.15
33.77
19.2
10.6
3.91
3.90
mmol/l
0.55
1998
17037
751
4885
1.77
33.39
5.4
3.4
0.21
0.25
e6/l
0.45
556
3409
2038
17579
2.13
33.29
19.1
10.5
139.68
139.48
mmol/l
5.22
2001
17106
1387
10740
1.68
31.69
10.5
8.2
0.20
0.19
e9/l
0.37
1229
9399
875
6027
1.70
31.16
4.1
3.6
28.92
30.43
u/l
0.77
841
5767
372
2001
2.00
29.71
2.4
2.1
2.40
2.40
mmol/l
0.22
324
1758
2006
17380
1.99
29.63
6.1
4.8
1.78
1.79
mu/l
0.27
1946
16611
395
2172
1.96
29.61
2.5
2.2
348.67
373.91
nmol/l
1.87
371
2044
1440
11374
1.65
29.39
13.6
9.8
3.88
3.80
e9/l
0.73
1255
9737
729
4871
1.70
28.52
2.5
2.7
2.59
2.46
mg/l
1.04
650
4290
1371
10773
1.62
27.86
9.8
7.7
2.20
2.14
e9/l
1.23
1219
9534
1764
14811
1.72
27.33
4.1
2.9
5.53
5.44
mmol/l
2.04
1686
13925
302
1562
2.05
26.75
3.6
4.0
0.22
0.22
g/l
0.06
285
1487
496
3024
1.79
26.62
4.8
3.0
0.71
0.92
e6/l
1.36
271
1452
680
4537
1.68
26.36
3.2
2.6
62.53
56.99
u/l
0.44
632
4223
79
207
3.87
26.26
22.2
24.3
1265.70
1398.38
nmol/l
0.79
79
198
424
2481
1.84
25.99
15.0
8.9
1.23
1.22
mmol/l
0.23
405
2359
77
201
3.88
25.74
16.4
17.1
779.55
818.72
nmol/l
0.30
77
194
1491
12095
1.60
25.36
5.9
4.0
1840.25
1382.42
e6/l
0.09
24
150
78
210
3.77
24.96
12.1
13.4
0.61
0.58
mmol/l
0.34
72
197
106
376
2.87
21.75
6.2
5.5
396.00
398.90
umol/l
0.07
93
338
429
2644
1.74
21.73
3.8
2.6
14.25
14.85
umol/l
0.96
409
2487
1277
10196
1.53
21.62
9.5
7.7
32.15
32.46
%
0.44
1221
9805
691
4868
1.57
20.50
3.8
3.0
1.02
1.69
kg/l
0.80
467
3025
1252
10019
1.51
20.50
9.4
7.6
53.31
53.19
%
0.14
1201
9684
361
2163
1.77
20.05
4.1
2.7
22.62
23.58
%
0.74
343
2036
238
1250
1.98
19.98
1.9
1.7
0.18
0.21
mg/l
0.47
100
531
1196
9524
1.49
19.76
13.3
10.2
0.00
0.00
e9/l
0.71
952
7571
2143
19528
2.01
19.70
16.7
10.5
66.89
66.73
umol/l
0.11
2124
19254
376
2291
1.74
19.67
12.6
8.1
1.05
1.24
mmol/l
0.60
326
1909
793
5816
1.53
19.40
2.0
1.8
1.39
1.29
mmol/l
2.05
725
5298
617
4298
1.57
18.98
7.8
5.6
91.19
90.73
%
0.20
610
4208
455
2946
1.65
18.93
5.1
3.1
4.04
3.33
e6/l
0.54
229
1373
380
2346
1.72
18.92
11.6
7.2
0.81
0.82
mmol/l
2.02
360
2252
377
2329
1.72
18.71
12.7
8.0
5.87
5.84
kpa
0.31
366
2276
376
2322
1.72
18.68
1.6
1.5
439.30
30912180.69
pmol/l
1.80
335
2051
1621
13843
1.51
18.27
4.7
3.6
36.18
35.75
mmol/mol
0.99
1563
13282
352
2153
1.73
18.07
12.4
8.0
5.02
4.98
kpa
0.14
340
2111
383
2409
1.68
17.71
4.0
2.6
2.54
2.53
g/l
0.14
363
2243
1237
10052
1.46
17.59
4.5
3.4
0.02
5.90
estimate
2.29
257
2015
275
1582
1.82
17.40
18.3
10.9
6.42
5.57
mmol/l
2.57
266
1546
1538
13056
1.48
17.31
4.5
3.3
31.63
29.74
u/l
0.93
1489
12597
1508
12765
1.47
17.11
4.8
3.9
7.93
7.33
mm/h
1.55
1424
12039
350
2182
1.69
16.67
25.5
12.8
24.61
24.62
mmol/l
0.02
350
2176
1220
9966
1.44
16.38
4.5
3.4
0.01
0.00
estimate
0.73
258
2050
321
1974
1.71
16.05
5.0
4.9
6.38
6.08
umol/l
0.10
272
1659
276
1634
1.76
15.80
2.4
2.4
28.53
61.93
u/l
0.57
230
1353
1228
10085
1.43
15.76
4.6
3.4
0.00
0.00
estimate
0.50
251
1983
46
119
3.88
15.65
3.0
2.2
14.57
15.93
umol/l
0.32
46
119
150
731
2.10
15.43
2.3
1.6
—
—
—
0
0
938
7368
1.43
15.23
1.7
1.6
2.45
2.16
u/ml
0.17
231
1794
206
1128
1.88
15.21
10.8
6.3
67.71
59.63
ng/l
1.01
201
1067
2117
19480
1.78
15.03
12.3
8.8
26.52
26.35
u/l
0.13
2079
18990
411
2739
1.59
14.88
3.4
3.1
311.49
313.79
umol/l
0.17
364
2551
348
2242
1.63
14.47
2.6
1.9
—
—
—
0
0
2120
19555
1.76
14.38
16.8
10.7
20.22
21.19
mg/l
0.76
1693
14957
686
5138
1.45
14.16
4.1
3.3
0.00
0.00
estimate
0.20
250
1946
263
1584
1.72
14.12
2.7
1.8
—
—
—
0
0
268
1624
1.71
14.07
2.7
1.8
—
—
—
0
0
112
512
2.22
13.56
2.8
2.1
—
—
—
0
0
835
6541
1.41
13.26
1.8
1.6
1.85
1.87
g/l
0.21
475
4034
299
1896
1.64
13.18
7.1
4.3
1513.15
715.17
ng/l
1.25
233
1462
540
3910
1.48
13.13
2.9
2.4
20.47
32.57
ng/l
0.92
251
1489
102
459
2.25
12.84
3.6
2.9
8.84
3.82
index
0.83
62
269
188
1062
1.82
12.56
21.3
14.9
1.24
1.06
mg/l
3.26
182
1030
1359
11605
1.38
12.52
4.2
3.4
60.53
64.59
ug/l
0.64
1297
11094
1719
15281
1.42
12.37
11.9
8.0
105.37
104.68
ml/min/173m2
0.69
1481
12774
46
140
3.30
12.36
4.3
5.0
189.80
221.13
umol/l
0.22
25
80
176
988
1.82
12.00
2.1
1.9
—
—
—
0
0
201
1186
1.74
11.57
4.1
4.5
64.10
67.23
e9/l
0.48
130
761
283
1827
1.61
11.55
4.1
3.1
9.49
9.93
g/l
1.48
275
1711
300
1966
1.58
11.50
15.5
8.0
5.05
5.04
kpa
0.08
295
1906
53
184
2.89
11.43
4.2
3.6
19.37
16.18
index
0.61
46
152
87
390
2.25
11.09
1.7
1.4
—
—
—
0
0
289
1894
1.58
11.06
1.8
1.6
355.00
311.54
mu/l
1.19
253
1710
26
57
4.55
11.00
8.5
9.2
—
—
—
0
0
1979
18183
1.49
10.92
22.1
13.8
13.24
13.10
%
6.58
1961
17934
112
558
2.03
10.91
2.4
1.9
4.77
7.12
ug/l
1.29
102
481
72
300
2.42
10.84
5.5
4.5
2.29
1.84
mmol/l
0.80
39
165
46
152
3.03
10.83
4.3
3.9
0.59
0.74
index
0.60
46
152
500
3698
1.43
10.59
3.4
2.6
1.67
1.13
mg/l
0.78
351
2617
285
1889
1.56
10.36
16.1
8.0
0.66
0.88
mmol/l
0.51
195
1363
186
1108
1.72
10.35
19.4
10.7
0.02
0.18
mmol/l
0.22
155
879
140
769
1.85
10.25
1.5
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
68
284
2.41
10.21
20.5
14.0
0.30
0.34
iu/ml
1.07
40
162
90
426
2.13
10.06
3.4
2.7
319.52
272.36
ug/l
0.33
77
393
294
1978
1.54
9.99
1.6
1.4
339.10
331.13
u/ml
0.03
270
1843
322
2216
1.51
9.83
4.5
3.0
352.91
739.12
ng/l
1.68
170
1089
354
2490
1.48
9.70
5.1
4.7
14.19
17.38
mg/mmol
0.19
256
1821
156
907
1.75
9.48
6.0
4.9
162.01
164.36
%
0.16
151
883
563
4322
1.38
9.47
3.2
2.5
—
—
—
0
0
92
450
2.06
9.46
13.0
8.1
466.00
1056.51
u/ml
0.44
11
35
32
92
3.47
9.44
11.5
9.3
832.00
2123.27
iu/ml
—
5
11
87
418
2.10
9.38
3.8
3.4
33.09
32.75
umol/l
0.07
82
389
331
2319
1.48
9.24
6.6
4.3
30.08
29.81
s
0.34
323
2271
183
1122
1.67
9.16
19.7
10.6
5.04
5.10
kpa
0.33
178
1073
1736
15731
1.35
9.10
4.3
3.3
2.75
2.72
mmol/l
0.65
1677
15044
64
275
2.34
9.06
2.8
3.8
1.63
1.71
umol/l
0.30
64
266
1603
14385
1.32
8.79
3.5
2.8
1.21
1.15
mmol/l
2.55
1543
13752
71
324
2.20
8.74
2.2
1.8
75.14
67.90
—
7
21
34
107
3.17
8.73
5.7
5.1
—
—
—
0
0
1733
15745
1.34
8.60
4.1
3.2
4.48
4.52
mmol/l
0.98
1674
15136
187
1176
1.62
8.48
5.2
4.4
—
—
—
0
0
103
546
1.91
8.46
12.9
7.9
399.31
600.00
iu/ml
0.24
16
59
218
1426
1.56
8.38
2.0
1.9
1.17
1.16
g/l
0.01
211
1341
2285
21960
2.20
8.27
26.2
16.3
268.44
264.27
e9/l
2.48
2248
21390
972
8203
1.29
8.26
3.5
3.0
—
—
estimate
—
0
0
158
960
1.67
8.20
8.0
5.5
3.16
3.13
g/l
0.09
151
933
219
1442
1.55
8.18
4.9
5.6
249.63
251.57
u/l
0.04
210
1390
164
1009
1.65
8.12
21.5
11.4
96.85
95.92
%
1.00
158
977
1716
15616
1.33
8.09
4.0
3.1
1.35
1.42
mmol/l
11.89
1653
14951
2285
21976
2.17
7.98
27.8
16.8
40.50
41.14
%
1.23
2271
21773
2285
21978
2.17
7.95
26.1
16.2
4.63
4.63
e12/l
0.01
2243
21365
2286
21993
2.18
7.92
26.2
16.3
6.97
6.80
e9/l
3.68
2243
21377
2284
21971
2.14
7.84
26.0
16.2
88.20
88.16
fl
0.17
2272
21778
2285
21987
2.15
7.79
26.5
16.4
135.81
136.34
g/l
1.07
2272
21795
251
1726
1.49
7.65
1.8
1.8
9.21
11.05
iu/l
0.92
186
1298
145
882
1.67
7.51
5.1
4.0
1.23
1.23
mmol/l
0.09
129
751
235
1608
1.50
7.34
18.1
8.5
9.67
9.67
kpa
0.01
229
1565
99
546
1.83
7.24
1.6
1.6
438.98
363.29
mu/l
0.89
81
446
512
4027
1.33
7.11
2.7
3.2
97.04
107.63
ug/g
0.34
409
3234
177
1150
1.57
7.02
3.7
2.5
—
—
—
0
0
125
745
1.70
7.01
2.5
1.9
112.45
114.40
au/ml
0.06
46
226
232
1606
1.48
6.84
1.8
1.9
5.90
7.21
u/l
2.42
163
1175
24
71
3.37
6.84
8.9
6.6
—
—
—
0
0
24
71
3.37
6.84
9.0
6.9
98100.00
591922.65
u/ml
—
6
17
51
228
2.24
6.67
1.7
1.4
1.12
1.33
promille
0.46
32
170
89
490
1.83
6.57
1.1
1.3
—
—
—
0
0
104
604
1.74
6.42
7.6
4.1
131.33
154.79
ng/l
0.35
95
514
156
1009
1.57
6.33
2.8
2.7
0.16
0.31
e6/l
0.86
148
960
388
2978
1.35
6.30
1.4
1.3
14.08
20.68
iu/ml
1.49
77
693
356
2708
1.35
6.12
1.4
1.3
5.09
7.69
u/ml
0.48
136
1033
864
7393
1.25
5.98
3.9
3.0
0.00
0.01
estimate
3.06
225
1712
37
152
2.43
5.89
1.5
1.3
—
—
—
0
0
210
2867
0.70
5.79
1.6
1.5
3.51
3.42
ratio
0.38
154
1964
880
7571
1.24
5.73
2.9
2.5
—
—
—
0
0
37
154
2.40
5.73
1.4
1.2
—
—
—
0
0
259
1893
1.40
5.70
2.6
2.2
10.53
11.17
nmol/l
0.53
236
1748
372
2884
1.33
5.61
2.9
2.6
5958.16
7405.97
u/l
0.37
114
1111
76
421
1.81
5.55
1.2
1.4
354.84
343.18
ug/g
0.15
32
197
163
2301
0.68
5.38
1.5
1.4
3.33
3.30
mmol/l
0.10
105
1436
37
159
2.32
5.36
2.5
1.5
13.96
5.25
ug/l
0.52
37
145
108
671
1.62
5.24
3.1
2.7
65.88
66.73
g/l
0.46
103
640
278
2085
1.36
5.22
1.2
1.3
168.61
150.94
u/ml
0.19
81
739
153
1034
1.50
5.13
1.6
1.5
—
—
—
0
0
29
114
2.54
5.09
1.3
1.3
1.66
1.29
nmol/l
0.72
23
104
58
306
1.90
4.97
4.9
3.3
—
—
—
0
0
924
8088
1.21
4.88
3.1
2.7
—
—
—
0
0
32
137
2.33
4.71
1.3
1.2
114.28
118.02
pmol/l
0.19
32
137
188
1345
1.42
4.70
2.7
3.5
4.85
4.86
pmol/l
0.05
175
1238
635
5367
1.23
4.70
2.8
2.5
—
—
—
0
0
164
1147
1.45
4.64
1.7
1.7
—
—
—
0
0
51
269
1.89
4.41
1.7
2.3
—
—
—
0
0
556
4662
1.24
4.40
2.5
2.3
—
—
—
0
0
82
502
1.64
4.27
4.8
7.2
23.49
23.74
mmol/l
0.34
82
489
21
77
2.71
4.26
1.5
1.7
—
—
—
0
0
66
384
1.72
4.17
1.3
1.4
6.21
4.07
u/ml
0.69
38
195
129
881
1.47
4.16
2.5
2.8
77.62
87.71
ml/min/173m2
1.35
53
320
35
166
2.10
4.08
1.8
1.5
—
—
—
0
0
74
447
1.66
4.08
1.8
1.3
—
—
—
0
0
74
447
1.66
4.08
1.8
1.3
—
—
—
0
0
83
517
1.61
4.06
2.6
1.9
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
30
134
2.23
4.05
1.1
1.2
—
—
—
0
0
8
10
7.94
4.03
9.6
4.8
4.77
7.85
mmol/l
—
8
10
93
599
1.56
3.96
3.2
2.6
191.65
6855.28
e6/l
0.50
77
445
92
592
1.56
3.93
3.2
2.6
12.39
20.46
e6/l
0.61
75
420
1971
18738
1.26
3.89
22.6
13.5
334.18
334.69
g/l
1.76
1966
18596
62
362
1.71
3.89
1.5
1.5
—
—
—
0
0
56
322
1.74
3.72
4.6
3.1
596.98
558.32
e6/l
0.21
42
223
56
326
1.72
3.58
4.8
3.2
189.50
202.22
e6/l
0.18
42
232
33
162
2.03
3.55
1.0
1.2
0.17
0.16
nmol/l
0.34
27
122
85
551
1.55
3.55
2.7
2.0
—
—
—
0
0
44
241
1.82
3.46
3.1
2.8
0.88
0.81
e9/l
0.31
44
235
57
338
1.68
3.42
2.7
1.8
—
—
—
0
0
64
393
1.63
3.37
1.3
1.4
4.41
4.46
u/ml
0.01
32
166
31
152
2.03
3.36
1.1
1.2
—
—
—
0
0
69
432
1.60
3.36
1.7
1.5
—
—
—
0
0
64
395
1.62
3.31
1.2
1.1
—
—
—
0
0
52
304
1.71
3.30
1.7
1.5
—
—
—
0
0
17
65
2.60
3.23
2.2
2.0
2.48
3.88
mg/l
0.74
12
46
140
1021
1.38
3.21
2.3
1.7
178.03
191.31
u/ml
0.31
92
552
7
11
6.31
3.16
1.4
1.7
192.21
266.36
ug/l
—
7
11
25
116
2.14
3.14
1.0
1.1
—
—
—
0
0
163
1226
1.34
3.08
1.5
1.4
—
—
—
0
0
19
79
2.39
3.06
1.8
1.6
0.83
1.28
iu/ml
—
8
44
37
203
1.82
2.94
2.1
2.2
0.12
0.11
nmol/l
0.12
28
161
268
2170
1.25
2.89
1.1
1.1
—
—
—
0
0
40
226
1.76
2.89
1.8
1.6
—
—
—
0
0
8
17
4.67
2.89
1.0
1.0
216.44
304.64
ng/l
—
8
11
8
17
4.67
2.89
1.0
1.1
28.16
41.74
ng/l
—
8
11
20
88
2.26
2.86
1.4
1.2
103.20
106.75
%
0.19
20
80
11
32
3.41
2.86
4.6
3.6
120.09
129.83
ng/l
0.07
11
32
35
191
1.82
2.83
2.1
1.7
—
—
—
0
0
103
731
1.41
2.80
1.6
1.5
—
—
—
0
0
8
18
4.41
2.76
3.0
1.4
29.27
13.11
nmol/l
—
8
18
48
291
1.64
2.71
2.7
3.0
18.01
17.65
%
0.35
48
282
21
97
2.15
2.70
1.4
1.2
0.27
0.29
g/l
0.30
14
83
132
985
1.34
2.66
1.5
1.6
4.55
3.78
mg/l
0.53
99
662
39
225
1.73
2.65
1.6
1.3
3.50
10.58
u/ml
2.91
27
141
15
60
2.48
2.64
1.1
1.4
—
—
—
0
0
27
139
1.93
2.62
1.4
1.5
11.58
33.47
u/l
0.82
27
129
83
575
1.44
2.60
1.3
1.1
—
—
—
0
0
23
112
2.04
2.60
3.5
2.6
1.99
1.75
ratio
0.10
14
62
38
219
1.73
2.60
1.4
1.5
257.65
434.87
pmol/l
2.11
31
189
5
7
7.08
2.53
1.2
1.3
28.00
28.14
umol/l
—
5
7
11
36
3.03
2.53
2.9
3.1
0.59
0.64
mmol/l
0.68
11
36
41
244
1.67
2.51
2.2
2.2
—
—
—
0
0
15
62
2.40
2.48
1.1
1.4
—
—
—
0
0
49
307
1.59
2.46
2.6
1.8
—
—
—
0
0
163
1269
1.29
2.46
3.0
2.8
1.04
1.17
ug/l
0.81
151
1134
98
709
1.38
2.43
1.7
1.6
0.24
0.41
nmol/l
2.74
78
585
16
69
2.30
2.42
2.4
1.5
0.09
0.34
iu/ml
—
8
40
6
12
4.96
2.38
1.3
1.2
—
—
—
0
0
113
840
1.35
2.37
1.1
1.1
0.25
0.67
u/ml
0.85
48
341
54
351
1.53
2.33
2.6
1.9
—
—
—
0
0
21
105
1.99
2.24
1.0
1.1
—
—
—
0
0
71
493
1.44
2.24
2.1
2.3
1.27
1.20
g/l
0.28
62
443
37
222
1.66
2.23
1.8
1.6
—
—
—
0
0
160
1265
1.27
2.17
3.7
2.6
30.35
31.86
%
1.10
131
968
15
67
2.22
2.12
1.4
3.0
33.09
25.02
mg/l
—
7
35
459
4025
1.16
2.11
1.5
1.6
—
—
—
0
0
31
180
1.71
2.11
1.1
1.2
—
—
—
0
0
25
136
1.83
2.11
2.5
1.5
—
—
—
0
0
81
583
1.39
2.11
1.3
1.1
—
—
—
0
0
12
49
2.43
2.05
1.1
1.1
—
—
—
0
0
20
102
1.95
2.04
1.6
1.4
21.43
22.11
mg/l
—
7
41
30
175
1.70
2.02
2.3
2.6
102.25
77.27
ug/min
0.14
20
121
35
213
1.63
2.02
1.2
1.4
—
140.00
—
0
7
202
1662
1.22
1.94
1.4
1.3
206.83
233.82
miu/ml
0.54
85
828
90
670
1.34
1.92
2.8
2.4
1.02
1.02
ratio
0.33
77
579
5
11
4.50
1.92
1.8
1.4
—
—
—
0
0
30
178
1.68
1.92
1.0
1.2
—
—
—
0
0
119
923
1.29
1.91
1.1
1.1
8.00
9.75
u/ml
0.33
64
525
31
186
1.66
1.90
2.2
2.2
28.33
25.60
mg/l
0.14
23
122
12
51
2.33
1.90
1.9
3.7
48.33
64.10
u/l
0.19
12
51
30
179
1.67
1.88
1.1
1.1
—
—
—
0
0
126
988
1.28
1.86
1.1
1.1
2.70
6.04
u/ml
3.00
74
603
118
919
1.28
1.84
3.1
2.7
21.98
23.69
%
0.33
27
217
164
1329
1.24
1.83
2.4
2.3
13.56
16.58
au/ml
0.39
14
167
53
364
1.45
1.82
1.2
1.1
6.80
1.44
u/ml
0.46
26
184
6
17
3.50
1.82
7.0
3.4
—
—
—
0
0
82
609
1.34
1.80
1.7
2.2
3.00
3.73
iu/l
0.40
32
283
40
260
1.53
1.79
1.3
1.1
27.47
37.18
mg/l
1.24
34
209
117
914
1.28
1.79
2.9
3.3
9.08
7.54
umol/l
0.34
94
719
99
758
1.30
1.77
1.5
1.6
3.80
6.44
u/ml
0.91
20
199
17
87
1.94
1.74
2.4
1.6
—
—
—
0
0
23
131
1.74
1.71
1.7
3.2
897.22
829.09
u/ml
0.11
23
131
23
131
1.74
1.71
6.3
6.2
91.04
84.52
mg/l
0.20
23
117
9
36
2.48
1.71
2.3
2.5
5.52
4.65
kpa
—
9
36
9
36
2.48
1.71
2.3
2.5
14.56
11.27
kpa
—
9
36
11
48
2.27
1.66
1.8
2.3
—
—
—
0
0
30
186
1.60
1.65
1.2
1.4
—
—
—
0
0
64
467
1.37
1.60
1.4
1.2
102.00
174.28
iu/ml
0.39
21
137
30
188
1.59
1.59
1.2
1.4
—
—
—
0
0
30
188
1.59
1.59
1.2
1.4
—
—
—
0
0
41
276
1.48
1.59
1.1
1.0
—
—
—
0
0
34
220
1.54
1.58
1.4
1.2
0.68
0.67
ratio
0.05
20
117
57
409
1.39
1.58
1.5
1.4
9.51
10.85
u/l
0.26
50
359
10
43
2.31
1.57
1.1
1.1
—
—
—
0
0
18
98
1.82
1.56
1.6
2.0
—
—
—
0
0
36
237
1.51
1.55
1.1
1.1
—
—
—
0
0
17
92
1.83
1.51
1.2
1.4
61.86
94.54
nmol/24h
1.57
17
92
5
15
3.30
1.50
1.2
1.1
—
—
—
0
0
5
15
3.30
1.50
3.4
2.4
—
—
—
0
0
13
64
2.01
1.50
5.8
4.7
5.21
5.09
kpa
0.08
13
64
16
86
1.85
1.46
1.1
1.2
—
—
—
0
0
19
108
1.75
1.45
3.7
3.4
105.16
117.69
umol/l
—
7
44
41
282
1.45
1.45
1.9
2.0
—
—
—
0
0
30
193
1.54
1.45
1.3
1.5
—
—
—
0
0
30
193
1.54
1.45
1.3
1.5
—
—
—
0
0
61
451
1.35
1.43
2.0
2.6
0.98
0.67
nmol/l
0.98
50
394
80
1006
0.78
1.41
1.1
1.1
0.54
0.61
ratio
—
6
63
18
102
1.75
1.40
1.1
1.2
—
—
—
0
0
21
125
1.67
1.38
1.2
1.2
—
—
—
0
0
7
29
2.39
1.37
1.0
1.3
1.19
1.19
mmol/l
—
7
29
11
53
2.06
1.35
1.1
1.1
—
—
—
0
0
153
1281
1.19
1.30
1.1
1.2
5.85
6.97
u/ml
0.41
95
869
10
47
2.11
1.30
1.1
1.4
—
—
—
0
0
10
47
2.11
1.30
1.1
1.4
—
—
—
0
0
13
68
1.90
1.29
4.8
6.2
—
—
—
0
0
11
54
2.02
1.29
1.1
1.1
—
—
—
0
0
30
199
1.50
1.29
1.3
1.5
—
—
—
0
0
9
43
2.07
1.28
1.1
1.1
—
—
—
0
0
36
501
0.71
1.28
1.9
1.7
7.29
7.45
mmol/l
0.23
36
483
8
158
0.50
1.24
1.5
1.3
239.03
197.68
pmol/l
—
8
158
138
1611
0.84
1.24
1.8
1.8
—
—
—
0
0
8
36
2.20
1.23
1.4
1.5
9.00
14.36
u/l
—
8
36
20
122
1.63
1.22
1.5
1.1
79.78
87.36
%
—
9
59
14
77
1.80
1.21
2.2
1.4
132.16
154.46
mmol/24h
0.82
14
77
56
422
1.32
1.20
1.4
1.3
15.58
12.05
u/ml
0.11
27
220
38
269
1.40
1.19
1.1
1.1
—
—
—
0
0
26
378
0.68
1.18
1.6
1.5
0.50
0.52
e9/l
0.17
26
378
166
1414
1.17
1.18
1.2
1.2
2.08
3.04
u/ml
0.77
102
885
148
1249
1.18
1.17
1.1
1.2
2.63
1.15
u/ml
0.66
83
732
35
245
1.42
1.17
1.9
2.1
288.07
290.96
mosm/kgh2o
0.67
29
183
100
814
1.22
1.16
1.9
2.1
9.81
5.82
iu/ml
0.37
22
176
20
124
1.60
1.16
1.4
1.1
88.78
93.07
%
—
9
59
5
20
2.48
1.13
1.2
1.3
244.20
245.80
umol/24h
—
5
20
13
72
1.79
1.11
1.1
1.1
—
—
—
0
0
10
180
0.55
1.10
4.8
5.9
6.30
8.83
%
—
10
180
10
180
0.55
1.10
2.4
2.9
47.30
43.59
%
—
10
180
952
8982
1.08
1.10
2.1
2.0
—
—
—
0
0
12
65
1.83
1.10
1.2
1.0
—
—
—
0
0
13
73
1.77
1.07
9.2
9.1
1.22
1.22
mmol/l
0.13
13
67
32
225
1.41
1.06
1.2
1.3
—
—
—
0
0
16
96
1.65
1.06
1.8
1.8
—
—
—
0
0
16
96
1.65
1.06
1.8
1.8
—
—
—
0
0
16
96
1.65
1.06
1.8
1.8
—
—
—
0
0
27
184
1.46
1.06
1.1
1.0
17.08
17.66
u/ml
0.03
14
121
30
210
1.42
1.03
1.7
1.5
—
—
—
0
0
61
477
1.27
1.03
1.6
1.6
—
—
—
0
0
69
549
1.25
1.01
1.1
1.3
42.16
5.77
u/ml
—
5
47
9
47
1.90
1.01
1.3
1.8
—
—
—
0
0
32
228
1.39
1.00
1.1
1.3
—
—
—
0
0
15
90
1.65
1.00
1.4
2.1
—
—
—
0
0
32
229
1.39
0.98
1.1
1.3
—
—
—
0
0
10
53
1.87
0.98
1.1
1.2
—
—
—
0
0
37
273
1.35
0.95
1.1
1.2
5.11
16.35
u/ml
0.63
29
210
12
69
1.72
0.93
1.1
1.1
—
—
—
0
0
9
51
1.75
0.93
4.2
2.2
99.67
98.16
g/l
—
9
51
7
37
1.87
0.92
1.6
1.2
—
—
—
0
0
10
55
1.80
0.89
1.2
1.4
9995.80
2538.72
e6/l
—
5
36
146
1265
1.15
0.88
1.1
1.2
3.08
2.79
u/ml
0.12
88
811
32
234
1.36
0.88
1.1
1.3
—
—
—
0
0
33
243
1.35
0.87
1.3
1.3
20.41
11.95
u/ml
0.24
26
187
131
1480
0.87
0.84
1.5
1.6
61.99
59.28
ug/l
0.27
131
1480
29
213
1.35
0.80
1.2
1.2
—
—
—
0
0
0
25
0.00
0.79
0.0
2.3
—
2.54
—
0
13
6
33
1.80
0.78
1.0
1.1
9.33
5.38
u/ml
—
6
33
64
760
0.83
0.77
1.8
2.0
—
—
—
0
0
33
250
1.31
0.75
9.5
5.4
6.06
6.05
pmol/l
0.00
33
250
22
157
1.39
0.73
1.5
1.1
—
—
—
0
0
11
67
1.63
0.72
8.1
9.8
1.24
1.22
mmol/l
0.37
11
61
5
25
1.98
0.72
1.4
1.3
502.60
836.01
u/l
—
5
25
12
75
1.59
0.72
1.1
1.1
—
—
—
0
0
32
244
1.30
0.71
4.2
3.3
1.00
1.00
%
0.00
27
216
614
5790
1.07
0.69
3.2
2.7
0.00
0.01
estimate
3.00
226
1701
26
193
1.34
0.69
1.1
1.1
—
27.91
—
0
11
17
118
1.43
0.66
1.1
1.1
2.57
3.20
u/ml
0.09
17
91
7
43
1.61
0.66
1.0
1.5
14.63
8.96
ug/l
—
7
43
29
222
1.30
0.64
1.1
1.3
—
—
—
0
0
14
94
1.48
0.64
1.6
2.1
21.57
17.96
nmol/l
—
7
27
41
329
1.24
0.63
4.8
4.8
23.35
13.27
u/ml
0.23
41
323
156
1703
0.90
0.63
1.7
1.7
—
—
—
0
0
43
347
1.23
0.63
1.7
2.7
—
—
—
0
0
32
250
1.27
0.61
1.1
1.3
—
—
—
0
0
14
95
1.46
0.61
1.0
1.1
0.30
0.48
u/ml
—
5
51
5
30
1.65
0.60
1.0
1.1
—
—
—
0
0
0
19
0.00
0.60
0.0
1.1
—
—
—
0
0
113
995
1.13
0.60
1.2
1.2
5.80
4.65
—
5
113
8
52
1.52
0.59
1.7
1.7
—
—
—
0
0
26
199
1.30
0.58
2.0
1.9
—
—
—
0
0
26
201
1.28
0.55
1.6
1.6
—
—
—
0
0
18
132
1.35
0.54
1.3
1.2
—
—
—
0
0
9
60
1.49
0.54
2.0
1.7
—
—
—
0
0
6
38
1.56
0.53
1.0
1.2
—
—
—
0
0
29
229
1.26
0.53
2.2
1.6
8157.38
13060.30
e6/l
0.46
21
164
13
90
1.43
0.53
1.0
1.0
—
—
—
0
0
9
63
1.41
0.51
2.3
2.0
—
—
—
0
0
9
63
1.41
0.51
2.3
2.0
—
—
—
0
0
9
63
1.41
0.51
2.3
2.0
—
—
—
0
0
9
63
1.41
0.51
2.3
2.0
—
—
—
0
0
14
99
1.40
0.51
2.8
1.4
—
—
—
0
0
1938
18971
1.06
0.50
4.4
4.0
—
—
—
0
0
347
3615
0.94
0.48
1.6
1.6
1108.91
971.31
mu/l
1.42
304
3190
13
92
1.40
0.48
2.7
2.2
—
—
—
0
0
7
46
1.51
0.48
1.3
1.3
—
22.86
—
0
7
14
101
1.37
0.47
2.0
1.6
—
—
—
0
0
59
508
1.15
0.46
2.4
2.1
—
—
—
0
0
15
110
1.35
0.46
1.0
1.1
1.76
4.86
u/ml
—
6
54
31
252
1.22
0.46
1.8
1.8
—
—
—
0
0
11
76
1.43
0.46
1.1
1.1
—
—
—
0
0
11
76
1.43
0.46
1.1
1.1
—
—
—
0
0
113
1225
0.91
0.44
1.8
2.0
—
—
—
0
0
9
126
0.71
0.43
1.8
1.5
4.77
5.19
mmol/l
—
9
121
39
327
1.18
0.43
1.5
1.5
—
—
—
0
0
9
129
0.69
0.43
1.2
1.2
9.44
7.81
mm/h
—
9
129
8
55
1.44
0.42
1.1
1.1
—
—
—
0
0
6
93
0.64
0.42
3.5
3.2
29.93
24.30
u/ml
—
6
93
24
192
1.24
0.41
1.3
1.3
—
—
—
0
0
8
58
1.37
0.41
1.0
1.1
—
—
—
0
0
8
60
1.32
0.39
1.4
2.9
1.76
1.80
ratio
—
8
55
9
66
1.35
0.38
2.0
1.7
—
—
—
0
0
200
1863
1.07
0.37
1.3
1.3
—
—
—
0
0
9
68
1.31
0.37
2.0
1.7
—
—
—
0
0
6
41
1.45
0.36
1.0
1.3
—
—
—
0
0
5
75
0.66
0.35
1.0
1.2
—
—
—
0
0
13
98
1.31
0.35
1.8
1.2
106.54
70.70
umol/l
0.36
13
98
48
419
1.14
0.34
1.1
1.3
—
—
—
0
0
18
143
1.25
0.34
1.1
1.1
1.03
1.08
u/l
—
8
59
6
44
1.35
0.34
2.2
2.2
—
—
—
0
0
6
44
1.35
0.34
2.2
2.2
—
—
—
0
0
28
236
1.18
0.31
1.6
2.4
27.33
2.73
u/ml
—
7
105
76
821
0.91
0.31
1.0
1.1
2.64
8.11
eliau/ml
—
9
110
7
52
1.33
0.31
1.3
1.4
—
—
—
0
0
223
2313
0.95
0.30
1.4
1.4
—
—
—
0
0
7
53
1.31
0.30
1.7
2.6
—
—
—
0
0
78
708
1.09
0.30
2.2
2.0
0.49
0.66
ug/l
1.55
39
260
17
137
1.23
0.29
1.5
1.6
—
—
—
0
0
7
55
1.26
0.29
1.1
1.1
—
—
—
0
0
8
106
0.75
0.29
1.3
1.3
—
39.14
—
0
7
82
753
1.08
0.25
1.1
1.1
21.00
18.08
au/ml
—
7
150
32
280
1.13
0.24
1.1
1.0
6.92
7.22
kpa
0.32
22
245
46
501
0.91
0.24
1.0
1.1
2.83
3.58
eliau/ml
—
10
208
116
1086
1.06
0.22
1.3
1.3
—
—
—
0
0
16
133
1.19
0.22
2.5
3.1
47.22
203.08
ug/l
0.41
16
117
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
12
97
1.22
0.21
2.8
2.5
2.68
2.31
nmol/l
0.12
12
92
12
97
1.22
0.21
1.3
1.1
—
—
—
0
0
0
13
0.00
0.20
0.0
1.1
—
0.32
—
0
5
6
48
1.24
0.20
2.2
2.1
—
—
—
0
0
12
142
0.84
0.19
1.3
1.3
82.00
73.79
ug/l
0.16
12
142
108
1016
1.05
0.19
1.4
1.4
—
—
—
0
0
31
277
1.11
0.18
1.1
1.0
3.30
3.29
kpa
0.01
21
242
50
461
1.07
0.16
2.3
2.0
—
—
—
0
0
31
280
1.10
0.15
1.1
1.0
-2.91
-1.90
mmol/l
—
7
57
36
328
1.09
0.15
1.2
1.2
—
—
—
0
0
21
231
0.90
0.14
1.1
1.5
—
146.92
—
0
13
34
364
0.92
0.14
1.1
1.1
14.87
15.69
u/ml
—
9
114
19
209
0.90
0.13
3.6
5.9
10.41
9.50
mg/l
0.23
14
173
53
495
1.06
0.13
3.2
3.9
2.55
6.17
ug/l
2.14
34
321
72
681
1.05
0.12
1.7
1.6
—
—
—
0
0
14
123
1.13
0.11
1.0
1.1
189.64
218.59
iu/ml
0.17
14
123
81
831
0.96
0.10
1.4
1.3
—
—
—
0
0
11
123
0.88
0.09
1.3
1.3
—
58.58
—
0
12
5
61
0.81
0.08
3.6
7.9
—
—
—
0
0
59
606
0.96
0.08
1.2
1.2
—
—
—
0
0
28
261
1.06
0.07
1.1
1.3
—
43.50
—
0
10
179
1740
1.02
0.07
1.5
1.5
—
—
—
0
0
9
85
1.05
0.07
1.4
2.2
108.00
106.09
mmol/l
—
9
85
13
117
1.10
0.06
1.1
1.2
0.54
1.16
u/ml
0.32
13
117
24
224
1.06
0.06
1.9
6.7
5.63
6.34
mmol/l
1.02
16
184
183
1788
1.01
0.05
1.5
1.5
0.96
0.94
ratio
0.30
113
1061
183
1788
1.01
0.05
1.5
1.5
1.28
1.19
ratio
0.50
113
1073
182
1781
1.01
0.04
1.5
1.5
1.16
1.16
ratio
0.04
112
1054
34
347
0.97
0.03
1.0
1.0
9.09
8.66
mu/l
0.16
27
306
81
811
0.99
0.02
1.7
1.5
0.01
0.13
iu/ml
0.93
15
150
195
1918
1.01
0.01
1.5
1.5
62.22
61.53
ug/l
0.06
169
1663
14
143
0.97
0.00
1.1
1.1
29.83
34.85
iu/ml
0.22
14
143
36
357
1.00
0.00
3.0
2.9
18.60
24.37
mg/l
0.68
24
234
19
186
1.01
0.00
1.1
1.1
1823.16
1430.48
miu/ml
0.68
19
186
39
383
1.01
0.00
1.1
1.1
1.97
6.27
iu/ml
—
7
81
14
140
0.99
0.00
2.4
3.8
—
—
—
0
0
14
140
0.99
0.00
2.4
3.8
—
—
—
0
0
10
102
0.97
0.00
1.2
1.6
—
79.42
%
—
0
12
56
555
1.00
0.00
1.1
1.1
2.68
2.40
—
5
67
113
1114
1.00
0.00
1.3
1.3
—
—
—
0
0
12
123
0.96
0.00
1.1
1.2
—
—
—
0
0
7
71
0.98
0.00
1.1
1.1
—
—
—
0
0
6
63
0.94
-0.00
1.0
1.1
0.97
1.30
mom
—
6
63
8
81
0.98
-0.00
1.5
2.3
1.22
1.19
mmol/l
—
8
81
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
4.4
—
0.29
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
387.17
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
8
80
0.99
-0.00
1.4
1.3
164.25
186.84
u/l
—
8
80
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_CHILDOTH – Other disorders starting during childhood or adolescence
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).